Chargemaster
Please note that due to the amount of information contained in the table below, this page may take longer to load than usual.
Disclaimer and explanation for standard hospital charge
Refugio County Memorial Hospital determines the standard charges for patient services with the use of a chargemaster. The chargemaster is a comprehensive list of charges for the components of patient care that go into every patient’s bill. These are the baseline rates for services provided by RCMH.
The concept of a chargemaster is similar to the manufacturer’s suggested retail price (MSRP) on a vehicle. It is the base price of each service performed and supplies used that are associated with the individual patient’s treatment. Updates are periodically made to the chargemaster to accurately reflect the hospital’s expenses to operate.
The standard charges shown below do not necessarily reflect what a patient may pay. Government insurance plans such as Medicare and Medicaid do not pay the chargemaster rates; they have their own set rates which hospitals are obligated to accept. Commercial insurance payments are based on contract negotiations with managed care payors and may or may not reflect the standard charges. Patients without commercial insurance or who are not covered by a government health care plan should contact the hospital prior to a procedure to discuss charges, alternative pricing, and payment terms.
DESCRIPTION | Chargemaster Item | CPT | HCPCS | Revenue Code | Price |
---|---|---|---|---|---|
80165 CPL | 42180165 | 80165 | 300 | 0 | |
81376 CPL | 42181376 | 81376 | 300 | 0 | |
82746 CPL | 42182746 | 82746 | 300 | 0 | |
82784 CPL | 42182784 | 82784 | 300 | 61.75 | |
83002 CPL | 42183002 | 83002 | 300 | 0 | |
83516 CPL | 42183516 | 83516 | 300 | 0 | |
83520 CPL | 42183520 | 83520 | 300 | 0 | |
83883 CPL | 42183883 | 83883 | 300 | 150.25 | |
84156 CPL | 42184156 | 84156 | 300 | 0 | |
84165 CPL | 42184165 | 84165 | 300 | 57.75 | |
84436 CPL | 42184436 | 84436 | 300 | 0 | |
84439 CPL | 42184439 | 84439 | 300 | 0 | |
84479 CPL | 42184479 | 84479 | 300 | 0 | |
85014 CPL | 42185014 | 85014 | 300 | 0 | |
85306 CPL | 42185306 | 85306 | 300 | 0 | |
85610 CPL | 42185610 | 85610 | 300 | 0 | |
85613 CPL | 42185613 | 85613 | 300 | 0 | |
85730 CPL | 42185730 | 85730 | 300 | 0 | |
86038 CPL | 42186038 | 86038 | 300 | 0 | |
86039 CPL | 42186039 | 86039 | 300 | 0 | |
86146 CPL | 42186146 | 86146 | 300 | 0 | |
86160 CPL | 42186160 | 86160 | 300 | 0 | |
86225 CPL | 42186225 | 86225 | 300 | 0 | |
86235 CPL | 42186235 | 86235 | 300 | 0 | |
86255 CPL | 42186255 | 86255 | 300 | 0 | |
86256 CPL | 42186256 | 86256 | 300 | 0 | |
86325 CPL | 42186325 | 86325 | 300 | 0 | |
86334 CPL | 42186334 | 86334 | 300 | 251 | |
86355 CPL | 42186355 | 86355 | 300 | 0 | |
86357 CPL | 42186357 | 86357 | 300 | 0 | |
86359 CPL | 42186359 | 86359 | 302 | 0 | |
86376 CPL | 42186376 | 86376 | 300 | 0 | |
86431 CPL | 42186431 | 86431 | 300 | 0 | |
86658 CPL | 42186658 | 86658 | 300 | 0 | |
86668 CPL | 42186668 | 86668 | 300 | 0 | |
86738 CPL | 42186738 | 86738 | 300 | 0 | |
86787 CPL | 42186787 | 86787 | 300 | 0 | |
87075 CPL | 42187075 | 87075 | 300 | 0 | |
87076 CPL | 42187076 | 87076 | 300 | 0 | |
87186 CPL | 42187186 | 87186 | 300 | 0 | |
87253 CPL | 42187253 | 87253 | 300 | 0 | |
87591 CPL | 42187591 | 87591 | 300 | 305 | |
ABORh. | 4220023 | 86901 | 390 | 90.25 | |
Body Fluid Cell Count 4 | 4200107 | 89051 | 309 | 65 | |
CSF Cell Count 6 | 4200299 | 89051 | 301 | 65 | |
RBC IRRADIATION | 4220043 | 86945 | 390 | 137.25 | |
Venipuncture Charge | VENI | 36415 | 300 | 27 | |
Hospital Admission Typically 30 Min - Clinic MD | |||||
Hospital Admission Typically 50 Min - Clinic MD | |||||
Hospital Admission Typically 70 Min - Clinic MD | |||||
Hospital Admit & Discharge - Clinic MD | |||||
Hospital Admit to Disc Brief - Clinic MD | |||||
Hospital Admit to Discharge COMP - Clinic MD | |||||
Hospital Discharge 30 Min or Less - Clinic MD | |||||
Hospital Discharge More than 30 Min - Clinic MD | |||||
Hospital Visit Typically 15 Min - Clinic MD | |||||
Hospital Visit Typically 25 Min - Clinic MD | |||||
Hospital Visit Typically 35 Min - Clinic MD | |||||
OBSERVATION Admit to Disc Brief - Clinic MD | |||||
OBSERVATION Admit to Disc Moderate - Clinic MD | |||||
OBSERVATION Admit to Discharge COMP - Clinic MD | |||||
OPO Discharge - Clinic MD | |||||
ObservationFirst Hour Charge | |||||
Outpatient Observation Typically 30 Min - Clinic MD | |||||
Outpatient Observation Typically 50 Min - Clinic MD | |||||
Outpatient Observation Typically 70 Min - Clinic MD | |||||
SWINGBED Admit Brief -Typically 25 Min - Clinic MD | |||||
SWINGBED Admit Complex - Typically 45 Min - Clinic MD | |||||
SWINGBED Admit Moderate - Typically 35 Min - Clinic MD | |||||
SWINGBED Discharge - 30 Minutes or Less - Clinic MD | |||||
SWINGBED Discharge - > 30 Minutes - Complex - Clinic MD | |||||
SWINGBED Sub Visit - Typically 10 Min - Clinic MD | |||||
SWINGBED Visit Complex - Typically 35 Min - Clinic MD | |||||
SWINGBED Visit Expanded - Typically 15 Min - Clinic MD | |||||
SWINGBED visit Sign Comp - Typically 25 Min - Clinic MD | |||||
ANES VASECTOMY 00921 | 4550921 | 921 | 173 | ||
ANESTHESIA CVPLINE INSERT | 4550532 | ||||
ANESTHESIA CVPLINE INSERT | 4550532 | ||||
37 degrees Celsius | 4220021 | 86921 | 302 | 305 | |
ABO | 4220015 | 86900 | 390 | 78.5 | |
ABO/Rh Interp | |||||
ABO/Rh. | |||||
ABO/Rh. Neonatal | |||||
ABORh | |||||
ABORh Newborn Interp | |||||
ABORh Retype | |||||
ABORh. | 4220015 | 86900 | 390 | 78.5 | |
AFFP CP2D Thawed | |||||
Anti-Human Globulin | 4220013 | 86922 | 302 | 247.25 | |
Antibody Screen Tube | 4220035 | 86850 | 302 | 143 | |
Aph ARBC ACDA AS3 LR Irr 1 | |||||
Aph FFP ACDA | |||||
Aph FFP ACDA Dv Thawed | |||||
Aph FFP ACDA RT<=24h | |||||
Aph FFP ACDA RT<=24h 1st Cont. | |||||
Aph FFP ACDA RT<=24h 2nd Cont. | |||||
Aph FFP ACDA RT<=24h 3rd Cont. | |||||
Aph FFP ACDA Thawed | |||||
Aph FFP CP2D | |||||
Aph FFP CP2D Thawed | |||||
Aph FFP Thawed ACDA RT<=24h | |||||
Aph FFP Thawed ACDA RT<=24h Div | |||||
Aph Plasma ACDA <-18C Frz <24h 1 | |||||
Aph Plasma ACDA <24 Hrs Thawed | |||||
Aph Plasma ACDA <24 Hrs Thawed Dv | |||||
Aph Plt ACDA | |||||
Aph Plt ACDA 1 | |||||
Aph Plt ACDA 2 | |||||
Aph Plt ACDA 3 | |||||
Aph Plt ACDA Irr | |||||
Aph Plt ACDA Irr 1 | |||||
Aph Plt ACDA Irr 2 | |||||
Aph Plt ACDA Irr 3 | |||||
Aph Plt ACDA Irr Var Con | |||||
Aph Plt ACDA Irr Var Con 1 | |||||
Aph Plt ACDA Irr Var Con 2 | |||||
Aph Plt ACDA LR | 4220036 | P9035 | 390 | 834.5 | |
Aph Plt ACDA LR 1 | 4220037 | P9036 | 390 | 834.5 | |
Aph Plt ACDA LR 2 | |||||
Aph Plt ACDA LR 3 | 4220038 | P9035 | 390 | 834.5 | |
Aph Plt ACDA LR <3 X log 11 | |||||
Aph Plt ACDA LR Irr | |||||
Aph Plt ACDA LR Irr 1 | |||||
Aph Plt ACDA LR Irr 2 | |||||
Aph Plt ACDA LR Irr 3 | |||||
Aph Plt ACDA LR Irr <3 X log 11 2 | |||||
Aph Plt ACDA LR Irr Var Con | |||||
Aph Plt ACDA LR Irr Var Con 3 | |||||
Aph Plt ACDA LR Var Con 1 | |||||
Aph Plt ACDA LR Var Con 2 | |||||
Aph Plt ACDA LR Var Con 3 | |||||
Aph Plt ACDA PASC LR IRR Var Con | |||||
Aph Plt ACDA PASC LR Irr | |||||
Aph Plt ACDA PASC LR Irr Cnt 1 | |||||
Aph Plt ACDA PASC LR Irr Cnt 2 | |||||
Aph Plt ACDA PASC LR Irr Cnt 3 | |||||
Aph Plt ACDA Var Con | |||||
Aph Plt ACDA Var Con 1 | |||||
Aph Plt ACDA Var Con 2 | |||||
Aph RBC ACDA AS1 LR | |||||
Aph RBC ACDA AS1 LR 1 | |||||
Aph RBC ACDA AS1 LR 2 | |||||
Aph RBC ACDA AS1 LR Irr | |||||
Aph RBC ACDA AS1 LR Irr 1 | |||||
Aph RBC ACDA AS1 LR Irr 2 | |||||
Aph RBC ACDA AS3 LR | 4220003 | P9016 | 390 | 453 | |
Aph RBC ACDA AS3 LR 1 | 4220003 | P9016 | 390 | 453 | |
Aph RBC ACDA AS3 LR 2 | 4220003 | P9016 | 390 | 453 | |
Aph RBC ACDA AS3 LR Irr | |||||
Aph RBC ACDA AS3 LR Irr 1 | |||||
Aph RBC ACDA AS3 LR Irr 2 | |||||
Aph RBC CP2D AS3 LR 1 | 4220003 | P9016 | 390 | 453 | |
Aph RBC CP2D AS3 LR 2 | 4220003 | P9035 | 390 | 453 | |
Aph RBC CP2D AS3 LR Irr | |||||
Aph RBC CP2D AS3 LR Irr 1 | |||||
Aph RBC CP2D AS3 LR Irr 2 | |||||
Auto Aph FFP Thawed ACDA RT<=24h | |||||
Auto Aph FFP Thawed ACDA RT<=24h Div | |||||
Bill Only ABO/Rh | |||||
Bill Only Unit Confirmation | |||||
Bill Ref ABO/RH | |||||
Bill Ref Ab Elution/Panel | |||||
Bill Ref Cell Pretreatment | |||||
Cord ABO/Rh | |||||
Cord Blood | |||||
Cord Blood. | |||||
Crossmatch Tube | |||||
Cryo AHF | |||||
Cryo Pooled | |||||
Dir Aph FFP Thawed ACDA RT<=24h | |||||
Dir Aph FFP Thawed ACDA RT<=24h Div | |||||
Direct Antiglobulin Test | 4220033 | 86880 | 302 | 121.5 | |
Direct Antiglobulin Test 2 | 4220034 | 86880 | 302 | 121.5 | |
FFP CPD | |||||
FFP CPDA1 | |||||
FFP Thawed CP2D | |||||
FFP Thawed CP2D Dv | |||||
FFP Thawed CPD | |||||
FFP Thawed CPD Dv | |||||
FFP Thawed CPDA1 | |||||
FFP Thawed CPDA1 Dv | |||||
Frz Plasma CPD Frozen<=24h | |||||
Immediate Spin | 4220021 | 86920 | 302 | 324.25 | |
Newborn ABORh | |||||
Plasma CPD Cryo Red | |||||
Plasma CPD Cryo Red Thawed | |||||
Plasma Thawed CP2D | |||||
Plasma Thawed CP2D <24 Hrs | |||||
Plasma Thawed CPD | |||||
Pooled Cryo <18C 5 units | |||||
Pooled Cryo AHF Thawed | |||||
Pooled Plts CP2D LR IRR BacT | |||||
Post TR ABORh | |||||
Post-Transfusion Reaction ABO/Rh | |||||
Pre TR ABORh | |||||
Pre-Transfusion Reaction ABO/Rh | |||||
RBC CP2D 450 LR | |||||
RBC CP2D AS3 500 Irr | |||||
RBC CP2D AS3 500 LR | 4220003 | P9016 | 390 | 453 | |
RBC CP2D AS3 500 LR Irr | 4220009 | P9021 | 390 | 285 | |
RBC CP2D AS3 500 LR Irr DV | |||||
RBC CPD 500 LR Irr | |||||
RBC CPD AS1 500 Irr | |||||
RBC CPD AS1 500 LR | 4220003 | P9016 | 390 | 453 | |
RBC CPD AS1 500 LR Irr | |||||
RBC CPD AS1 500 LR Irr | |||||
RBC CPD AS1 500 LR Irr Dv | |||||
RBC CPD AS5 500 Irr | |||||
RBC CPD AS5 500 LR | |||||
RBC CPD AS5 500 LR Irr | |||||
RBC CPDA1 500 Irr | |||||
RBC CPDA1 500 LR Irr | |||||
RBC CPDA1 500 LR Irr Dv | |||||
REF Antibody Screen | 4210628 | 86885 | 302 | 27.5 | |
REF Phenotype | |||||
RHIG | |||||
Reference ABO/Rh | |||||
Rhogam Info | |||||
Rhogam Request | |||||
Thawed Aph FFP ACDA 200-400 mL | |||||
Thawed Aph FFP ACDA <200 mL | |||||
Thawed Aph FFP ACDA RT<=24h 1st Cont. | |||||
Thawed Aph FFP ACDA RT<=24h 2nd Cont. | |||||
Thawed Aph FFP ACDA RT<=24h 3rd Cont. | |||||
Thawed Aph Plasma ACDA <24H Frz <24H 4 | |||||
Thawed Aph Plasma ACDA Frz <24h 1 | |||||
Thawed Aph Plasma ACDA Frz <24h 2 | |||||
Thawed Cryo AHF | |||||
Thawed Plasma CP2D Cryo Red | |||||
Thawed Plasma CPD <24h | |||||
Thawed Plasma CPDA1 <24h | |||||
Thawed Pooled Cryo | |||||
Thawed Pooled Cryo Open 10 units | |||||
Thawed Pooled Cryo Open 5 units | |||||
Type and Cross Lab Only | |||||
Type and Screen RMH | |||||
Undocumented Mother ABO-Rh | |||||
Unit ABO/Rh | |||||
Abd paracentesis w/o imaging guidance | |||||
Ambulatory Blood Pressure Monitor [MDMH] | |||||
BILL BH1102 | |||||
BILL BH1116 | |||||
BILL BH1123 | |||||
BILL BH1130 | |||||
BILL BH1136 | |||||
BILL BH1143 | |||||
BILL BH1147 | |||||
BILL BH1154 | |||||
BILL BH1167 | |||||
BILL BH1206 | |||||
BILL BH1276 | |||||
BILL BH421 | |||||
BILL BH647 | |||||
BILL BH692 | |||||
BILL BH743 | |||||
BILL BH765 | |||||
BILL BH814 | |||||
BILL BH825 | |||||
BILL BH839 | |||||
BILL BH888 | |||||
BILL BH939 | |||||
COLOR FLOW DOPP [MDMH] | |||||
Cardiac Doppler, Limited [MDMH] | |||||
Complete bil noninvasive Doppler, 3 or more levels w/exercise | |||||
DOPPLER, COMPLETE [MDMH] | |||||
Duplex Scan Lower Extremity Arteries or Arterial Bypass Grafts, Complete Bilateral Charge | |||||
EKG 12 Lead, Interp/Report Only Charge | |||||
EKG 12 Lead, w/Interp/Report | |||||
EKG Rhythm, 1-3 Leads Interp/Report Charge | |||||
EKG Task | |||||
EKG performed as a screening for IPPE TC/PC global | |||||
Echocardiogram, Complete [MDMH] | |||||
Echocardiogram, Complete, with bubble study [MDHM] | |||||
Echocardiogram, Limited [MDMH] | |||||
Echocardiogram, Limited, with bubble study [MDMH] | |||||
Electrocardiogram OPD | |||||
Electrocardiogram Stress Exercise [MDMH] | |||||
Electrocardiogram [MDMH] | |||||
Electrocardiogram [MDMH] BCE | |||||
Event Monitor, up to 30 days [MDMH] | |||||
Extremity Artery Study, Single Charge | |||||
Holter 48 | |||||
Holter Interp [MDMH] BCE | |||||
Holter Monitor 24 hr [MDMH] | |||||
Holter Monitor 24hr | |||||
Holter Monitor 48 hr [MDMH] | |||||
Limited Echo, IHI | |||||
Limited Stress Echo Interp [MDMH] BCE | |||||
Pulmonary Stress Testing; Simple (Eg, Prolonged Exercise Test For Bronchospasm) | |||||
RT Holter Monitor 24hr - MS TECH CHARGE CADDO | |||||
Stress Echo Interp [MDMH] BCE | |||||
Stress Echo, Dobutamine, IHI | |||||
Stress Echo, Dobutamine, IHI | |||||
Stress Echo, Exercise, IHI | |||||
Stress Echo, Exercise, IHI | |||||
Stress Echocardiogram, Dobutamine [MDMH] | |||||
Stress Echocardiogram, Exercise, Treadmill [MDMH] | |||||
Stress Echocardiogram, Limited [MDHM] | |||||
Stress Echocardiogram, Limited, Dobutamine [MDMH] | |||||
Stress Test Interp [MDMH] BCE | |||||
zzzElectrocardiogram, ER, Uninterpreted | |||||
90460 Immunization administration | 4920905 | 90471 | G0008 | ||
90471 Flu Adminstration for Medicaid | 4920955 | 90471 | |||
90471 Immunization administration; 1 vaccine | 4920905 | 90471 | G0008 | 40.75 | |
90473 Immunization administration, oral | 4920909 | 90473 | |||
96372 Therapeutic; prophylactic, or diagnostic injection, subcutaneous or intramuscular | 4920017 | 96372 | |||
96402 Therapeutic, prophylactic, or diagnostic injection, subcutaneous or intramuscular | |||||
Drugs unclassified injection | 4920725 | J3490 | |||
Each additional vaccine | 4920907 | 90472 | |||
Eligard/ Leuprolide acetate suspnsion PER 7.5 MG | 4920587 | J9217 | |||
Japanese Encephalitits Vaccine Inactivated IM TechFee Med | |||||
Orphenadrine injection | 4920679 | J2360 | |||
Synvisc per 1 mg | 4920553 | J7325 | |||
VFC Immunization administration ea add'l vaccine | |||||
VFC Immunization adminstration 1 vaccine | |||||
IV Injection, add new drug THERAPEUTIC OR DIAGNOSTIC | 3100023 | 96375 | 260 | 264 | |
IV Push, add same drug | 3600329 | 96376 | 260 | 208 | |
IVP INJECTION therapeutic or diagnostic ER | 3500315 | 96374 | 260 | 264 | |
96365 - IV TX, FIRST HOUR | 3100005 | 96365 | 260 | 450.5 | |
96366 - IV TX, EACH ADDITIONAL HOUR/CRITICAL CARE | 3100007 | 96366 | 260 | 336.75 | |
99284 - ED Level 4 | 3600069 | 99284 | 450 | 869.75 | |
99285 - ED Level 5 | 3600071 | 99285 | 450 | 963.75 | |
CRITICAL CARE 1ST HOUR hosp tech | 3600053 | 99291 | 450 | 2340 | |
Critical Care, each 30 min | 3600056 | 99292 | 450 | 963 | |
DCP_GENERIC | |||||
ED Level 1 | 3600063 | 99281 | 450 | 305.75 | |
ED Level 2 | 3600065 | 99282 | 450 | 357.5 | |
ED Level 3 | 3600067 | 99283 | 450 | 583.5 | |
HYDRATION, FIRST HOUR | 3100019 | 96360 | 260 | 450.5 | |
IV THERAPY HYDRATION, EACH ADDITIONAL HOUR | 3100021 | 96361 | 260 | 336.75 | |
IV tx, sequential infusion | 3100041 | 96367 | 260 | 336.75 | |
ZZZ96368 - IV tx, concurrent infusion | 3100043 | 96368 | 260 | 85.5 | |
ZZZ96373 - Intra-Arterial injection | |||||
zzz96372 - Subq/IM Injection | 3100009 | 96372 | 260 | 97 | |
Application Of A Modality To One Or More Areas; Ultrasound, Each 15 Minutes | |||||
Colposcopy of the cervix w/endocervical curettage | |||||
Colposcopy of the vulva with bx | |||||
Echo guide for biopsy | |||||
Electrocardiographic Monitoring For 24 Hours By cont Original Ecg Waveform Record & Storage | |||||
Endocervical curettage (not done with D&C) | |||||
Esophageal Manometry with Impedance | |||||
Fetal biophys profil w/o nst | |||||
Fetal biophys profil w/o nst Interp | |||||
Fetal contract stress test | |||||
Fetal contract stress test tech. | |||||
Middle cerebral artery echo | |||||
OB US fetal & maternal eval plus detailed fetal anatomic exam, transabdominal | |||||
Ob us < 14 wks single fetus | |||||
Ob us >/= 14 wks addl fetus | |||||
Ob us >/= 14 wks addl fetus Tran. | |||||
Ob us >/= 14 wks addl fetus Tran | |||||
Ob us >/= 14 wks sngl fetus | |||||
Ob us >/= 14 wks sngl fetus interp | |||||
Ob us follow-up per fetus | |||||
Ob us follow-up per fetus Interp | |||||
Ob us limited fetus(s) | |||||
Ob us limited fetus(s) Interp | |||||
Transvaginal us non-ob | |||||
Transvaginal us non-ob Interp | |||||
Transvaginal us obstetric | |||||
Transvaginal us obstetric Complete | |||||
Transvaginal us obstetric Interp | |||||
US pregnant follow up transabdominal | |||||
US pregnant transabdominal limited | |||||
Us exam abdom complete | |||||
Us exam abdom complete Tech | |||||
Us exam breast(s) | |||||
Vascular flow imaging | |||||
Cerumen removal with Instrumentation | |||||
99284 Level 4 Lynx Visit Level - BO | |||||
ABG Draw ER Charge | |||||
ANOSCOPY DIAGNOSTIC ER | 3610001 | ||||
Abd paracentesis w/o imaging guidance | |||||
BCE 99281 - Level 1 | |||||
BCE 99282 - Level 2 | |||||
BCE 99283 - Level 3 | |||||
BCE 99284 - Level 4 | |||||
BCE 99285 - Level 5 | |||||
BCE 99291 - Critical Care | |||||
Cardiopulmonary Resuscitation ER Charge | |||||
Cardioversion elective external | |||||
Closed Treatment of Radial Head or Neck Fracture with manipulation | |||||
Closed Trtmt of Proximal Humeral (Surgical or Anatomical Neck) Fx; w/o Manipulation Charge | |||||
Closed tx of supracondylar/transcondylar humeral fx w/manipulation | |||||
Closed tx shoulder dislocation w/ fx of greater humeral tuberostity w/ manipulation | |||||
Closure laceration vestibule of mouth 2.5 cm or less | |||||
Emergency Department Visit Level 2 - 99282 | |||||
Gastric Intubation/Aspiration/Tube Lavage Charge | |||||
I & D ABSCESS SIMP/S | |||||
Injection cervical or thoracic | |||||
Insert Straight Catheter Tech Chg | |||||
Irrigation of implanted venous access device (Port Flush) | |||||
Lumbar Puncture Charge | |||||
PNEUMONIA ADMINISTRATION | 4920237 | 90472 | G0009 | 771 | 103.5 |
Placement of needle for intraosseous infusion | |||||
Stapping Knee | |||||
TRANSVENOUS PACING TEMP | 3600009 | 92953 | 480 | 1212 | |
TRAUMA ACTIVATE < 30 MIN | 3600331 | 99291 | 684 | 1205.25 | |
TRAUMA ACTIVATION | 3600333 | G0390 | 684 | 1205.25 | |
Venous Access Cutdown > 1Year | |||||
ZZZConcurrent infusion | |||||
ZZZequential infusion up to 1 hr | |||||
closed tx of fx distal tibia w/ traction or manipulation | |||||
11760 REPAIR OF NAIL BED - ED PF | 3601176 | 11760 | 450 | 878.25 | |
12032 Repair, intermediate, wounds of scalp, axillae, trunk and/or extremities (excluding hands and feet) | 3600219 | 12032 | 450 | 679 | |
3610017 BURN DRESS/DEBRIDE MED PROFEE | 3610017 | ||||
3610021 CARDIOPULMONARY ARREST PROFEE | 3610021 | 944 | |||
3610033 CAST LEG SHORT WALK APPLY PROFEE | 3610033 | ||||
3610055 DIGITIAL BLOCK SINGLE PROFEE | 3610055 | ||||
3610067 HEMATOMA EVACUATE PROFEE | 3610067 | ||||
3610079 I&D ABSCESS COMPLICATED PROFEE | 3610079 | ||||
3610099 NERVE BLOCK INTERCOSTAL PROFEE | 3610099 | ||||
3610107 PERICARDIOCENTESIS 1ST PROFEE | 3610107 | ||||
3610109 PERICARDIOCENTESIS SUB PROFEE | 3610109 | ||||
3610115 REMOVAL FB CONJUNCTIVAL PROFEE | 3610115 | ||||
3610117 REMOVAL FB CORNEAL PROFEE | 3610117 | ||||
3610119 REMOVAL FB EXTERNAL EAR PROFEE | 3610119 | ||||
3610121 REMOVAL FB INTRANASAL PROFEE | 3610121 | ||||
3610131 RPR CMPLX SCLP ARM LEGS PROFEE | 3610131 | ||||
3610133 RPR CMPLX TONGUE PROFEE | 3610133 | ||||
3610147 RPR SMPLE SCLP NECK TRUNK PROFEE | 3610147 | 12004 | 450 | 708.5 | |
3610163 THORACENTESIS INSERT TUBE PROFEE | 3610163 | ||||
3610203 VENIPUNCTURE 3YR OR OLDER PROFEE | 3610203 | ||||
3610204 TRT PHAL SHAFT FRAC W/MAN PROFEE | 3610204 | ||||
3610221 PHY TRANSPORT 24MO OR > PROFEE | 3610221 | ||||
3610235 RPR SMPLE SCLP/NECK/TRUNK PROFEE | 3610235 | ||||
3610281 RPR SMPL EXTREMITIES PROFEE | 3610281 | ||||
3610285 RPR INTRMD FOREARM 10CM PROFEE | 3610285 | ||||
3610289 RPR CMPLX HANDS/FEET PROFEE | 3610289 | ||||
3610295 RPR EXTENSOR TENDON HAND PROFEE | 3610295 | ||||
3610305 RMV FOREIGN BODY PHARYNX PROFEE | 3610305 | ||||
3612055 TRIGGER POINT INJ 1 OR > PROFEE | 3612055 | ||||
3612393 I&D UPR ARM/ELBO DEEP ABS PROFEE | 3612393 | ||||
3615170 CHANGE CYSTOSTOMY TUBE SM PROFEE | 3615170 | ||||
4000086 Ceftriaxone (Ancef) 1gm | 4000086 | J0696 | 251 | 16.5 | |
4000254 NS 0.9% 100 ml | 4000254 | 547 | 21.5 | ||
4000255 NS 0.9% 100 ml | 4000255 | 547 | 21.5 | ||
4000257 I-Gel Alternative Airway | 4000257 | 547 | 42.75 | ||
93041 CARDIAC MONITOR-ER | |||||
96372 INJECTION FEE IM,SQ ED Charge | 3600101 | 96372 | 260 | 103.75 | |
99217 OBS DISCHARGE DAY -CCCPF | 3610253 | ||||
99218 OBS INITIAL L-1 -CCCPF | 3610265 | ||||
99219 OBS INITIAL L-2 -CCCPF | 3610267 | ||||
99220 OBS INITIAL L-3 -CCCPF | 3610269 | ||||
99281 EMERGENCY RM-LEVEL I ED Charge | 3600063 | 99281 | 450 | 327.25 | |
99282 EMERGENCY RM-LEVEL 2 ED Charge | 3600065 | 99282 | 450 | 382.5 | |
99283 EMERGENCY RM-LEVEL 3 ED Charge | 3600067 | 99283 | 450 | 624.25 | |
99284 EMERGENCY RM-LEVEL 4 ED Charge | 3600069 | 99284 | 450 | 930.25 | |
99285 EMERGENCY RM-LEVEL 5 ED Charge | 3600071 | 99285 | 450 | 1031.25 | |
99291 CRITICAL CARE ED Charge | 3600053 | 99291 | 450 | 2503.75 | |
ACENTESIS JNT INTM ProFee | 3610227 | ||||
ACENTESIS JNT MAJOR ProFee | 3610007 | ||||
ACENTESIS JNT SMALL ProFee | 3610009 | ||||
ADENOSINE 6MG IM/IV | 4000105 | 547 | 282.75 | ||
ADM IMMUN SINGLE VAC | 3600229 | 90471 | 450 | 64.25 | |
AIRWAY ORAL BLS | 4000057 | 541 | 12.75 | ||
ALBUTEROL 2.5MG INH | 4000109 | 547 | 6 | ||
ALS-1 EMERGENCY TRANSPORT | 4000019 | A0427 | 540 | 1732.75 | |
ALS-1 NONEMERGENT TRANSPR | 4000029 | A0426 | 540 | 1085.75 | |
ALS-2 EMERGENCY TRANSPORT | 4000023 | A0433 | 540 | 2315.5 | |
AMIODARONE 3ML IV | 4000107 | 547 | 114.25 | ||
AMMONIA INHALANT | 4000111 | 547 | 6 | ||
AMP FING/THB FLAP* | |||||
ANOSCOPY DIAGNOSTIC | 4920019 | 46600 | 450 | 1855 | |
APPLY SHORT ARM SPLINT PROFEE | 3610151 | ||||
ARTERIAL PUNCTURE (PRO FEE) | 3610005 | ||||
ARTERIAL PUNCTURE Charge | 3600011 | 36600 | 450 | 274 | |
ARTHROCENTISIS LG | 4920013 | 20610 | 521 | 619 | |
ARTHROCENTISIS SM | 4920015 | 20600 | 450 | 619 | |
ASPIRATE BLADDER BY NEEDL ProFee | 3610011 | ||||
ASPIRATE P-TONSILLAR ABSC | 3600261 | 42999 | 450 | 578 | |
ASPIRATE PERITONSILL ABSC ProFee | 3610225 | ||||
ASPIRATION BLADDER | 3600017 | 51100 | 450 | 1137 | |
ASPIRIN (BABY) 81MG TAB | 4000113 | 547 | 2.75 | ||
ATIVAN | 4000239 | 541 | 129.5 | ||
ATROPINE SULFATE 1MG IM | 4000115 | 547 | 38.75 | ||
AUTISM SCREENING | 4920962 | 96110 | |||
AVULSION NAIL PLATE PART | 4920023 | 11730 | 450 | 267 | |
AVULSION NAIL PLATE ProFee | 3610003 | ||||
Acetaminophen 1gm/100ml | 4000102 | 547 | 131.25 | ||
Adenosine 12mg IV | 4000104 | 547 | 282.75 | ||
Arthrocentesis major joint w/ US guidance | |||||
BANDAGE TRIANGULAR | 4000073 | 541 | 8 | ||
BLOOD TRANSFUSION > 8HR | 3600251 | 36430 | 391 | 2758.5 | |
BLS EMERGENCY TRANSPORT | 4000027 | A0429 | 540 | 1348.75 | |
BLS NONEMERGENT TRANSPORT | 4000025 | A0428 | 540 | 1032.75 | |
BONE INJ GUN ADULT ALS | 4000231 | 541 | 710.25 | ||
BONE INJ GUN PEDI ALS | 4000233 | 541 | 710.25 | ||
BURN 1ST DEGREE INITIAL | 3600021 | 16000 | 450 | 301.5 | |
BURN 1ST DEGREE INITIAL Charge | 3610015 | ||||
BURN DRESS/DEBRIDE LARGE ProFee | 3610013 | ||||
BURN DRESS/DEBRIDE LG | 3600019 | 16030 | 450 | 514.25 | |
BURN DRESS/DEBRIDE MED | 3600023 | 16025 | 450 | 440.5 | |
BURN DRESS/DEBRIDE SM | 4920035 | 16020 | 450 | 515.75 | |
BURN DRESS/DEBRIDE SMALL ProFee | 3610019 | ||||
BURN SHEET BLS | 4000061 | 541 | 72.75 | ||
Betamethasone 30mg/5ml | 4000106 | 547 | 256.5 | ||
CAMBION SHOCK ABSB GEL"" | 4000247 | L3003 | 274 | 79.5 | |
CANNULA NASAL ADULT | 4000085 | 541 | 33.75 | ||
CANNULA NASAL CHILD | 4000087 | 541 | 30 | ||
CARDIOPULMONARY ARREST | 3600029 | 92950 | 450 | 1306.25 | |
CARDIOVERSION ELECTIVE | 3600031 | 92960 | 480 | 1306.25 | |
CARDIOVERSION ELECTIVE E Charge | 3610023 | ||||
CAST ARM LONG APPLY ER Charge | 3600033 | 29065 | 450 | 511.5 | |
CAST ARM LONG SUPPLY ProFee | 3610025 | ||||
CAST ARM SHORT APPLY | 4920025 | ||||
CAST ARM SHORT APPLY ER Charge | 3600035 | 29075 | 450 | 511.5 | |
CAST LEG LONG APPLY | 3600037 | 29345 | 450 | 511.5 | |
CAST LEG LONG APPLY Prof Fee Charge | 3610029 | ||||
CAST LEG SHORT APPLY | 4920027 | ||||
CAST LEG SHORT APPLY ER Charge | 3600039 | 29405 | 450 | 511.5 | |
CAST LEG SHORT WALK APPLY | 3600041 | 29425 | 450 | 511.5 | |
CATH ASPIRATE NASOTRACH | 3600283 | 31720 | 450 | 112.5 | |
CATH NON-TUNNELED CATH | 3600253 | 36556 | 450 | 1149 | |
CATH OBTAIN SPECIMAN ONLY | 3600257 | P9612 | 300 | 181 | |
CATH TUNNELED CV ProFee | 3610273 | ||||
CATH URETHA SIMPLE | 3600043 | 51701 | 450 | 253.5 | |
CATH URETHRA SMPLE ProFee | 3610035 | ||||
CATHETER IV | 4000097 | 541 | 21.5 | ||
CEFAZOLIN 1GM VIALS | 4000191 | 547 | 11 | ||
CEFTRIAXONE 1GM | 4920649 | J0696 | 251 | 16.5 | |
CHANGE CYSTOSTOMY TUBE SM | 3605170 | 51705 | 360 | 1546.75 | |
CHANGE GASTROSTOMY TUBE CHARGE | 3610307 | ||||
CLONIDINE 0.1MG TAB | 4000193 | 547 | 6 | ||
CLOSURE OF LACERATION VESTIBULE OF MOUTH > 2.5 CM OR COMPLEX CHARGE | |||||
CLSD DISLC SHLDR W ANETH ProFee | 3610293 | ||||
CLSD TX FEMORAL FX D | |||||
CNTRL BLEED ANT CMPLX ProFee | 3610043 | ||||
CNTRL BLEED NASAL INITIAL ProFee | 3610041 | ||||
CNTRL BLEED NOSE SMPLE ProFee | 3610039 | ||||
COLLAR CERVICAL DISP BLS | 4000099 | 541 | 122.75 | ||
COLPOCENTESIS ProFee | 3610049 | ||||
COMBITUBE ESOPH TRAC AIRW | 4000227 | 541 | 131.5 | ||
CONTROL BLEED NOSE ANTER | 3600051 | 30903 | 450 | 643 | |
CONTROL BLEED NOSE POST | 3600049 | 30905 | 450 | 643 | |
CONTROL BLEED NOSE SIMPLE | 3600047 | 30901 | 450 | 643 | |
CPAP OS BRTHNG CIR/W MASK | 4000217 | A7031 | 541 | 64.25 | |
CRITICAL CARE 1ST HR ProFee | 3610045 | ||||
CRITICAL CARE ADD 30 MIN ProFee | 3610047 | ||||
CULPOCENTESIS | 3600057 | 57020 | 450 | 2607.25 | |
CV CATH NONTUNNEL > 5YR | 3600125 | 36556 | 450 | 1291.25 | |
CV CUTDOWN > AGE 2 ProFee | 3610205 | ||||
CVP PLACE > AGE 2 ProFee | 3610113 | ||||
Calcium Chloride 10% 500 | 4000108 | 547 | 25.25 | ||
Capnography ET | 4000211 | 547 | 32.75 | ||
Capnography Nasal | 4000210 | 547 | 32.75 | ||
Captopril 25mg | 4000112 | 547 | 3 | ||
D10 W 250 ml/500 ml | 4000251 | 547 | 104.25 | ||
D5LR 1000ml | 4000114 | 547 | 163.5 | ||
D5W 100ML IV | 4000117 | 547 | 124.75 | ||
D5W 250ML IV BAG | 4000205 | 547 | 118 | ||
D5W 500ML IV | 4000119 | 547 | 118 | ||
DAILY HOSP CARE LEVEL 1 ProFee | 3610051 | ||||
DEBRID SKIN/SUBCUTANEOUS ProFee | 3610277 | ||||
DEBRIDE SKIN PART THICK | 3600059 | 97597 | 450 | 514.25 | |
DEBRIDE SKIN PART THICK Charge | 3610053 | ||||
DEBRIDE SKIN/SUBCUTANEOUS | 3600279 | 11042 | 450 | 600 | |
DELIVERY OF PLACENTA ProFee | 3610334 | ||||
DELIVERY PLACENTA | 3600334 | 59414 | 450 | 1103.75 | |
DEVELOPMENTAL SCREENING | 4920961 | 96110 | |||
DEXTROSE 50% PREF 25GM IV | 4000121 | 547 | 50.75 | ||
DEXTROSE 50% VIAL 25GM IV | 4000123 | 547 | 61.25 | ||
DIAZEPAM 5MG IM/IV | 4000001 | 547 | 23 | ||
DIGITIAL BLOCK SINGLE | 4920033 | 64450 | 450 | 966.25 | |
DIPHENHYDRAMINE 50MG IM/I | 4000125 | 547 | 23 | ||
DOPAMINE 400MG/250ML IV | 4000127 | 547 | 263.75 | ||
DOS | 4000215 | 540 | 0 | ||
DRAINAGE ABSCESS/CYST HEM | 3604180 | 41800 | 450 | 853 | |
DRAINAGE ABSCESS/CYST/HEM ProFee | 3614180 | ||||
DRESSING GAUZE 2X2 BLS | 4000045 | 541 | 2.75 | ||
DRESSING GAUZE 4X4 BLS | 4000079 | 541 | 2.75 | ||
DRESSING KLING 3 BLS" | 4000047 | 541 | 9 | ||
DRESSING MULTI TRAUMA BLS | 4000049 | 541 | 50.75 | ||
DRESSING OCCLUSIVE 3X3 BL | 4000055 | 541 | 12.75 | ||
DRESSING TRAUMA LG BLS | 4000037 | 541 | 241.25 | ||
DRESSING TRAUMA MED ALS | 4000039 | 541 | 100.75 | ||
DRESSING TRAUMA SM ALS | 4000041 | 541 | 50.75 | ||
DUONEB 2.5MG INH | 4000129 | 547 | 18.25 | ||
Diltiazem (Cardizem) 25mg | 4000116 | 547 | 56.25 | ||
EASY CAP II CO2 DEFECTOR | 4000211 | 541 | 38.75 | ||
EPI 1:1000 1MG AMP IM/SC | 4000131 | 547 | 25 | ||
EPI 1:1000 30MG IV | 4000133 | 547 | 122.75 | ||
EPI 1:10000 1MG IM/IV | 4000135 | 547 | 122.75 | ||
EPI PEN AUTO INJ 0.3 | 4000043 | J0171 | 547 | 391.25 | |
ER VISIT L-1 PROF | 3610057 | ||||
ER VISIT L-2 PROF | 3610059 | 99282 | |||
ER VISIT L-3 PROF | 3610061 | ||||
ER VISIT L-4 PROF | 3610063 | ||||
ER VISIT L-5 PROF | 3610065 | ||||
ET TUBE HOLDER | 4000207 | 541 | 21.5 | ||
EX BEN LES FACE | 4920089 | 11441 | 450 | 687.75 | |
EX NAIL PART OR CMPLTE ProFee | 3610069 | ||||
EX NAIL PART OR COMPLTE | 3600077 | 11750 | 450 | 355.25 | |
EX THROMB HEMORRHOID EXT | 3600073 | 46320 | 450 | 680.5 | |
EX THROMBOSED HEMORRID EX ProFee | 3614632 | ||||
EXAM NO TRANSPORT | 4000103 | A0998 | 540 | 83.5 | |
EXAM PELVIC ProFee | 3610223 | ||||
EXAM SEXUAL ASSULT ProFee | 3610071 | ||||
EZ-IO | 4000212 | 547 | 301.75 | ||
Enoxaprin (Lovenox) 100mg | 4000020 | J1650 | 547 | 123 | |
Enoxaprin (Lovenox) 30mg | 4000015 | J1650 | 547 | 70.5 | |
Enoxaprin (Lovenox) 40mg | 4000018 | J1650 | 251 | 66 | |
FINE NEEDLE ASPIRATION CHARGE | 4921002 | 10021 | 450 | 578 | |
FINE NEEDLE ASPIRATION Charge | 3610275 | ||||
FP INJ ADM THRPTIC/PROP | 4920574 | 96372 | |||
FUROSEMIDE 20MG IM/IV | 4000003 | 547 | 9 | ||
FX BIMAL ANKLE W/MAN | |||||
FX DIST FIB W/MAN* | |||||
FX HUM SHAFT W/MANIP | |||||
FX TALUS W/MANIP | |||||
Famatodine (Pepcid) 20mg | 4000118 | 547 | 3 | ||
Fosphenoytoin (cerebyx) 500mg | 4000120 | 547 | 295.75 | ||
GASTRIC INTUBATE ProFee | 3610073 | ||||
GASTRIC INTUBATION | 3600079 | 43753 | 450 | 408.5 | |
GLUCAGON 1MG IM/IV | 4000225 | 547 | 392.75 | ||
GLUCOSE PASTE INST 30GM | 4000141 | 547 | 25 | ||
H & P L-1 ProFee | 3610237 | ||||
H & P L-2 ProFee | 3610239 | ||||
H & P L-3 ProFee | 3610241 | ||||
H&P L-1 | 4920403 | 99221 | |||
H&P L-2 | 4920405 | 99222 | |||
H&P L-3 | 4920407 | 99223 | |||
HEMATOMA EVACUATE | 3600075 | 11740 | 450 | 680.5 | |
HEMORRHOIDECTOM EXT CMPL ProFee | 3610309 | ||||
HEMORRHOIDECTOMY 2+ COL | 3600317 | 46250 | 450 | 2581.75 | |
HHN INHALATION TRMT | 4920821 | 94640 | 410 | 174.5 | |
HOSP CARE DAILY L-1 | 4920409 | 99231 | |||
HOSP CARE DAILY L-1 ProFee | 3610243 | ||||
HOSP CARE DAILY L-2 | 4920411 | 99232 | |||
HOSP CARE DAILY L-2 ProFee | 3610245 | ||||
HOSP CARE DAILY L-3 | 4920413 | 99233 | |||
HOSP CARE DAILY L-3 ProFee | 3610247 | ||||
HOSP DISCHG 30MIN OR < ProFee | 3610249 | ||||
HOSP DISCHG 30MIN OR > ProFee | 3610251 | ||||
HOSP DISCHG DAY 30MIN < | 4920415 | 99238 | |||
HOSP DISCHG DAY 30MIN > | 4920417 | 99239 | |||
Haloperidol 5mg/1ml | 4000122 | 547 | 53.25 | ||
I&D ABCESS SIMPLE ProFee | 3610081 | ||||
I&D ABSCESS BARTHOLINS ProFee | 3610085 | ||||
I&D ABSCESS CMPLCTD/MULTI | 4920419 | 10061 | |||
I&D ABSCESS PERIRECTAL | 3600083 | 46040 | 450 | 680.5 | |
I&D ABSCESS PERIRECTAL ProFee | 3610083 | ||||
I&D ABSCESS SMPL/SNGL | 3620421 | 10060 | 450 | 585 | |
I&D BARTHOLINS ABSCESS | 3600089 | 56420 | 450 | 760 | |
I&D COPLX,PSTOP WOUND INF | 3601018 | 10180 | 360 | 1246.25 | |
I&D FINGER ABCESS/SMPL | 3602601 | 26010 | 450 | 859.5 | |
I&D FINGER ABSCESS/SMPL ProFee | 3612601 | ||||
I&D FNGR ABSCESS; SMPL | 4920507 | 26010 | |||
I&D FURUNCLE SIMPLE | 3600091 | 10060 | 450 | 585 | |
I&D HEMATOMA | 3600093 | 10140 | 450 | 1071 | |
I&D HEMATOMA ED Charge | 3610087 | ||||
I&D OF VULVA | 3600323 | 56405 | 450 | 1033.5 | |
I&D PARONYCHIA | 3600095 | 10060 | 450 | 585 | |
I&D PILONIDAL CYST SIMPLE | 3600097 | 10080 | 450 | 593.25 | |
I&D PILONIDAN CYST ProFee | 3610089 | ||||
I&D RMVE FB SUBQ SMPLE ProFee | 3610091 | ||||
I&D UPR ARM/ELBO DEEP ABS | 3602393 | 23930 | 450 | 1890.5 | |
I&R FB SUBQ COMPLICATED | 3600081 | 10121 | 450 | 1895.75 | |
I&R FB SUBQ SIMPLE | 4920107 | 10120 | 450 | 593.25 | |
I&RMVE FB SUBQ COMPLICATE ProFee | 3610077 | ||||
IMMOBILIZER HEAD DISP BLS | 4000065 | 541 | 57.5 | ||
INCISION & RMV OF FB ProFee | 3610233 | ||||
INCISION & RMVL FB | 4920495 | 10120 | 321.25 | ||
INSERT FOLEY CATH ER Charge | 3600285 | 51702 | 450 | 363.5 | |
INTRAOSSEOUS INFUSION | 3600309 | 36680 | 450 | 282.5 | |
INTRAOSSEOUS INFUSION Charge | 3610301 | ||||
INTUBATION ENDOTRACHEAL EMERGENCY PROCEDURE CHARGE | 3610093 | ||||
IPECAC ADMINISTRATION | 3600109 | 99175 | 450 | 330.25 | |
IPECAC ADMINISTRATION Charge | 3610095 | ||||
IV PUSH EA ADD SAME MED | 3600235 | 96376 | 260 | 222.25 | |
IV PUSH SAME DRUG ER Charge | 3600329 | 96376 | 450 | 222.25 | |
Insulin Regular 300 IU/3M | 4000124 | 547 | 13.5 | ||
KETAMINE 500mg/ 10 ml (CONTROL DRUG) | 4000253 | 547 | 23.75 | ||
KIT IV PREP DISP EA | 4000095 | 541 | 21.5 | ||
KIT OB ALS | 4000053 | 541 | 72.75 | ||
KIT RETRO INTUBATION | 4000083 | 541 | 0 | ||
Ketamine 500mg/10ml | 4000148 | 547 | 32 | ||
LIDOCAINE 10MG/D5W 500ML | 4000145 | 547 | 270.5 | ||
LIDOCAINE 2% 100MG/5ML IV | 4000143 | 547 | 131.5 | ||
LIPOTPR 10MG TAB | 4000181 | 547 | 25 | ||
LORAZEPAM 2MG/ML 1ML VIAL | 4000187 | 540 | 129.5 | ||
LOVENOX 10MG SYRINGE | 4000015 | 547 | 71.75 | ||
LR 1000ML | 4000179 | 547 | 143.5 | ||
LUMBAR PUNCTURE DX | 3610097 | ||||
LUMBAR PUNCTURE DX ER CHARGE | 3600115 | 62270 | 450 | 1409.5 | |
Labetalol 100mg/20ml | 4000126 | 547 | 77.25 | ||
Levafloxacin (Levaquin) 500mg/100ml | 4000128 | 547 | 118.75 | ||
Lorazepam (Ativan) 2mg | 4000130 | 547 | 21.25 | ||
MAGNESIUM SU 500MG/1ML IV | 4000005 | 547 | 6 | ||
MAGNESIUM SULF 500MG IV | 4000223 | 547 | 6 | ||
MASK BAG VALVE BLS | 4000059 | 541 | 140 | ||
MASK NRB ADULT | 4000089 | 541 | 33.75 | ||
MASK NRB CHILD | 4000091 | 541 | 33.75 | ||
MD Pro Closed treatment of articular fracture; with manipulation, each | |||||
MD Pro Destruction Of Lesion, Palate Or Uvula | |||||
MD Pro Puncture aspiration of abscess, hematoma, bulla, or cyst | |||||
METOPROLOL 1MG/ML ING 5ML | 4000185 | 547 | 74.25 | ||
MIDAZOLAM 5MG/ML 1ML VIAL | 4000189 | 547 | 49 | ||
MILEAGE EMERGENCY | 4000021 | A0425 | 540 | 24.5 | |
MILEAGE EMERGENCY DOA | 4000245 | A0425 | 540 | 4.25 | |
MILEAGE NON EMERGENCY | 4000031 | A0425 | 540 | 24.5 | |
MORPHINE SULF 10MG IM/IV | 4000147 | 547 | 25 | ||
MUCOSAL ATOMIZATION DEVICE (MAD) | 4000256 | 547 | 26.75 | ||
MYRINGOTOMY ICLUDING ASPI | 3606942 | 69420 | 360 | 945.5 | |
MYRINGOTOMY INCLUDING ASP ProFee | 3616942 | ||||
Mask, Nebulizer | 4000214 | 547 | 6.75 | ||
Metronidazole 500mg/100ml | 4000132 | 547 | 15 | ||
NACL 0.9% 500ML IRRIG | 4000013 | 541 | 11 | ||
NALOXONE 0.4MG IM/IV | 4000155 | 547 | 42 | ||
NERVE BLOCK INTERCOSTAL | 3600117 | 64421 | 450 | 966.25 | |
NITRODRIP PREMIX 25MG | 4000203 | 547 | 78 | ||
NITROGLYCERIN 0.4MG TAB | 4000157 | 547 | 50.75 | ||
NITROLINGUAL SPARY | 4000201 | 547 | 8 | ||
NITROPRUSSIDE INJ 5MG/2ML | 4000195 | 547 | 25 | ||
NON-CVRD MLS BEYOND FACIL | 4000241 | A0888 | 541 | 21.25 | |
NS 0.45% 1000ml | 4000154 | 547 | 133.25 | ||
NS 10 cc PREFILL SYRINGE | 4000252 | 547 | 10.75 | ||
NS 1000ML IV | 4000153 | 547 | 133.25 | ||
NS 50ml IV | 4000152 | 547 | 99.5 | ||
NS SYRINGE 10ML INJCT | 4000151 | 547 | 23 | ||
Nifedipine (Procardia) 20mg | 4000134 | 547 | 13.5 | ||
Nitro Tubing IV | 4000144 | 541 | 6.75 | ||
OBS DISCHARGE DAY | 4920429 | 99217 | |||
OBS F/U LN L-4 ProFee | 3610261 | ||||
OBS F/U NP L-1 ProFee | 3610255 | 99201 | |||
OBS F/U NP L-2 ProFee | 3610257 | 99202 | |||
OBS F/U NP L-3 ProFee | 3610259 | 99203 | |||
OBS F/U NP L-4 ProFee | 4920447 | 99204 | |||
OBS F/U NP L-5 ProFee | 3610263 | 99205 | |||
OBS IN & OUT LEVEL 1 ProFee | 3610101 | ||||
OBS IN & OUT LEVEL 2 ProFee | 3610103 | STAT | |||
OBS IN & OUT LEVEL 3 ProFee | 3610105 | ||||
OBS/IP ADMIT/DISCHG L-1 | 4920423 | 99234 | |||
OBS/IP ADMIT/DISCHG L-2 | 4920425 | ||||
OBS/IP ADMIT/DISCHG L-3 | 4920427 | 99236 | |||
OP VISIT EP L-2 | 4920457 | 99212 | |||
OP VISIT EP L-3 | 4920459 | 99213 | |||
OP VISIT EP L-4 | 4920461 | 99214 | |||
OP VISIT EP L-5 | 4920463 | 99215 | |||
OP VISIT NP L-1 | 4920465 | 99201 | |||
OP VISIT NP L-2 | 4920467 | 99202 | |||
OP VISIT NP L-3 | 4920469 | 99203 | |||
OP VISIT NP L-4 | 4920471 | 99204 | |||
OP VISIT NP L-5 | 4920473 | 99205 | |||
OXYGEN & SUPPLIES ALS BLS | 4000081 | A0422 | 541 | 36 | |
Ondansetron (Zofran) 4mg | 4000150 | 547 | 13.5 | ||
Oxytocin 10IU/1ml | 4000136 | J2590 | 547 | 14.5 | |
PACK COLD BLS | 4000033 | 541 | 11 | ||
PACK HOT BLS | 4000063 | 541 | 11 | ||
PAD EYE BLS | 4000101 | 541 | 2.75 | ||
PADS DEFIB ALS | 4000035 | 541 | 28 | ||
PERICARDIOCENTESIS 1ST | 3600119 | 33010 | 450 | 1064.5 | |
PERICARDIOCENTESIS SUB | 3600121 | 33011 | 450 | 1064.5 | |
PERITONEOCENTESIS | 3600319 | 49082 | 450 | 749.75 | |
PERITONEOCENTESIS PROFEE | 3610311 | ||||
PERITONEOCENTESIS SUB | 3600321 | 49081 | 450 | 641.75 | |
PERITONEOCENTIESIS | 4920509 | 49082 | |||
PHENERGAN 25MG IM/IV | 4000159 | 547 | 25 | ||
PHY TRANSPORT 24MO OR > ProFee | 3610219 | ||||
PLAVIX 75MG TAB | 4000183 | 547 | 101.5 | ||
PROCTO CONTROL BLEED | 3600123 | 45317 | 450 | 825.25 | |
PROCTO RIGID CNTRL BLEED ProFee | 3610111 | ||||
PSYCH INTERVIEW EXAM | 4920497 | 90801 | |||
Procainamide 1gm/2ml | 4000138 | 547 | 306 | ||
Propofol 200mg/20ml | 4000140 | 547 | 67.25 | ||
QUICKTRACH DEVICE | 4000235 | 541 | 0 | ||
QuickClot Combat gauze | 4000974 | 547 | 69.5 | ||
REMOVAL FB CONJUNCTIVAL | 4920039 | 65205 | 450 | 775.75 | |
REMOVAL FB CORNEAL | 3600129 | 65220 | 450 | 775.75 | |
REMOVAL FB EXTERNAL EAR | 3600131 | 69200 | 450 | 305 | |
REMOVAL FB INTRANASAL | 3600133 | 30300 | 450 | 486.75 | |
REMOVAL FB MUSCLE TENDON | 3600135 | 20520 | 450 | 1169.25 | |
REMOVAL IMPACT CERUM 69209 | 3606920 | 69209 | 450 | 266.25 | |
REMOVAL IMPACTED CERUMEN | 3600137 | 69210 | 450 | 305 | |
REMOVAL IMPACTED CERUMEN CHARGE | 3610125 | ||||
RMV FOREIGN BODY PHARYNX | 3600313 | 42809 | 450 | 790.75 | |
RMVL FB CORNEAL W/O LAMP | 4920475 | 65220 | |||
RMVL FB EAR | 4920477 | 69200 | |||
RMVL FB FOOT SUBQ | 4920401 | 28190 | |||
RPR CMPLX EYELID/NOSE/EAR ProFee | 3611315 | ||||
RPR CMPLX EYELID;NOSE/EAR | 3601315 | 13152 | 450 | 2045.25 | |
RPR CMPLX FACE 1.0 & < | 3600139 | 13150 | 450 | 506 | |
RPR CMPLX FACE 1.1-2.5 | 3600141 | 13151 | 450 | 1095.25 | |
RPR CMPLX FACE 2.6-7.5 | 3600025 | 13132 | 450 | 2351.25 | |
RPR CMPLX HANDS/FEET | 3600297 | 13131 | 450 | 1737.75 | |
RPR CMPLX SCLP ARM LEG | 4920479 | 13120 | 450 | 1095.25 | |
RPR CMPLX SCLP ARM LEGS | 4920043 | 13121 | 450 | 1095.25 | |
RPR CMPLX SCLP ARM LEGS PROFEE | 3610131 | ||||
RPR CMPLX TONGUE | 3600145 | 41250 | 450 | 485 | |
RPR CMPLX TRNK | 4920439 | 13100 | |||
RPR COMPLEX FACE 2.6-7.5 ProFee | 3610229 | ||||
RPR CPMLX SCLP ARM LEGS ProFee | 3610135 | ||||
RPR DISLOCATE SHLDR W/ANE | 3600301 | 23655 | 450 | 1691.5 | |
RPR EA ADD'L 5 CM OR LESS | 3600259 | 13122 | 450 | 724 | |
RPR EXTENSOR TENDON HAND | 3600303 | 26410 | 450 | 3846 | |
RPR HERNIA FEMORAL INTL | 4920483 | 49550 | |||
RPR INTER NK,HND, FT/EXT | 3600291 | 12041 | 450 | 834 | |
RPR INTER SCLP TRK/EXTREM | 4920205 | 12031 | 450 | 818.5 | |
RPR INTER SCLP,TRK/EXTREM | 3600221 | 12034 | 450 | 1390.75 | |
RPR INTER WOUND EXT ProFee | 3611205 | ||||
RPR INTER WOUND EXT | 3601205 | 12052 | 450 | 1409 | |
RPR INTERMEDIATE FACE | 3600295 | 12051 | 450 | 880.25 | |
RPR INTRM WOUND FC/EAR/EY ED Charge | 3601205 | 12053 | 450 | 1443.25 | |
RPR INTRMD FACE 2.5 OR < ProFee | 3610287 | ||||
RPR INTRMD FOREARM 10CM | 3600293 | 12044 | 450 | 1930.5 | |
RPR INTRMD NK,HND,FT/EXT ProFee | 3610283 | ||||
RPR INTRMD SCLP,TRK/EXTRE ProFee | 3610207 | ||||
RPR INTRMD WND NCK/HND/FT ProFee | 3610010 | ||||
RPR INTRMD WUND NCK/HND/F | 3600010 | 12042 | 450 | 1048.5 | |
RPR LIP FULL THK/VERMILI ProFee | 3610303 | ||||
RPR LIP FULL/THK/VERMILN | 3600311 | 40650 | 450 | 1949.25 | |
RPR SIMPLE FACE 2.5-7.5 cm | 4920485 | 12011 | 450 | 327.25 | |
RPR SIMPLE FACE 7.6-12.5 cm | 4920487 | 12015 | |||
RPR SMP LACERATION | 3600287 | 12006 | 450 | 1223 | |
RPR SMPL EXTREMITIES | 3600289 | 12007 | 450 | 1377 | |
RPR SMPL FC/EAR/EYE | 3600237 | 12014 | 450 | 974.5 | |
RPR SMPL FC/EARS/EYE ProFee | 3610271 | ||||
RPR SMPL LACERTAION ProFee | 3610279 | ||||
RPR SMPL SCLP NK TRNK EXT | 4920489 | 12002 | 450 | 708.5 | |
RPR SMPLE FACE 2.5 & < | 4920045 | 12011 | 450 | 708.5 | |
RPR SMPLE FACE 2.5 OR < ProFee | 3610137 | ||||
RPR SMPLE FACE 2.6-5.0 | 4920117 | 12013 | 450 | 708.5 | |
RPR SMPLE FACE 7.6-12.5 | 3600151 | 12015 | 450 | 708.5 | |
RPR SMPLE SCLP NECK TRUNK ProFee | 3610143 | ||||
RPR SMPLE SCLP/NECK/TRUNK | 4920199 | 12001 | 450 | 445.75 | |
SALINE LOCK | 4000243 | 541 | 49 | ||
SET BLOOD DRIP 10GTT/ML | 4000167 | 541 | 71.75 | ||
SET BURETROL SOL 114 DIS" | 4000177 | 541 | 109.25 | ||
SET BURETROL SOL 84 DIS" | 4000175 | 541 | 109.25 | ||
SET C-FLO SOL W/TBNG 83",SET C-FLO SOL W/TBNG 83"" | |||||
SET C-FOL SOL 110 DISP" | 4000171 | 541 | 50.75 | ||
SET CHEST DECOMPRESSION | 4000229 | 541 | 131.5 | ||
SET DRIP 60 GTTS | 4000237 | 541 | 83.25 | ||
SHV EOUD/DERML LESION/SGL | 3601130 | 11303 | 360 | 687.75 | |
SODIUM BICARB 4.2% 5MEQ | 4000161 | 547 | 67.75 | ||
SODIUM BICARB 8.4% 50MEQ | 4000163 | 547 | 31.75 | ||
SOLU MEDROS 125 MG INJ | 4000197 | 547 | 42 | ||
SP02 FINGER PROBES | 4000213 | A4606 | 541 | 89 | |
SPECIALITY CARE TRANSPORT | 4000169 | A0434 | 540 | 2766.5 | |
SPINAL PUNC THRP DRAIN ProFee | 3610014 | ||||
SPINAL PUNC THRP DRAN | 3600012 | 62272 | 450 | 828.75 | |
SPLINT ARM LONG APPLY ER Charge | 4920209 | 29105 | 450 | 392.75 | |
SPLINT ARM LONG SUPPLY ProFee | 3610149 | ||||
SPLINT ARM SHORT APPLY | 3600161 | 29125 | 450 | 289.5 | |
SPLINT FINGER APPLY | 3600165 | 29130 | 450 | 58.75 | |
SPLINT FINGER APPLY STA | 3610155 | ||||
SPLINT LEG LONG APPLY Charge | 3610153 | ||||
SPLINT LEG LONG APPLY ER Charge | 4920053 | 29505 | 450 | 346.5 | |
SPLINT LEG SHORT APPLY | 4920051 | ||||
SPLINT LEG SHORT APPLY ER Charge | 3600167 | 29515 | 450 | 570.75 | |
STERIL WATER 20ML INJ | 4000082 | 250 | 18.5 | ||
STRAPPING ANKLE | 3600269 | 29540 | 450 | 201.75 | |
STRAPPING ELBOW OR WRIST | 3600275 | 29260 | 450 | 359.75 | |
STRAPPING HAND OR FINGER | 3600273 | 29280 | 450 | 359.75 | |
STRAPPING KNEE ER Charge | 3600271 | 29530 | 450 | 249.5 | |
STRAPPING SHOULDER ER Charge | 3600169 | 29240 | 450 | 641.75 | |
STRAPPING SHOULDER Prof Fee Charge | 3610159 | ||||
STRAPPING TOES | 3600267 | 29550 | 450 | 189.5 | |
STRAPPING UNNA BOOT | 3600265 | 29580 | 450 | 373.5 | |
SUCCINYLCHOLINE 20MG IM | 4000017 | 251 | 2.75 | ||
SUCTION TIP YANKAUER BLS | 4000071 | 541 | 8 | ||
SYRINGE 1CC-5CC ALS | 4000077 | 541 | 8 | ||
SYRINGE 20CC-50CC ALS | 4000075 | 541 | 8 | ||
TACTICAL TOURNIQUET | 4000258 | 547 | 42.75 | ||
THORACENTESIS INITIAL SUB ProFee | 3610161 | ||||
THORACENTESIS INITIAL/SUB | 3600171 | 32421 | 450 | 1356.25 | |
THORACENTESIS INSERT TUBE | 3600173 | 32422 | 450 | 1064.5 | |
THROMBOLYSIS | 3600175 | 92977 | 450 | 483.75 | |
TORADOL 15MG IM/IV | 4000011 | 547 | 38.75 | ||
TRACHEOSTOMY CRICOTHYROID | 3600307 | 31605 | 450 | 1351.75 | |
TRACHEOSTOMY CRICOTHYROID MEMBRANE CHARGE | 3610299 | ||||
TRANEXAMIC ACID (TXA) 1G | 4000250 | 547 | 272 | ||
TRANSFER CONTRACT RATE | 4000219 | 540 | 227.75 | ||
TRANSFUSION TO 4HR | 3600243 | 36430 | 391 | 2370.5 | |
TRANSFUSION TO 5HR | 3600245 | 36430 | 391 | 1696.5 | |
TRANSFUSION TO 6HR | 3600247 | 36430 | 391 | 1696.5 | |
TRANSFUSION TO 7HR | 3600249 | 36430 | 391 | 2370.5 | |
TRANSVENOUS PACING TEM ProFee | 3610165 | ||||
TRIGGER POINT INJ 1 OR > | 4920010 | 20552 | 450 | 172.25 | |
TRIMMING OF NAILS | 4920499 | 11719 | |||
TRMT NSL BNE FX W/O MANIP ProFee | 3610291 | ||||
TRT AC CLOSED DISLOCATE | 3600177 | 23545 | 450 | 481.75 | |
TRT AC CLSD DISLOCATE ProFee | 3610167 | ||||
TRT CLAVICLE FX W/O MNP | 3600179 | 23500 | 450 | 481.75 | |
TRT CLAVICULAR FX W/O MAN ProFee | 3610169 | ||||
TRT CLSD ANKLE W/O ANESTH | 3600305 | 27840 | 450 | 1558.75 | |
TRT CLSD ANKLE W/O ANESTH ProFee | 3610297 | ||||
TRT CLSD HUMERAL HD FX ProFee | 3610075 | ||||
TRT CLSD TMJ DISLOCATE ProFee | 3610199 | ||||
TRT COLLES FX W/O MNP | 3600181 | 25600 | 450 | 636 | |
TRT COLLES FX W/O MNP ProFee | 3610171 | ||||
TRT DIST PHALANGE CLSD EA ProFee | 3610173 | ||||
TRT DIST PHALANGEAL CLSD | 3600183 | 26750 | 450 | 481.75 | |
TRT ELBOW CLSD DISLOCATE | 3600185 | 24600 | 450 | 636 | |
TRT ELBOW CLSD DISLOCATE ProFee | 3610175 | ||||
TRT FIB SHF PROX FX CLSD | 3600187 | 27780 | 450 | 636 | |
TRT FIB/SHF PROX FX CLSD ProFee | 3610177 | ||||
TRT IP DISLOCATE ProFee | 3610179 | ||||
TRT IP JNT DISLOCATE | 3600191 | 26770 | 450 | 481.75 | |
TRT IP JNT DISLOCATE ProFee | 3610181 | ||||
TRT KNEE CLSD DISLOCATE | 3600193 | 27550 | 450 | 636 | |
TRT KNEE CLSD DISLOCATE ProFee | 3610183 | ||||
TRT MCP JNT DISLOCATE | 3600199 | 26700 | 450 | 481.75 | |
TRT METACARP FX CLSD | 3600195 | 26600 | 450 | 636 | |
TRT METACARP FX CLSD ProFee | 3610185 | ||||
TRT METACARPO JNT DISLOCA ProFee | 3610187 | ||||
TRT MT CLSD FX ProFee | 3610189 | ||||
TRT MT CLSD FX W/O MNP | 3600197 | 28470 | 450 | 636 | |
TRT NSL BNE FX W/O MANIP | 3600299 | 21310 | 450 | 555.5 | |
TRT PATELLAR DISLOCATE | 3600201 | 27560 | 450 | 636 | |
TRT PATELLAR CLSD DISLOCA ProFee | 3610191 | ||||
TRT PHAL SHAFT FRAC W/MAN | 3600204 | 26725 | 450 | 2062.25 | |
TRT PHALANGEA SHAFT FX | 3600203 | 26720 | 450 | 481.75 | |
TRT RAD HEAD FX CLSD | 3600205 | 24650 | 450 | 636 | |
TRT RAD HEAD FX CLSD ProFee | 3610193 | ||||
TRT RIB FX EACH | 3600207 | 450 | 450.25 | ||
TRT RIB FX EACH ProFee | 3610195 | ||||
TRT SHOULDER CLSD DIS W/M | 3600209 | 23650 | 450 | 481.75 | |
TRT SHOULDER CLSD DISLOCA ProFee | 3610197 | ||||
TRT T-MANDIULAR DISLOCATE | 3600211 | 21480 | 450 | 486.75 | |
TUBE ENDOTRACHEAL ALS | 4000067 | 541 | 25 | ||
TUBE ENDOTRACHEAL ALS 2 | 4000093 | 541 | 21.5 | ||
TUBE NASO GASTRIC ALS | 4000051 | 541 | 25 | ||
TUBE THORACOSTOMY (PRO FEE) | 3610037 | ||||
TUBE THORACOSTOMY ER Charge | 3600045 | 32551 | 450 | 1063 | |
Tetracaine .5% 15ml | 4000142 | 547 | 55.25 | ||
Tt-pod combat, Trauma Pelvic Orthotic Device | 4000972 | 547 | 187.25 | ||
VAGINAL DELIVERY | 3600213 | 59409 | 450 | 3260.25 | |
VAGINAL DELIVERY ONLY ProFee | 3610201 | ||||
VASOTEC 1.25MG IM/IV | 4000165 | 547 | 38.75 | ||
VECURONIUM 10MG IM/IV | 4000149 | 547 | 241.25 | ||
VENIPUNCTURE 3YR OR OLDER | 3600215 | 36410 | 450 | 35 | |
Venipuncture, Cutdown; Age 1 Or Over | |||||
Vented IV Tubing | 4000146 | 541 | 13 | ||
WAITING TIME 30 MIN | 4000069 | 541 | 47.25 | ||
WATER STERILE IRRIG 500ML | 4000009 | 541 | 43.75 | ||
WEDGE EXCESION OF NAIL | 4920493 | 11765 | |||
WEDGE EXCESION OF NAIL ProFee | 3610231 | ||||
XOPONEX 1.25MG CONCENTRAT | 4000199 | 547 | 30 | ||
90471 THS Flu Vaccine Administration fee | 4920257 | 90471 | |||
90887 INTERPJ/EXPLNAJ RESULTS PSYCHIATRIC EXAM FAMILY | |||||
99213 OV/OP VISIT EST PT L-3 | 4920057 | 99213 | |||
99394 Preventive Medicine Established Patient - 12 to 17 years | 4920299 | 99394 | |||
99406 Tobacco cessation counseling intensive > 10 minutes | |||||
ALZHEIMER EST LEV I | |||||
ALZHEIMER EST LEV II | |||||
ALZHEIMER EST LEV III | |||||
ALZHEIMER EST LEV IV | |||||
ALZHEIMER VISIT-EST | |||||
ALZHEIMER VISIT-NEW | |||||
Adjacent tissue transfer or rearrangement, trunk 10 sq cm or less | |||||
Advanced care planning additional 30 minutes 99498 | |||||
Advanced care planning for 30 minutes | |||||
Annual Wellness Visit, Initial (AWV) | |||||
Annual Wellness Visit, Subsequent (AWV) | |||||
Antepartum Care 4-6 Visits - 59425 | |||||
Antepartum Care 7 or More Visits - 59426 | |||||
Assisted living established pt - Level 1 | |||||
Assisted living established pt - Level 2 | |||||
Assisted living established pt - Level 3 | |||||
Assisted living new pt - Level 2 | |||||
Assisted living new pt - Level 3 | |||||
Assisted living new pt, low severity - Level 1 | |||||
Attendance at Delivery | |||||
BX Muscle, Percutaneous Needle | |||||
Brief counseling alcohol misuse 15 minutes | |||||
Bypass graft, with other than vein | |||||
Cardio Critical Care 1 hour | |||||
Cardio Critical Care 30 min | |||||
Cardio Office Visit Est 10 Min | |||||
Cardio Office Visit Est 15 Min | |||||
Cardio Office Visit Est 25 Min | |||||
Cardio Office Visit Est 40 Min | |||||
Cardio Office Visit Est 5 Min | |||||
Cardio Office Visit NP 10 Min | |||||
Cardio Office Visit NP 20 Min | |||||
Cardio Office Visit NP 30 Min | |||||
Cardio Office Visit NP 45 Min | |||||
Cardio Office Visit NP 60 Min | |||||
Cardiology ED visit level 1 | |||||
Cardiology ED visit level 2 | |||||
Cardiology ED visit level 3 | |||||
Cardiology ED visit level 4 | |||||
Cardiology ED visit level 5 | |||||
Cardiovas stress test using maximal/submaximal treadmill or bike exercise, cont.electrocardiographic | |||||
Cardiovas stress test using maximal/submaximal treadmill or bike exercise, cont.report only | |||||
Chronic Care Management | |||||
Chronic Care Management - G0511 | |||||
Critical Care Services Evaluation and Treatment for Each Additional 30 Minutes - 99292 | |||||
Critical Care Services Evaluation and Treatment for First 30 - 74 Minutes - 99291 | |||||
Critical Care Services Evaluation and Treatment for First 30 - 74 Minutes | |||||
Critical Care Services Evaluation and Treatment for First 30 - 74 Minutes Professional - 99291 | |||||
DPH - General Physical Exam | |||||
Debridement open wound ongoing care per session first 20 sq cm or less | |||||
Delivery/birthing room resuscitation, PPV or chest compression | |||||
Depression screening | |||||
Dietary Consult Follow Up | |||||
Dietary Consult Initial (15min) | |||||
Domicil/r-home care supervision of patient, 15-29 min | |||||
Domicil/r-home care supervision of patient, 30 min or more | |||||
Domiciliary or rest home visit for est patients (History, Examination and MDM) | |||||
Domiciliary or rest home visit for est patients (History, Examination and MDM of low complexity) | |||||
Emergency Department Nursing Visit Level 1 | |||||
Emergency Department Nursing Visit Level 2 | |||||
Emergency Department Nursing Visit Level 3 | |||||
Emergency Department Nursing Visit Level 4 | |||||
Emergency Department Nursing Visit Level 5 | |||||
Emergency Department Visit Level 1 - 99281 | |||||
Emergency Department Visit Level 3 - 99283 | |||||
Emergency Department Visit Level 4 - 99284 | |||||
Emergency Department Visit Level 5 - 99285 | |||||
Emergency Dept Visit Level 2 - 99282 | |||||
Exc of rectal tumor, transanal approach | |||||
Excision tumor soft tissue abd wall 3cm | |||||
Excision tumor soft tissue abd wall 5 cm or greater | |||||
G0437-Tobacco cessation counseling intensive > 10 minutes | |||||
Health And Behavior Intervention, Each 15 Minutes, Face-To-Face; Family (W/O The Patient Present) | |||||
Health and behavior intervention, each 15 minutes, face-to-face; family (with the patient present) | |||||
Hemoglobin POC. | 4920529 | 85018 | |||
Hm Vis For E&M Of Estab Pat,Req At Least 2:Comp Inter Hx,Exam;Med Dec Making Mod-High Complx;Care | |||||
Hme Vis For E&M Of New Pat,Req:Comp Hx,Exam;Med Dec Making Of High Complx;Care Consist W Prob | |||||
Home Health Care Plan Oversight 15-29 Mins Per Month Charge | |||||
Home Visit Level 1 Established - 99347 | |||||
Home Visit Level 1 New - 99341 | |||||
Home Visit Level 2 Established - 99348 | |||||
Home Visit Level 2 New - 99342 | |||||
Home Visit Level 3 Established - 99349 | |||||
Home Visit Level 3 New - 99343 | |||||
Home health CPO is indicated for the supervision of a patient under the care of certified HH agency | |||||
Hospital Discharge Management 30 min or Less - 99238 | |||||
Hospital Discharge Management More Than 30 min - 99239 | |||||
I&D Hip Joint Deep Abscess Infected Bursa | |||||
Individual psychotherapy, approximately 45-50 min with medical evaluation and management services | |||||
Initial Annual Wellness Visit Charge | |||||
Initial Hospital Care Level 1 - 99221 | |||||
Initial Hospital Care Level 2 - 99222 | |||||
Initial Hospital Care Level 3 - 99223 | |||||
Initial Inpatient Consult Level 3 - 99253 | |||||
Initial Inpatient Consultation Level 1 - 99251 | |||||
Initial Inpatient Consultation Level 2 - 99252 | |||||
Initial Inpatient Consultation Level 4 - 99254 | |||||
Initial Inpatient Consultation Level 5 - 99255 | |||||
Initial Nursing facility care (History, Examination and MDM) | |||||
Initial Nursing facility care (History, Examination and MDM of moderate complexity) | |||||
Initial Observation Care Level 1 - 99218 | |||||
Initial Observation Care Level 1 | |||||
Initial Observation Care Level 2 - 99219 | |||||
Initial Observation Care Level 3 - 99220 | |||||
Initial eval mgmnt of pt an annual nsg facility assessment. Physician spends 45 minutes | |||||
Initial hosp care,per day, for E&M of normal newborn infant adm & d/c same day | |||||
Initial hospital or birthing center care, per day, for E&M of normal newborn infant | |||||
Initial hospital or birthing cntr care, per day, for eval and mgmt of normal newborn infant same day | |||||
Initial hospital, per day, for E&M of normal newborn infant admitted and discharged on the same date | |||||
Initial inpatient neonatal critical care, per day, critically ill neonate, >28 days | |||||
Initial preventive exam | |||||
Ins Phy - Age 18-39 | 4920301 | 99395 | |||
Interactive psychiatric diagnostic interview examination | |||||
Interrogation device evaluation (in person) with physician analysis, review and report, connection | |||||
Interrogation device evaluation (in person) with physician analysis, review and report, includes con | |||||
Life Insurance Physical - 99450 | |||||
MD Application of forearm cast | |||||
MD Application of long arm cast | |||||
MD Application of short leg cast | |||||
MD Application of short leg cast; walking | |||||
MD arthrocentesis, aspiration and or injection small joint or bursa | |||||
Montana State Fund - written questions that require written response from provider | |||||
No Charge Visit - RMHO | 4920367 | 99499 | |||
Nursing Facility Discharge Management 30 min or Less - 99315 | |||||
Nursing Facility Discharge Management More Than 30 min - 99316 | |||||
Observation Care Discharge | |||||
Observation Care Discharge - 99217 | |||||
Observation/ Same Day Inpatient Care Level 1 - 99234 | |||||
Observation/ Same Day Inpatient Care Level 3 - 99236 | |||||
Observation/Inpatient, Admit-D/C Same Day Care Level 2 - 99235 | |||||
Office Consultation Level 4 - 99244 | 4920171 | 99244 | |||
Office Consultation Level 5 - 99245 | 4920173 | 99245 | |||
Office Visit Level 4 New - 99204 | 4920873 | 99204 | |||
Office Visit Level 5 New - 99205 | |||||
Office/OP Established Visit Level 1 99211 | |||||
Office/OP Established Visit Level 2 99212 | 4920093 | 99212 | |||
Office/OP Established Visit Level 4 99214 | 4920883 | 99214 | |||
Office/OP Established Visit Level 5 99215 | |||||
Office/OP Established Visit Level 5 SC 99215 | |||||
Office/OP Established Visit Level 1 SC 99211 | |||||
Office/OP Established Visit Level 2 SC 99212 | |||||
Office/OP Established Visit Level 3 SC 99213 | |||||
Office/OP Established Visit Level 4 SC 99214 | |||||
Office/OP New Visit Level 1 99201 | 4920071 | 99201 | |||
Office/OP New Visit Level 1 SC 99201 | |||||
Office/OP New Visit Level 2 99202 | 4920073 | 99202 | |||
Office/OP New Visit Level 2 99202 | |||||
Office/OP New Visit Level 2 SC 99202 | |||||
Office/OP New Visit Level 3 99203 | 4920075 | 99203 | |||
Office/OP New Visit Level 3 SC 99203 | |||||
Office/OP New Visit Level 4 99204 | 99204 | 99204 | |||
Office/OP New Visit Level 4 SC 99204 | |||||
Office/OP New Visit Level 5 99205 | 4920079 | 99205 | |||
Office/OP New Visit Level 5 99205 Tech Chg | 4920069 | 99215 | |||
Office/OP New Visit Level 5 SC 99205 | |||||
Office/Other Outpatient Consultation Level 1 - 99241 | 4920137 | 99241 | |||
Office/Other Outpatient Consultation Level 2 - 99242 | 4920167 | 99242 | |||
Office/Other Outpatient Consultation Level 3 - 99243 | 4920169 | 99243 | |||
Office/Outpatient Urgent Care Visit Level 1 New - 99201 | |||||
Office/Outpatient Urgent Care Visit Level 2 New - 99202 | |||||
Office/Outpatient Urgent Care Visit Level 4 New - 99204 | |||||
Office/Outpatient Urgent Care Visit Level 5 New - 99205 | |||||
Office/Outpatient Urgent CareVisit Level 3 New - 99203 | |||||
Office/Outpatient Visit Level 1 Established - 99211 | 4920091 | 99211 | |||
Office/Outpatient Visit Level 1 New - 99201 | |||||
Office/Outpatient Visit Level 2 Established - 99212 | 99212 | 99212 | |||
Office/Outpatient Visit Level 2 New - 99202 | |||||
Office/Outpatient Visit Level 3 Established - 99213 | 4920065 | 99213 | |||
Office/Outpatient Visit Level 3 New - 99203 | |||||
Office/Outpatient Visit Level 4 Established - 99214 | |||||
Office/Outpatient Visit Level 5 Established - 99215 | |||||
Oncology Est Patient Visit Level 2 | |||||
Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | |||||
Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculations | |||||
Ophthalmological services: medical examination and evaluation with initiation of diagnostic | |||||
Ophthalmological services: medical examination,evaluation w/ initiation of diag and treatment pgm | |||||
Ophthalmological services: medical examination and evaluation, w/ initiation or continuation of diag | |||||
Ophthalmological services: medical exam and eval with initiation or continuation of diag; comprehens | |||||
Orthoptic and/or pleoptic training, with continuing medical direction and evaluation | |||||
Osteopathic manipulative treatment (OMT); 5-6 body regions involved | 4921927 | 98927 | |||
Outpatient Office Consultation | |||||
Pharmacologic management, including prescription, use, and review of medication | |||||
Phys Supervsn,Pat Receiv Medicare-Coverd Srv Prov By Part Hha Req Complx&Multidisc Care Modalities | |||||
Physician Standby Service Requiring Prolonged Physician Attendance Each 30 Minutes - 99360 | |||||
Postoperative Follow-Up Visit Included in Global Service - 99024 | |||||
Postpartum Care only - 59430 | |||||
Preventive Medicine 1-4 years Established - 99392 | 4920895 | 99392 | |||
Preventive Medicine 1-4 years Established | |||||
Preventive Medicine 1-4 years Est - 99392. | |||||
Preventive Medicine 1-4 years New - 99382 | 4920887 | 99382 | |||
Preventive Medicine 12-17 years Established - 99394 | 4920899 | 99394 | |||
Preventive Medicine 12-17 years New - 99384 | 4920891 | 99384 | |||
Preventive Medicine 12-17 years Est - 99394. | |||||
Preventive Medicine 18-39 years Established - 99395 | 4920901 | 99395 | |||
Preventive Medicine 18-39 years New - 99385 | 4920951 | 99385 | |||
Preventive Medicine 18-39 years Established | |||||
Preventive Medicine 18-39 years Est - 99395. | |||||
Preventive Medicine 40-64 years Established - 99396 | 4920303 | 99396 | |||
Preventive Medicine 40-64 years New - 99386 | 4920291 | 99386 | |||
Preventive Medicine 40-64 years Est - 99396. | |||||
Preventive Medicine 5-11 years Established - 99393 | 4920897 | 99393 | |||
Preventive Medicine 5-11 years Established | |||||
Preventive Medicine 5-11 years Est - 99393. | |||||
Preventive Medicine 5-11 years New - 99383 | 4920889 | 99383 | |||
Preventive Medicine 65+ years Established - 99397 | 4920305 | 99397 | |||
Preventive Medicine 65+ years Est - 99397. | |||||
Preventive Medicine 65+ years New - 99387 | 4920293 | 99387 | |||
Preventive Medicine < 1 year Established - 99391 | 4920893 | 99391 | |||
Preventive Medicine < 1 year Est - 99391. | |||||
Preventive Medicine < 1 year New - 99381 | 4920885 | 99381 | |||
Preventive Medicine Counseling And/Or Risk Factor Reduction Intervention(S), Individual;15 Min | |||||
Prof services for the supervision of preparation and provision antigens allergen immunother single | |||||
Prof services for the supervision of preparation and provision antigens allergen immunother 2+ | |||||
Prolonged Eval And Mgmt Service Before And/Or After Direct Patient Care; Each Additional 30 Minutes | |||||
Prolonged Physician Service Inpatient with Direct Patient Contact Each Additional 30 Minutes - 99357 | |||||
Prolonged Physician Service Inpatient with Direct Patient Contact First Hour - 99356 | |||||
Prolonged Physician Service Outpatient with Direct Patient Contact First Hour - 99354 | |||||
Prolonged Physician Service Outpatient with Direct Patient Contact Each Addl 30 Minutes - 99355 | |||||
Prolonged Physician Service Without Direct Patient Contact First Hour - 99358 | |||||
Psychiatric diagnostic interview examination | |||||
RMNC Hospital Discharge 30 min or less - 99238 | |||||
RMNC Hospital Discharge > 30 min - 99239 | |||||
RMNC OFC/OUTPT E/M Estab Low-Mod 15 min | |||||
RMNC Office Consult Level 5 - 99245 | |||||
RMNC Office/OP Established Visit Level 1 99211 | |||||
RMNC Office/OP Established Visit Level 2 99212 | |||||
RMNC Office/OP Established Visit Level 4 99214 | |||||
RMNC Office/OP Established Visit Level 5 99215 | |||||
RMNC Office/OP New Visit Level 1 99201 | |||||
RMNC Office/OP New Visit Level 3 99203 | |||||
RMNC Office/OP New Visit Level 3 99202 | |||||
RMNC Office/OP New Visit Level 4 99204 | |||||
RMNC Office/OP New Visit Level 5 99205 | |||||
RMNC Subseq Hospital Care Level 1 - 99231 | |||||
RMNC Subseq Hospital Care Level 2 - 99232 | |||||
RMNC Subseq Hospital Care Level 3 - 99233 | |||||
Screening alcohol misuse | |||||
Sensorimotor examination w/ multiple measurements of ocular deviationwith interpretation and report | |||||
Service(s) provided in the office during regularly scheduled evening, weekend, or holiday hours | 4921999 | 99051 | |||
Shaving of epidermal or dermal lesion trunk, arms or legs over 2.0cm | |||||
Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; lesion diameter over 2.0 | |||||
Subsequent Annual Wellness Visit Charge | |||||
Subsequent Hospital Care Level 1 - 99231 | |||||
Subsequent Hospital Care Level 2 - 99232 | |||||
Subsequent Hospital Care Level 3 - 99233 | |||||
Subsequent Observation Care - Detailed | |||||
Subsequent Observation Care - Expanded Problem Focused | |||||
Subsequent Observation Care - Problem Focused | |||||
Subsequent Observation Care Level 1 | |||||
Subsequent Observation Care Level 2 | |||||
Subsequent Observation Care Level 3 | |||||
Subsequent eval mgmnt of pt an annual nsg facility assessment. Physician spends 25 minutes | |||||
Subsequent hospital care, per day, for evaluation and management of normal newborn | |||||
Subsequent inpatient neonatal critical care | |||||
Subsequent intensive care, per-day, for the E/M of recovering infant (wt grams)) | |||||
Subsequent nursing facility care (History, Examination and MDM | |||||
Subsequent nursing facility care (History, Examination and MDM of low complexity | |||||
Subsequent nursing facility care (History, Examination and MDM of moderate complexity) | |||||
Subsequent nursing facility care, per day, for the eval and mgmt of a patient, High complexity | |||||
Subsequent observation care, per day | |||||
Subsequent observation care, per day 35 min | |||||
Subsequent observation care, per day, for the evaluation and management of a patient,w/ 2 key | |||||
Therapy for cardiovascular disease | |||||
Thrombectomy artery/vein graft w/revision of artery or venous graft | |||||
Tobacco cessation counseling intermediate | |||||
Transitional Care Management high complexity w/i 7 Days | |||||
Transitional Care Management high complexity w/i 14 Days | |||||
Unlisted Evaluation and Management Service | |||||
Vision Acuity Screening | |||||
Visual field examination, unilateral or bilateral, with interpretation and report; ext examination | |||||
Welcome MC Preventative | |||||
Work Related Or Medical Disability Exam By Treating Physician Medical History; Exam; Diagnosis, | |||||
Work Related or Medical Disability Insurance Evaluation by Other Than Treating Provider - 99456 | |||||
annual nursing facility assessment visit | |||||
closed tx of fx distal tibia w/ traction or manipulation | |||||
initial hospital care of the neonate who requires intensive intervention but is not critically ill | |||||
Anoscopy Charge | |||||
Colorectal CA Screen High Risk; Colonoscopy Medicare Charge | |||||
Colorectal CA Screen Non-High Risk; Colonoscopy Medicare Charge | |||||
Medicare prostate screening exam | |||||
Prostate CA Screen; Digital Rectal Exam Medicare Charge | |||||
.%fPSA Reflex LC | |||||
.AFB ID by DNA Probe Rflx AST LC | |||||
.ANA Reflex Panel PSPC | |||||
.Aerobic Bacteria ID by Seq LC | |||||
.Aerobic Bacteria, ID by Seq. LC | |||||
.Aerobic ID by MALDI LC | |||||
.Anaerobic Bacteria ID by Seq LC | |||||
.Anaerobic Bacteria, ID by Seq. LC | |||||
.Anaerobic ID by MALDI LC | |||||
.Anti-Centromere B Abs LC | |||||
.Anti-Jo-1 LC | |||||
.Anti-dsDNA Antibodies LC | |||||
.Antichromatin Abs LC | |||||
.Antiribosomal P Abs LC | |||||
.Antiscleroderma-70 Abs LC | |||||
.Body Fluid Cult LC | |||||
.Cardiolipin (Phospholip) Ab IgM/IgG AMS | |||||
.Deletion/Duplication LC | |||||
.ENA+DNA/DS+Antich+Centro+Jo... LC | |||||
.ENA+DNA/DS+Sjorgen's LC | |||||
.FLT3 Inter. Tandem Dup(Itd) PCR LC | |||||
.FVII ACT+PT 1:1 NP LC | |||||
.Factor V Leiden Mutation LC | |||||
.Fibrinogen Activity+Antigen LC | |||||
.GTT - 1Hr | |||||
.GTT 2 Hour (75gm) | |||||
.GTT 3 Hour (100gm) | |||||
.GTT 3 Hour (75gm) | |||||
.GTT Glucose Fasting | 4200083 | 82947 | 300 | 62.5 | |
.GTT-1 Hr | 4200280 | 82951 | 300 | 80.5 | |
.GTT-2 Hr | 4200279 | 82951 | 300 | 160.5 | |
.GTT-3 Hr | 4200005 | 82952 | 300 | 180.75 | |
.GTT-4 Hr | 4200282 | 82952 | 300 | 259.5 | |
.GTT-5 Hr | |||||
.HAV IgM LC | |||||
.HCV Ab Verification LC | |||||
.HCV Real-Time, PCR, Quant LC | |||||
.HIV 1/2 Supplemental Ab Test LC | |||||
.HPV, high-risk LC | |||||
.HPV, low volume rfx LC | |||||
.HSV Viral Identification LC | |||||
.Hepatitis C Genotype LC | |||||
.Hexagonal Phase Phospholipid LC | |||||
.Immunofixation Elect LC | |||||
.Lupus Anticoagulant Eval AMS | |||||
.Lyme, Western Blot, Serum LC | |||||
.M. marinum Susceptibility LC | |||||
.MAC Susceptibility Broth LC | |||||
.Methadone Conf GC/MS LC | |||||
.Mold ID by Sequencing LC | |||||
.Mold, ID by Sequencing LC | |||||
.Mtb AST Confirmation LC | |||||
.Mtb Susceptibility Broth LC | |||||
.Mycobacteria ID by MALDI LC | |||||
.Mycobacteria ID by Seq LC | |||||
.Mycobacteria, ID by Seq. LC | |||||
.Nocardia ID by MALDI LC | |||||
.Nocardia ID by Sequencing LC | |||||
.Nocardia Susceptibility Broth LC | |||||
.Nocardia, ID by Sequencing LC | |||||
.Opiates Confirmation, Urine LC | |||||
.Org ID by Sequencing Rflx AST LC | |||||
.Organism Identification 1 LC | |||||
.Organism Identification 2 LC | |||||
.Organism Identification 3 LC | |||||
.Organism Identification 4 LC | |||||
.Organism Identification 5 LC | |||||
.Organism Identification 6 LC | |||||
.PTT-LA Incub Mix LC | |||||
.PTT-LA Mix LC | |||||
.RNP Abs LC | |||||
.Rapid Grower Broth Suscep LC | |||||
.STVN BB Crossmatch Request | |||||
.Sjoren's SSA LC | |||||
.Sjoren's SSB LC | |||||
.Slow Grower Broth Suscep LC | |||||
.Smith Abs LC | |||||
.Smith/RNP Abs LC | |||||
.TT Mix+TTN LC | |||||
.Thyroglobulin by IMA LC | |||||
.Thyroglobulin by RIA LC | |||||
.Varicella Viral Identification LC | |||||
.Yeast ID by MALDI LC | |||||
.Yeast ID by Sequencing LC | |||||
.Yeast, ID by Sequencing LC | |||||
.dRVVT Confirm LC | |||||
10 Panel Drug Screen | 4210249 | 300 | 65.5 | ||
17-Hydroxyprogesterone, Urine CVT | |||||
17-OH Progesterone LC | |||||
183558 Giardia lamblia, direct detection EIA and Cryptosporidium, Direct Detection EIA | |||||
2 Hour Postprandial Glucose | |||||
2hr Postprandial | 4200277 | 82950 | 300 | 68 | |
4 Hr GTT | |||||
5 Hiaa, 24 Hr Urine, With Creatinine QST | |||||
5 Hr GTT. | |||||
5 Panel Drug Screen | 4210247 | 301 | 34.25 | ||
5-HIAA Qn, Random Urine LC | |||||
5-HIAA,Quant.,24 Hr Urine LC | |||||
551781 HIV-1 Genosure Archive | |||||
6 Panel Drug Screen | 4210251 | 301 | 40 | ||
A. Alternata IgE CPL | 4211105 | 86003 | 302 | 34.25 | |
A. Fumigatus IgE CPL | 4211106 | 86003 | 302 | 34.25 | |
A. NIger IgE CPL | 4211107 | 86003 | 302 | 34.25 | |
ABO Rh | |||||
ABO/RH(D) PSPC | |||||
ACID FAST BACTERIA, PSPC | |||||
ACTH CPL | 4210049 | 82024 | 302 | 263.75 | |
ACTH, Plasma LC | |||||
AFB Culture (Sputum/Bronc Wash) PSPC | |||||
AFB Culture and Smear AMS | |||||
AFB Culture/Stain AEL | |||||
AFB ID by DNA Probe LC | |||||
AFP Maternal Serum Screen 4 NAH | |||||
AFP Quad Scrn PSPC | |||||
AFP Tetra LC | |||||
AFP With AFP-L3% LC | |||||
AFP, Quad Screen | |||||
AFP, Serum, Tumor Marker LC | |||||
AFP, Triple Screen | |||||
AFP, Tumor Marker CPL | 4210033 | 82105 | 301 | 36.25 | |
AFP/HCG/UE3/DIA MATERNAL SERUM IHC | |||||
ALP Isoenzymes PSPC | |||||
ALPHA-FETOPROTEIN (AFP); AFP-L3 FRACTION ISOFORM AND TOTAL AFP (INCLUDING RATIO | |||||
AMA+ASMA+LKM Ab LC | |||||
AML Fish Panel LC | |||||
AMPHETAMINES, SERUM/PLASMA QUANT PSPC | |||||
ANA Ab Reflex Cascade LC | |||||
ANA Autoimmune Profile CPL | 4211111 | 86038 | 302 | 107 | |
ANA Cascade NAH | |||||
ANA Comprehensive Panel | |||||
ANA Comprehensive Panel (Ref) | |||||
ANA Comprehensive Panel LC | |||||
ANA Comprehensive Plus Profile LC | |||||
ANA Non-Reflex To Titer CPL | |||||
ANA Screen, IFA with Reflex to Titer/Pattern/Cascade QST | |||||
ANA w/ Reflex CPL | 4210073 | 86038 | 302 | 54 | |
ANA w/Reflex LC | |||||
ANA w/Reflex if Positive LC | |||||
ANA+CCP(IgG/A) Antibodies LC | |||||
ANCA IP | |||||
ANCA Panel (Ref) | |||||
ANCA Panel LC | |||||
ANCA Screen CVT | |||||
ANCA Screen with Reflex to Titer QST | |||||
ANTIEXTRACTABLE NUCLEAR + ANGIOTENSION CONVERTING | |||||
APRI Score XN | |||||
ASO Titer CPL | 4210599 | 86060 | 302 | 117 | |
Ab Screen | |||||
Ab to Extractable Nuclear Ag Eval NAH | |||||
Acetaminophen Level | 4200015 | 80329 | 301 | 194.75 | |
Acetone Ql | 4200017 | 82009 | 301 | 65 | |
Acetylcholine Antibody Panel IP | |||||
Acetylcholine Receptor Ab, All LC | |||||
Acid Fast Smear+Culture (Ref) | |||||
Acid Fast Smear+Culture LC | |||||
Acid Fast Smear+Culture W/Rflx LC | |||||
Acid Fast Stain & Culture | |||||
Actin (Smooth Muscle) Ab IgG CVT | |||||
Actin (Smooth Muscle) Antibody LC | |||||
Acute Hepatitis Panel | |||||
Acute Hepatits Panel, CPL | 4210593 | 80074 | 302 | 103.5 | |
Adalimumab and Anti-Adalimumab Ab AMS | |||||
Adalimumab and Anti-Adalimumab Ab NLL | |||||
Adalimumab+Ab (Serial Monitor) LC | |||||
Adiponectin CPL | 4218945 | 83520 | 301 | 320.5 | |
Adrenocorticotropic Hormone CVT | |||||
Adult Food Allergy Panel IP | |||||
Aerobe ID and Suscept LC | |||||
Aerobic & Anaerobic Culture Profile CPL | |||||
Aerobic Bacterium ID x3 QST | |||||
Aerobic Culture Send Out QST | |||||
Aggressive B Cell Lymphoma LC | |||||
Alanine Aminotransferase | 4200117 | 84460 | 301 | 86.5 | |
Albumin CPL | 4200019 | 82040 | 301 | 63.5 | |
Albumin Level | 4200019 | 82040 | 301 | 68 | |
Albumin/Creatinine Ratio, Urine AMS | |||||
Alcohol Level | 4200021 | 80320 | 301 | 181 | |
Aldolase CPL | 4210057 | 82085 | 301 | 161 | |
Aldolase CVT | |||||
Aldolase LC | |||||
Aldosterone CPL | 4210059 | 82088 | 301 | 66.75 | |
Aldosterone CVT | |||||
Aldosterone LCMS, Serum LC | |||||
Aldosterone/Plasma Renin Activity Ratio LC/MS/MS QST | |||||
Aldosterone/Renin Activity Ratio IHC | |||||
Aldosterone/Renin Activity Ratio | |||||
Aldosterone/Renin Ratio (Ref) | |||||
Aldosterone/Renin Ratio LC | |||||
Alk Phos Isoenzyme (Ref) | |||||
Alk Phos Isoenzyme LC | |||||
Alkaline Phosphatase | 4200023 | 84075 | 301 | 62.75 | |
Alkaline Phosphatase Iso QST | |||||
Alkaline Phosphatase Isoenz AEL | |||||
Alkaline Phosphatase Isoenzymes CPL | 4211104 | 84080 | 301 | 134.75 | |
Alkaline Phosphatase Isoenzymes AMS | |||||
Alkaline Phosphatase Isoenzymes SV | |||||
Allergen Basic Foods Profile, PSPC | |||||
Allergen Pediatric 3 - 6 Years LC | |||||
Allergen Profile, Basic Food LC | |||||
Allergen Profile, Food-Citrus LC | |||||
Allergen Profile, Food-Fish LC | |||||
Allergen Profile, Food-Fruit LC | |||||
Allergen Profile, Latex Plus LC | |||||
Allergen Profile, Mold LC | |||||
Allergen Profile,Zone 11 SV | |||||
Allergen Shell Fish Profile ALI | |||||
Allergen,Resp Panel Region 15 IHC | |||||
Allergens w/Total IgE Area 12 LC | |||||
Allergens w/Total IgE Area 13 LC | |||||
Allergens w/Total IgE Area 14 LC | |||||
Allergens w/Total IgE Area 15 LC | |||||
Allergens w/Total IgE Area 19 LC | |||||
Allergens, Inhalants, Profile 18 IgE ALI | |||||
Allergens, Mold Profile ALI | |||||
Allergens, Ped Allergy, March Profile IgE ALI | |||||
Allergens, Seafood Profile ALI | |||||
Allergens, Zone 19 LC | |||||
Allergens, Zone 6 LC | |||||
Allergy Panel - Mold QST | |||||
Allergy Profile A (ie.NE Rast) IgE ALI | |||||
Allergy Profile, Pediatric IgE, IHC | |||||
Allergy, Food Comprehensive Profile 1 ALI | |||||
Allergy, Food,Profile 13 ALI | |||||
Allergy,Common Adult Food ALI | |||||
Allermetx Amer. Cockroach IgE CPL | 4211109 | 86003 | 302 | 34.25 | |
Almond IgE CPL | 4211110 | 86003 | 302 | 34.25 | |
Alpha Fetopro,L3 CVT | |||||
Alpha Fetoprotein Tumor Marker CVT | |||||
Alpha-1 Antitrypsin CVT | |||||
Alpha-1 Antitrypsin Phenotype PSPC | |||||
Alpha-1-Antitrypsin (AAT) Quantitation and Phenotype QST | |||||
Alpha-1-Antitrypsin CPL | 4210061 | 82103 | 301 | 160.5 | |
Alpha-1-Antitrypsin Phenotyp (Ref) | |||||
Alpha-1-Antitrypsin Phenotyp LC | |||||
Alpha-1-Antitrypsin, Serum LC | |||||
Alpha-Fetoprotein Tetra Profile SV | |||||
Alpha-Thalassemia DNA LC | |||||
Alprazolam, Serum CPL | |||||
Ammonia CPL | |||||
Ammonia Level | 4200025 | 82140 | 301 | 116 | |
Amph Confirm Mec NAH | |||||
Amphetamine Screen | 4200027 | 301 | 69.5 | ||
Amylase Creat Clearance Ratio | |||||
Amylase Isoenzymes (Ref) | |||||
Amylase Level | 4200029 | 82150 | 301 | 110.75 | |
Amylase Level 24 Hour Urine | |||||
Amylase, Random Urine W/Creatinine QST | |||||
Ana+Ena+Dna/DS+Sjogre LC | |||||
Anaerobe ID and Suscept (Ref) | |||||
Anaerobe ID and Suscept LC | |||||
Anaerobic Culture Send Out QST | |||||
Anaerobic and Aerobic Culture LC | |||||
Anaerobic/Aerobic/Gram Stain LC | |||||
Anal(Rectal) Cytology, LBP (Chart) LC | |||||
Anaplasma Phagocytophilum PSPC | |||||
Anemia Panel RCMH | |||||
Anemia Profile 2 | |||||
Anemia, Megaloblastic, Serum (Ref) | |||||
Angio Converting Enzyme CPL | |||||
Angiotensin-Converting Enzyme LC | |||||
Animal Epi/Dander/Feather Mix Profile ALI | |||||
Anti C3 and Anti IgG QST | |||||
Anti ENA (Smith + RNP Ab) IP | |||||
Anti- Parietal Cell Ab CVT | |||||
Anti-C1Q Antibocy, IgG CPL | 4211114 | 302 | 178.75 | ||
Anti-Centromere Antibody CVT | |||||
Anti-DNA(SS)IgG, Ab, Qn LC | |||||
Anti-Double Strand DNA Ab CVT | |||||
Anti-Mullerian Hormone CPL | 4218951 | 83520 | 301 | 280.5 | |
Anti-Mullerian Hormone LC | |||||
Anti-Nuclear Ab Screen CVT | |||||
Anti-Sjogren Ab (SS-A,SS-B) IP | |||||
Anti-Smith Antibody QST | |||||
Anti-Streptolysin O Ab CVT | |||||
Anti-Thyroid ABS PSPC | |||||
Anti-Thyroid Ab | |||||
Anti-dsDNA Antibodies LC | |||||
Antiadrenal Antibody Screen With Reflex To Titer QST | |||||
Antibody Identification LC | |||||
Anticardiolip Ab, IgA/G/M, Qn (Ref) | |||||
Anticardiolip Ab, IgA/G/M, Qn LC | |||||
Anticardiolipin Ab IgG, IgM | |||||
Anticardiolipin Ab Panel IgA, IgM, IgG | |||||
Anticardiolipin Ab, IgG, Qn LC | |||||
Anticardiolipin Ab, IgG/M, Qn LC | |||||
Antidepressant Drug Screen AMS | |||||
Antiextractable Nuclear Ag (Ref) | |||||
Antiextractable Nuclear Ag LC | |||||
Antineutrophil Cytoplasmic Ab (Ref) | |||||
Antineutrophil Cytoplasmic Ab LC | |||||
Antineutrophil Cytoplasmic Ab Reflex To MPO/PR3AB SV | |||||
Antinuclear Antibodies Direct LC | |||||
Antinuclear Antibody Screen NAH | |||||
Antipancreatic Islet Cells LC | |||||
Antiphospholipid Antibody Panel QST | |||||
Antiphospholipid Antibody Panel CPL | |||||
Antiphospholipid Syndrome Comp LC | |||||
Antiscleroderma-70 Antibodies LC | |||||
Antistreptolysin O Ab LC | |||||
Antithrombin Activity LC | |||||
Antithrombin III Activity CPL | 4218953 | 85300 | 301 | 131.5 | |
Antithrombin III, Func/Immunol (Ref) | |||||
Antithrombin III, Func/Immunol LC | |||||
Apolipoprotein A1 and B, P CDR | |||||
Apolipoprotein B CVT | |||||
Apolipoprotein B LC | |||||
Apolipoprotein B/A Ratio IP | |||||
Arbovirus Battery AEL | |||||
Arginine Vasopressin CVT | |||||
Arterial Bld Gas Complete | |||||
Arterial Blood Gas RT Complete | |||||
Arterial Blood Gas RT Standard | |||||
Arterial Blood Gas RT Standard | |||||
Arterial Blood Gas Standard | |||||
Arterial Cord Blood Gas RT Standard | |||||
Arthritic/Collagen Disease l | |||||
Aspartate Aminotransferase | 4200115 | 84450 | 301 | 84.5 | |
Aspergillus Abs, Quantitative DID (Ref) | |||||
Autoimmune Hepatitis Panel IP | |||||
Autoimmune Liver Disease Evaluation with Reflex to Smooth Muscle Ab (SMA), IgG by IFA ARUP | |||||
B Natriuretic Peptide CPL | |||||
B pertussis IgA Ab LC | |||||
B pertussis IgA IgG LC | |||||
B pertussis IgG Ab LC | |||||
B pertussis IgG/IgM Ab LC | |||||
B. Cinerea IgE CPL | 4211117 | 86003 | 302 | 34.25 | |
B. pertussis/parapertus PCR CVT | |||||
B.pertussisB.parapertussis PCR (Ref) | |||||
B.pertussisB.parapertussis PCR LC | |||||
B2 Microglobulin, Serum CVT | |||||
B2Glycoprotein I Abs, IgG/IgM IHC | |||||
BB ABO/Rh Request | |||||
BB RhIg Workup | |||||
BCID Panel (BioFire) | |||||
BCID Panel (FilmArray) | |||||
BCR-ABL (M-TH only) (Ref) | |||||
BCR-ABL (M-TH only) LC | |||||
BCR-ABL1 Kinase Domain LC | |||||
BCR-ABL1 kinase domain (Ref) | |||||
BCR-ABL1, Quant, CML Monitoring (P210) CPL | 4211123 | 81206 | 412 | ||
BCR-ABL1, Quant, Minor (P190) CPL | 4211124 | 81207 | 412 | ||
BF Lactate Dehydrogenase CVT | |||||
BILL ALPHA PAIN CARE PHYSICIANS PANEL-URINE COM | |||||
BILL ALPHA PAIN CARE PHYSICIANS PANEL-URINE MCR | |||||
BILL BARBITURATES-COM | |||||
BILL BARBITURATES-MCR | |||||
BILL BH 607 | |||||
BILL BH1004 | |||||
BILL BH1008 | |||||
BILL BH1011 | |||||
BILL BH1016 | |||||
BILL BH102 | |||||
BILL BH1023 | |||||
BILL BH1025 | |||||
BILL BH1027 | |||||
BILL BH1029 | |||||
BILL BH1033 | |||||
BILL BH1033.93 | |||||
BILL BH1035 | |||||
BILL BH1043 | |||||
BILL BH1044 | |||||
BILL BH1048 | |||||
BILL BH1059 | |||||
BILL BH1078 | |||||
BILL BH1084 | |||||
BILL BH109 | |||||
BILL BH1090.4 | |||||
BILL BH1099 | |||||
BILL BH1106 | |||||
BILL BH1107 | |||||
BILL BH1109 | |||||
BILL BH1111 | |||||
BILL BH1114 | |||||
BILL BH1117 | |||||
BILL BH1118 | |||||
BILL BH1121 | |||||
BILL BH1124 | |||||
BILL BH1125 | |||||
BILL BH1126 | |||||
BILL BH1128 | |||||
BILL BH1137 | |||||
BILL BH1140 | |||||
BILL BH1151 | |||||
BILL BH1155 | |||||
BILL BH1157 | |||||
BILL BH1158 | |||||
BILL BH1159 | |||||
BILL BH1160 | |||||
BILL BH1161 | |||||
BILL BH1164 | |||||
BILL BH1181 | |||||
BILL BH1183 | |||||
BILL BH1184 | |||||
BILL BH1194 | |||||
BILL BH1198 | |||||
BILL BH1203 | |||||
BILL BH1205 | |||||
BILL BH1207 | |||||
BILL BH1208 | |||||
BILL BH1210 | |||||
BILL BH1215 | |||||
BILL BH1217 | |||||
BILL BH1220 | |||||
BILL BH1222 | |||||
BILL BH1223 | |||||
BILL BH1227 | |||||
BILL BH1237 | |||||
BILL BH1239 | |||||
BILL BH1240 | |||||
BILL BH1242 | |||||
BILL BH1244 | |||||
BILL BH1246 | |||||
BILL BH1249 | |||||
BILL BH1254 | |||||
BILL BH1273 | |||||
BILL BH1282 | |||||
BILL BH1287 | |||||
BILL BH1301 | |||||
BILL BH1303 | |||||
BILL BH1318 | |||||
BILL BH1328 | |||||
BILL BH1337 | |||||
BILL BH1345 | |||||
BILL BH1364 | |||||
BILL BH151 | |||||
BILL BH1690 | |||||
BILL BH173 | |||||
BILL BH1766.81 | |||||
BILL BH182 | |||||
BILL BH1955 | |||||
BILL BH1995 | |||||
BILL BH200 | |||||
BILL BH2015 | |||||
BILL BH214 | |||||
BILL BH217 | |||||
BILL BH2473 | |||||
BILL BH2477 | |||||
BILL BH25 | |||||
BILL BH2515 | |||||
BILL BH2531 | |||||
BILL BH2545 | |||||
BILL BH2583 | |||||
BILL BH2637 | |||||
BILL BH325 | |||||
BILL BH423.93 | |||||
BILL BH427 | |||||
BILL BH431 | |||||
BILL BH439 | |||||
BILL BH47 | |||||
BILL BH473 | |||||
BILL BH525 | |||||
BILL BH559 | |||||
BILL BH602 | |||||
BILL BH627.95 | |||||
BILL BH628 | |||||
BILL BH642 | |||||
BILL BH644 | |||||
BILL BH650 | |||||
BILL BH652 | |||||
BILL BH660 | |||||
BILL BH661 | |||||
BILL BH662 | |||||
BILL BH664 | |||||
BILL BH665 | |||||
BILL BH686 | |||||
BILL BH689 | |||||
BILL BH690 | |||||
BILL BH694 | |||||
BILL BH702 | |||||
BILL BH716 | |||||
BILL BH721 | |||||
BILL BH761 | |||||
BILL BH774 | |||||
BILL BH778 | |||||
BILL BH782 | |||||
BILL BH790.93 | |||||
BILL BH794 | |||||
BILL BH796 | |||||
BILL BH801 | |||||
BILL BH802 | |||||
BILL BH803 | |||||
BILL BH81 | |||||
BILL BH811 | |||||
BILL BH812 | |||||
BILL BH815 | |||||
BILL BH824 | |||||
BILL BH84 | |||||
BILL BH843 | |||||
BILL BH845 | |||||
BILL BH862 | |||||
BILL BH864 | |||||
BILL BH867 | |||||
BILL BH868 | |||||
BILL BH873 | |||||
BILL BH892 | |||||
BILL BH896 | |||||
BILL BH909 | |||||
BILL BH912 | |||||
BILL BH915 | |||||
BILL BH917 | |||||
BILL BH923 | |||||
BILL BH925 | |||||
BILL BH927 | |||||
BILL BH931 | |||||
BILL BH935 | |||||
BILL BH942 | |||||
BILL BH943 | |||||
BILL BH946 | |||||
BILL BH948 | |||||
BILL BH950 | |||||
BILL BH952 | |||||
BILL BH958 | |||||
BILL BH960 | |||||
BILL BH966 | |||||
BILL BH970 | |||||
BILL BH971 | |||||
BILL BH989 | |||||
BILL BH995 | |||||
BILL BMM BLUE DIAMOND MED SPA PAIN PANEL-URINE-COM | |||||
BILL BMM BLUE DIAMOND MED SPA PAIN PANEL-URINE MCR | |||||
BILL BUPRENORPHINE-COM | |||||
BILL BUPRENORPHINE-MCR | |||||
BILL BUTORPHANOL-COM | |||||
BILL BUTORPHANOL-MCR | |||||
BILL CYCLOBENZAPRINE-COM | |||||
BILL CYCLOBENZAPRINE-MCR | |||||
BILL DRUG SCREEN 10R MCR | |||||
BILL DRUG SCREEN 10R-COM | |||||
BILL DRUG SCREEN 11R MCR | |||||
BILL DRUG SCREEN 11R-COM | |||||
BILL FENTANYL-COM | |||||
BILL FENTANYL-MCR | |||||
BILL GABAPENTIN-COM | |||||
BILL GABAPENTIN-MCR | |||||
BILL HEROIN METABOLITE MCR | |||||
BILL HEROIN METABOLITE-COM | |||||
BILL KETAMINE-COM | |||||
BILL KETAMINE-MCR | |||||
BILL LITTLE RIVER HEALTHCARE PAIN PANEL-ORAL FLUID COM | |||||
BILL LITTLE RIVER HEALTHCARE PAIN PANEL-ORAL FLUID MCR | |||||
BILL MALE PHYSICIANS CENTER PA PAIN PANEL-COM | |||||
BILL MALE PHYSICIANS CENTER PA PAIN PANEL-URINE MCR | |||||
BILL MARIJUANA METABOLITE(THC-COOH)-COM | |||||
BILL MARIJUANA METABOLITE(THC-COOH)-MCR | |||||
BILL METHADONE-COM | |||||
BILL METHADONE-MCR | |||||
BILL METHAMPHETAMINE2-COM | |||||
BILL METHAMPHETAMINE2-MCR | |||||
BILL METHYLPHENIDATE-$ | |||||
BILL METHYLPHENIDATE-COM | |||||
BILL NALTREXONE-COM | |||||
BILL NALTREXONE-MCR | |||||
BILL NL CENTER FOR ORTHO AND SPORTS MED REFLEX PANEL-URINE COM | |||||
BILL NL CENTER FOR ORTHO AND SPORTS MED REFLEX PANEL-URINE | |||||
BILL NL DRAB FUQUA FAMILY PRACTICE AND UC REFLEX PANEL-URINE COM | |||||
BILL NL DRAB FUQUA FAMILY PRACTICE AND UC REFLEX PANEL-URINE | |||||
BILL NL MASON PARK MED CLINIC REFLEX PANEL-URINE COM | |||||
BILL NL MASON PARK MED CLINIC REFLEX PANEL-URINE | |||||
BILL NL MINH LE MD REFLEX PANEL-URINE COM | |||||
BILL NL MINH LE MD REFLEX PANEL-URINE | |||||
BILL OF CODEINE-$ | |||||
BILL OF CODEINE-COM | |||||
BILL OF GABAPENTIN-COM | |||||
BILL OF GABAPENTIN-MCR | |||||
BILL OF HYDROCODONE-COM | |||||
BILL OF HYDROCODONE-MCR | |||||
BILL OF ZOLPIDEM-COM | |||||
BILL OF ZOLPIDEM-MCR | |||||
BILL POS BUPRENORPHINE-COM | |||||
BILL POS BUPRENORPHINE-MCR | |||||
BILL POS COCAINE-COM | |||||
BILL POS COCAINE-MCR | |||||
BILL POS HEROIN METABOLITE1-COM | |||||
BILL POS HEROIN METABOLITE1-MCR | |||||
BILL POS HEROIN METABOLITE4-COM | |||||
BILL POS METHADONE-COM | |||||
BILL POS METHADONE-MCR | |||||
BILL POS PCP-COM | |||||
BILL POS PCP-MCR | |||||
BILL POS THC/CANNABINOIDS-COM | |||||
BILL POS THC/CANNABINOIDS-MCR | |||||
BILL PREMIER PAIN CONSULTANTS SCREEN AND CONFIRM PANEL-URINE COM | |||||
BILL PREMIER PAIN CONSULTANTS SCREEN AND CONFIRM PANEL-URINE MCR | |||||
BILL REFLEX FAMILY HEALTH CENTER OF BASTROP PAIN PANEL-URINE COM | |||||
BILL REFLEX FAMILY HEALTH CENTER OF BASTROP PAIN PANEL-URINE MCR | |||||
BILL ROCKDALE PAIN MGMT CONSTANT PANEL-URINE COM | |||||
BILL ROCKDALE PAIN MGMT CONSTANT PANEL-URINE MCR | |||||
BILL ROCKDALE PAIN MGMT REFLEX PANEL-URINE COM | |||||
BILL ROCKDALE PAIN MGMT REFLEX PANEL-URINE MCR | |||||
BILL SILSBEE FAMILY MEDICINE PAIN PANEL-URINE COM | |||||
BILL SILSBEE FAMILY MEDICINE PAIN PANEL-URINE MCR | |||||
BILL SOUTH TEXAS SPINAL CLINIC PAIN PANEL-URINE COM | |||||
BILL SOUTH TEXAS SPINAL CLINIC PAIN PANEL-URINE MCR | |||||
BILL SPINE AND PAIN CENTER OF SAN ANTONIO-URINE COM | |||||
BILL SPINE AND PAIN CENTER OF SAN ANTONIO-URINE MCR | |||||
BILL SPRINTZ CENTER FOR PAIN AND DEPENDENCY PANEL-URINE COM | |||||
BILL SPRINTZ CENTER FOR PAIN AND DEPENDENCY PANEL-URINE MCR | |||||
BILL TMA AMC REFLEX PAIN PANEL-URINE COM | |||||
BILL TMA AMC REFLEX PAIN PANEL-URINE MCR | |||||
BILL TMA AMC WORK COMP REFLEX PAIN PANEL-URINE COM | |||||
BILL TMA AMC WORK COMP REFLEX PAIN PANEL-URINE MCR | |||||
BILL TMA DEM REFLEX PAIN PANEL-URINE COM | |||||
BILL TMA DEM REFLEX PAIN PANEL-URINE MCR | |||||
BILL TMA VO REFLEX PAIN PANEL-URINE COM | |||||
BILL TMA VO REFLEX PAIN PANEL-URINE MCR | |||||
BILL TMA WALKER REFLEX PAIN PANEL-URINE COM | |||||
BILL TMA WALKER REFLEX PAIN PANEL-URINE MCR | |||||
BILL TRAMADOL-COM | |||||
BILL TRAMADOL-MCR | |||||
BILL URGENT BEHAVIORAL HEALTH CARE PANEL-ORAL FLUID COM | |||||
BILL URGENT BEHAVIORAL HEALTH CARE PANEL-ORAL FLUID MCR | |||||
BILL VALIDATION PANEL (VP) COM | |||||
BILL VALIDATION PANEL (VP) MCR | |||||
BILL ZOLPIDEM- COM | |||||
BILL ZOLPIDEM-MCR | |||||
BK Quant PCR (Plasma/Serum) LC | |||||
BK Vir DNA Quant RT PCR, Ur CVT | |||||
BK Vir DNA RT-PCR CVT | |||||
BK Virus DNA Quant, QST | |||||
BK Virus QNT PCR, Urine IP | |||||
BK Virus Qn PCR, Urine IP | |||||
BRCAssure Comprehensive Test LC | |||||
BUN 24 Hour Urine | |||||
BUN/Creat Ratio | |||||
BUN/Creatinine | |||||
Babesia Microti ABS IgG/IgM, PSPC | |||||
Babesia Species By PCR CPL | |||||
Babesia microti Ab Panel LC | |||||
Bahia Grass IgE CPL | 4211118 | 86003 | 302 | 34.25 | |
Banana IgE CPL | 4211119 | 86003 | 302 | 34.25 | |
Barbiturate Screen | 4200033 | 301 | 69.5 | ||
Barley IgE CPL | |||||
Bartonella AB | |||||
Bartonella Antibodies, IgG, IgM AMS | |||||
Bartonella Antibody Panel (Ref) | |||||
Bartonella Antibody Panel LC | |||||
Bartonella Henselae/Quintana Abs AEL | |||||
Bartonella henselae Antibodies (IgG, IgM) with Reflex to Titer QST | |||||
Basic Lymphocyte Subset Analysis By Flow Cytometry CPL | 4211120 | 86360 | 302 | 91 | |
Basic Metabolic Panel2 | 4200167 | 80048 | 301 | 145 | |
Beef IgE CPL | 4211125 | 86003 | 302 | 34.25 | |
Benzodiazepine Screen | 4200035 | 301 | 69.5 | ||
Bermuda Grass IgE, CPL | 4211126 | 86003 | 302 | 34.25 | |
Beta 2 Glycoprotein I Ab (IgG, IgA, IgM) QST | |||||
Beta HCG, Quantitative CVT | |||||
Beta-2 GP1 AB Panel NLL | |||||
Beta-2 Glycoprotein 1 Abs AMS | |||||
Beta-2 Glycoprotein 1 Abs, IgG & IgM ALI | |||||
Beta-2 Glycoprotein 1 IgG/IgM CPL | 4211127 | 86146 | 302 | 85.5 | |
Beta-2 Glycoprotein Antibodies SV | |||||
Beta-2 Glycoprotein I Ab, G/M LC | |||||
Beta-2 Glycoprotein I Ab,G,A,M (Ref) | |||||
Beta-2 Glycoprotein I Ab,G,A,M LC | |||||
Beta-2 Glycoprotein I IgG/M/A AEL | |||||
Beta-2 Glycoprotein IgA CPL | |||||
Beta-2 Microglobulin CPL | 4210601 | 82232 | 300 | 68.75 | |
Beta-2 Microglobulin, Serum LC | |||||
Bile Acids LC | |||||
Bilirubin - Total, Direct, Indirect | |||||
Bilirubin Direct | 4200191 | 82248 | 301 | 72.75 | |
Bilirubin Indirect | |||||
Bilirubin Total | 4200189 | 82247 | 301 | 72.75 | |
Bilirubin Total & Direct CVT | |||||
Bilirubin Total and Direct | |||||
Bilirubin, Direct CPL | |||||
Bilirubin, Direct CVT | |||||
Bilirubin, Fractionated QST | |||||
Bilirubin, Total CVT | |||||
Bill 216655 EBV Acute Infection Abs | |||||
Bill 40 Baseline Panel | |||||
Bill 40 Follow-Up Panel | |||||
Bill 41 Female Hormone w/Hysterectomy Panel | |||||
Bill 42 Female Hormone w/o Hysterectomy Panel | |||||
Bill 43 Male Hormone Panel | |||||
Bill 44 Thyroid Panel | |||||
Bill 45 Rheum Auto Immune Panel | |||||
Bill 46 Baseline Panel | |||||
Bill 47 Follow-Up Panel | |||||
Bill 48 Baseline Panel | |||||
Bill 49 Baseline Panel | |||||
Bill 50 Follow-Up Panel | |||||
Bill 51 Baseline Panel | |||||
Bill 52 Follow-Up Panel | |||||
Bill 602641 Allergens w/ total Ige Area 11 | |||||
Bill 77 Foster Panel | |||||
Bill ALVARADO SPINE AND PAIN CENTER - URINE | |||||
Bill Antigen Screen x 2 [i] | |||||
Bill Antigen Screen x 3 [i] | |||||
Bill Brucella IgG/IgM, Qst | |||||
Bill Cyto, Hemosiderin, Urine | |||||
Bill DOT Drug Screen Fee | 4210259 | 301 | 40 | ||
Bill DOT Drug Screen No Kit | 4210253 | 301 | 80.25 | ||
Bill FESCO Drug Screen | 4210255 | 300 | 28.5 | ||
Bill FISH CML/ALL BCR/ABL, Qst | |||||
Bill General Health Panel 10 | 4200285 | 80050 | 310 | 560.75 | |
Bill Genosure Integrase | |||||
Bill Immunoglobulin G Subclass Panel QST | |||||
Bill Leukemia/Lymph Panel | |||||
Bill Lymphocyte Act | |||||
Bill Newborn Screening | |||||
Bill Non-DOT Drug Screen Fee | 4210261 | 301 | 37.5 | ||
Bill Non-DOT Drug Screen No Kit | 4210257 | 301 | 80.25 | ||
Bill Only - APOLIPRPROTEIN | |||||
Bill Only - Adiponectin | |||||
Bill Only - Boston Heart Cholesterol Balanceâ„¢ | |||||
Bill Only - Boston Heart HDL Mapâ„¢ | |||||
Bill Only - Lipid Panel | |||||
Bill Only - ORGANIC ACID SINGLE QUANT | |||||
Bill Only - QUANTITATIVE RIA 2 | |||||
Bill Only - QUANTITATIVE RIA 5 | |||||
Bill Only 2 MASS SPECTROMETRY QUANT | |||||
Bill Only 3 Assay of Opiates | |||||
Bill Only 3 MASS SPECTROMETRY QUANT | |||||
Bill Only 4 Assay of opiates | |||||
Bill Only Assay of amitriptyline | |||||
Bill Only Assay of benzodiazepines | |||||
Bill Only Assay of opiates | |||||
Bill Only BBREF ABO/Rh Grouping | |||||
Bill Only BBREF Drugs Dependent Antibody Studies | |||||
Bill Only BBREF Extended Phenotype | |||||
Bill Only BBREF Thermal Amplitude | |||||
Bill Only COLUMN CHROMOTOGRAPH/ISOTOPE | |||||
Bill Only DRUG SCREEN CLASS LIST A | |||||
Bill Only DRUG SCREENING BARBITURATES | |||||
Bill Only DRUG SCREENING OXYCODONE | |||||
Bill Only MASS SPECTROMETRY QUANT | |||||
Bill PKU (Phenylketonuria)[i] | |||||
Bill Panel 53 Thyroid RX w/o TPO | |||||
Bill Panel 54 BioTE Male Patient Pre-Pellet | |||||
Bill Panel 55 BioTE Female Post Pellet | |||||
Bill Panel 56 BioTE Male Post Pellet | |||||
Bill Panel 57 BioTE Female Post Pellet | |||||
Bill Panel 58 BioTE Female New Patient Pre-Pellet | |||||
Bill Panel 59 Baseline | |||||
Bill Panel 60 Follow-Up Panel | |||||
Bill Pap, Conventional Diagnostic | |||||
Bill Pap, Smear Conventional Screening | |||||
Bill Pap, Thin Prep Diagnostic | |||||
Bill Pap, Thin Prep Screening | |||||
Bill Profile 4 Baseline | |||||
Bill Profile 4 Follow-Up | |||||
Bill Profile 5 Baseline | |||||
Bill Profile 5 Follow-UP | |||||
Bill Respiratory Allergy Profile Region X : OK, TX QST | |||||
Bill TSH W/HAMA Treatment, Qst | |||||
Bill VAP Cholesterol | |||||
Bipolaris Spicifera IgE CPL | 4211129 | 86003 | 302 | 34.25 | |
Bleeding Time | 4200283 | 85002 | 305 | 78.5 | |
Blood Culture ID Panel PCR SV | |||||
Blood Culture PCR - GPC NAH | |||||
Blood Culture PCR-GNR NAH | |||||
Blood Gas Arterial | |||||
Blood Gas Arterial - Chem 5 POCT | |||||
Blood Gas Arterial with Co-Ox POCT | |||||
Blood Smear Pathologist Review CVT | |||||
Blood Urea Nitrogen | 4200121 | 84520 | 301 | 78.5 | |
Blood Urea Nitrogen | 4200121 | 84520 | 301 | 78.5 | |
Blood Urea Nitrogen | 4200121 | 84520 | 301 | 78.5 | |
Body Fluid Cell Count 4 | 4200217 | 89050 | 309 | 65 | |
Body Fluid Cell Count and Differential Standard | |||||
Body Fluid Culture (Aerobic and Anaerobic) AMS | |||||
Bone Marrow Aspiration [i] | |||||
Bordetella IgG/IgM/IgA CPL | |||||
Bordetella Panel Rapid | |||||
Bordetella Pertussis Ab AEL | |||||
Bordetella Pertussis IGM/IGG IP | |||||
Bordetella Pertussis QST | |||||
Bordetella Pertussis-Parapertussis NLL | |||||
Bordetella pertussis Antibody (IgG), MAID QST | |||||
Brain Natriuretic Peptide (BNP) | 4200255 | 83880 | 301 | 134.75 | |
Breath Alcohol | 4210258 | 82075 | 300 | 28.5 | |
Brucella Antibodies SV | |||||
C DIFFICILE EIA | |||||
C Diff Ag & Toxin | |||||
C Diff Ag and Toxin | |||||
C Difficile Cytotoxin Ab CPL | 4211130 | 87230 | 235.5 | ||
C Reactive Protein CPL | 4210541 | 86140 | 302 | 108.5 | |
C- Peptide CVT | |||||
C-1 Esterase Inhibitor IP | |||||
C-Peptide CPL | 4210559 | 84681 | 301 | 36.75 | |
C-Peptide, Serum LC | |||||
C. Diff Antigen and Toxin | |||||
C. Diff Cult, Rflx Cytotoxin Cell Assay CPL | 4211131 | 87015 | 775.75 | ||
C. Diff Toxin B By PCR CPL | 4218969 | 87493 | 301 | 144.5 | |
C. Difficile Gdh Reflex Toxin/PCR CPL | 4211133 | 87324 | 96.25 | ||
C. Globosum IgE* CPL | |||||
C. Herbarum IgE CPL | 4211135 | 86003 | 302 | 34.25 | |
C. Lunata IgE CPL | 4211136 | 86003 | 302 | 34.25 | |
C. difficile PCR CVT | |||||
C. trach/N. gonorr DNA, SDA QST | |||||
C.DIFFICILE EIA PSPC | |||||
C1 Inhibitor Protein QST | |||||
C3 CPL | 4210473 | 86160 | 302 | 40 | |
C4+C3 LC | |||||
CA 125 Antigen CVT | |||||
CA 125 CPL | 4210035 | 86304 | 302 | 87.75 | |
CA 19-9 CVT | |||||
CA 27.29 CPL | 4210039 | 86300 | 302 | 31.25 | |
CA 27.29 LC | |||||
CANDIDA AB IGG, IGA, IGM, ELISA | |||||
CARDIOLIPIN AB, IgG & IgM IHC | |||||
CBC (INCLUDES DIFF/PLT) WITH PATHOLOGIST REVIEW | |||||
CBC w/ Auto Diff | 4200071 | 85025 | 305 | 119.25 | |
CBC w/ Diff CPL | 4200071 | 85025 | 305 | 111.5 | |
CBC w/ Differential CVT | |||||
CBC w/Man Diff Standard | |||||
CBC with Manual Diff | |||||
CBG With Free Cortisol (Ref) | |||||
CCP Antibodies IgG/IgA LC | |||||
CCP IgG CPL | 4211089 | 86200 | 302 | 119.5 | |
CD20 CPL | 4211139 | 86356 | 302 | 65.25 | |
CD57 For Lyme Disease CPL | 4211140 | 86359 | 302 | 128.5 | |
CEA CPL | 4210047 | 82378 | 301 | 64.75 | |
CEA LC | |||||
CH50 CPL | 4210205 | 86162 | 302 | 40 | |
CK Electrophoresis IP | |||||
CK Isoenzymes CPL | 4211148 | 82552 | 124.75 | ||
CK Isoenzymes SV | |||||
CK Total And CKMB SV | |||||
CK, CKMB w/Index | |||||
CK, Total CPL | 4200075 | 82550 | 301 | 90.5 | |
CK, Total+Isoenzymes, Serum (Ref) | |||||
CK, Total+Isoenzymes, Serum LC | |||||
CK-MB with Rel Index | |||||
CKMB CPL | 4200063 | 82553 | 301 | 90.5 | |
CKMB PSPC | |||||
CLL FISH Panel LC | |||||
CMP 10 | 4200105 | 80053 | 301 | 160.75 | |
CMP 16 | 4200105 | 80053 | 301 | 160.75 | |
CMP CPL | 4200105 | 80053 | 301 | 150.25 | |
CMV Abs IgG/IgM LC | |||||
CMV Antibodies IP | |||||
CMV Antibodies IgG And IgM SV | |||||
CMV Culture IP | |||||
CMV PCR LC | |||||
COLLECTION: Arterial Draw | |||||
COLLECTION: Venous Draw | 4200149 | 36415 | 300 | 27 | |
CONNECTIVE TISSUE DISEASES PROFILE | |||||
COPPER 24 HOUR URINE | |||||
CORTISOL, URINE FREE BY LCMSMS IHC | |||||
CRP HS CPL | 4211163 | 86141 | 302 | 42.75 | |
CSF CULTURE CDR | |||||
CSF Cell Count 10 | |||||
CSF Cell Count 6 | 4200205 | 89050 | 309 | 65 | |
CSF Cell Count w/ Differential | |||||
CT/NG, TMA Urine CPL | 4211165 | 87491 | 117 | ||
CTNG Xpert | |||||
Ca+Creat+P+PTH Intact LC | |||||
Ca+PTH Intact LC | |||||
Calcitriol(1,25 di-OH Vit D) LC | |||||
Calcium CPL | |||||
Calcium Level Total | 4200211 | 82310 | 301 | 62.75 | |
Calcium, 24 Hr Ur PSPC | |||||
Calcium, 24Hr Urine LC | |||||
Calcium, Ionized CPL | 4210489 | 82330 | 301 | 40 | |
Calcium, Ionized, Serum LC | |||||
Calcium, Random Urine (w/ Creatinine) QST | |||||
Calcium, Random Urine LC | |||||
Calcium, Ur 24hr CVT | |||||
Calcium, Urine, 24 Hr CPL | |||||
Calcium/Crea Ratio Urine Spot | |||||
Calcium/Creatinine Ratio LC | |||||
Calcium/Creatinine Ratio, Random Urine NLL | |||||
Calculi, Urinary LC | |||||
Calprotectin Fecal LC | |||||
Calprotectin Stool CVT | |||||
Campylobacter Culture LC | |||||
Cancer AntIgen 19-9 CPL | 4210037 | 86301 | 302 | 254.75 | |
Cancer Antigen (CA) 15-3 LC | |||||
Candida Antibodies IgG,IgA,IgM LC | |||||
Cannabinoid Confirmation, Ur LC | |||||
Carbamazepine Level | 4200233 | 80156 | 301 | 232.5 | |
Carbamazepine(Tegretol), LC | |||||
Carbohydrate Antigen 19-9 | |||||
Carbon Dioxide Level | 4200221 | 82374 | 301 | 69.5 | |
Carcinoembryonic Ag CVT | |||||
Cardiac Enzymes | |||||
Cardiac Panel | |||||
Cardiac Panel 11 | |||||
Cardiac Panel 2 | |||||
Cardiac Panel 3 | |||||
Cardiac Panel Standard | |||||
Cardio IQ Advanced Lipid Panel QST | |||||
Cardio IQ Apolipoprotein Evaluation QST | |||||
Cardiolipin ABS, IgA, M, G PSPC | |||||
Cardiolipin Ab (IgA, IgG, IgM) QST | |||||
Cardiolipin Ab (IgG,IgM) QST | |||||
Cardiolipin Ab IgG,IgM,And IgA AEL | |||||
Cardiolipin Abs CPL | 4211137 | 86147 | 302 | 101.75 | |
Cardiolipin Antibodies IP | |||||
Cardiolipin Antibody SV | |||||
Cat Epithelium IgE CPL | 4211138 | 86003 | 302 | 34.25 | |
Cat Scratch Fever Abs IgG/IgM ALI | |||||
Catecholamines & VMA, 24Hr Urine | |||||
Catecholamines, Fractionated CVT | |||||
Catecholamines, Ur 24hr CVT | |||||
Catecholamines,Ur.,Free,24 Hr LC | |||||
Cedar, Red IgE* CPL | |||||
Cel Dis AB Prof PSPC | |||||
Celiac Ab Profile SV | |||||
Celiac Ab tTG DGP TIgA LC | |||||
Celiac Dis Ab Screen w/Rfx PSPC | |||||
Celiac Disease Ab Panel AEL | |||||
Celiac Disease Ab Screen w/Rfx LC | |||||
Celiac Disease Comprehensive Ab Profile | |||||
Celiac Disease Comprehensive LC | |||||
Celiac Disease Comprehensive Panel QST | |||||
Celiac Disease Genotype CPL | 4211143 | 81376 | 301 | 342.5 | |
Celiac Disease HLA DQ Assoc. LC | |||||
Celiac Disease II LC | |||||
Celiac Disease Panel CPL | 42190601 | 83516 | 301 | 146.25 | |
Celiac Disease Panel LC | |||||
Celiac Disease Profile IV NLL | |||||
Celiac Panel QST | |||||
Celiac Reflexive Panel ALI | |||||
Celiac Reflexive Panel IHC | |||||
Cell Count, Fluid CVT | |||||
Cell Ct+Cryst+Mucin(Synovial) LC | |||||
Cell Ct, Serous Fluid LC | |||||
Cell count, Synovial w crystals, LC | |||||
Central Texas IgE Panel CPL | |||||
Centromere Ab IP | |||||
Cerebrospinal Fluid Culture Send Out QST | |||||
Ceruloplasmin CPL | 4210479 | 82390 | 301 | 130 | |
Ceruloplasmin CVT | |||||
Ceruloplasmin LC | |||||
Chem 5 Art POCT | |||||
Chem 5 Ven POCT | |||||
Chem 6 Art POCT | |||||
Chem 6 Ven POCT | |||||
Chikungunya AB w/Rflx to Titer CVT | |||||
Chikungunya Abs, IgG/IgM LC | |||||
Chikungunya Virus RNA Ql PCR LC | |||||
Childhood Allergy IgE CPL | |||||
Childhood Allergy Profile QST | |||||
Chlam/ GC Nucleic Acid Screen AMS | |||||
Chlamydia GC DNA Probe IP | |||||
Chlamydia Pneumoniae Ab Panel PSPC | |||||
Chlamydia Psittaci IgM/IgG AbS AEL | |||||
Chlamydia Trachomatis Antibodies QST | |||||
Chlamydia Trachomatis RNA, TMA QST | |||||
Chlamydia Trachomatis and N gonorrhoeae AMS | |||||
Chlamydia Trachomatis/GC by Aptima WMC | |||||
Chlamydia trachomatis Culture, (Ref) | |||||
Chlamydia trachomatis PCR CVT | |||||
Chlamydia/GC Amplification (Ref) | |||||
Chlamydia/GC Amplification LC | |||||
Chlamydia/GC DNA Amplification, PCR | |||||
Chlamydia/GC, DNA Probe LC | |||||
Chlamydia/GC, PCR DLS | |||||
Chlamydia/N. Gonorrhoeae RNA, TMA QST | |||||
Chlmy/GC DNA Pr Amp PSPC | |||||
Chloride Level | 4200219 | 82435 | 301 | 49 | |
Chloride Level 24 Hour Urine | |||||
Chloride, 24Hr Urine LC | |||||
Chloride, Random Urine CPL | 4210485 | 82436 | 301 | 17.25 | |
Chloride, Ur CVT | |||||
Cholesterol High Density Lipid | 4200135 | 83718 | 301 | 134.75 | |
Cholesterol Low Density Lipids | 4200070 | 83721 | 301 | 113 | |
Cholesterol Total | 4200187 | 82465 | 301 | 62.75 | |
Chromatin Antibody CVT | |||||
Chromium CPL | |||||
Chromium and Cobalt, WB (MoM) LC | |||||
Chromium, Plasma CVT | |||||
Chromogranin A CPL | 4211147 | 86316 | 302 | 190.75 | |
Chromogranin A LC | |||||
Chromosome Analysis | |||||
Chromosome Analysis Blood QST | |||||
Chromosome Analysis, CLL/LPD QST | |||||
Chromosome, Blood, Routine (Ref) | |||||
Chromosome, Blood, Routine LC | |||||
Circulating Lupus Assessment AEL | |||||
Citalopram CPL | |||||
Citric Acid Level | |||||
Citric Acid,24 Hour Urine (With Creatinine) QST | |||||
Client Bill Breath Alcohol | 4210258 | 82075 | 300 | 28.5 | |
Clobazam, Serum CPL | 4211149 | 80339 | 301 | 80.25 | |
Clonazepam CPL | |||||
Clopidogrel CYP2C19 Genotype CVT | |||||
Clostridium Difficile Toxin AEL | |||||
Co-Ox Art POCT | |||||
Co-Ox Ven POCT | |||||
Co-Oximetry | |||||
Co-Oximetry Arterial Standard | |||||
Co-Oximetry Venous Standard | |||||
Cobalt, Blood CVT | |||||
Cocaine Screen | 4200037 | 301 | 69.5 | ||
Coccidiodes Antibodys IP | |||||
Coccidioides Abs, IgG/IgM, EIA LC | |||||
Coccidioides Antibodies NAH | |||||
Coccidioides Immitis Antibodies LC | |||||
Cocklebur IgE CPL | 4211150 | 86003 | 302 | 34.25 | |
Cockroach, German IgE CPL | 4211151 | 86003 | 302 | 34.25 | |
Comp panel: Leukemia/Lymphoma LC | |||||
Complement C4 CVT | |||||
Complement C3 & C4 CPL | 4211152 | 86160 | 302 | 80.25 | |
Complement C3 CVT | |||||
Complement C3, Serum LC | |||||
Complement C4 CPL | 4210475 | 86160 | 306 | 40 | |
Complement C4, Serum LC | |||||
Complement, Total (CH50) LC | |||||
Complement,CH50 Total CVT | |||||
Compliance Drug Analysis, Ur LC | |||||
Comprehensive Metabolic Panel + e-GFR CPL | |||||
Comprehensive Thyroglobulin LC | |||||
Connective Tissue Disease w/reflex, S CDR | |||||
Copper Serum LC | |||||
Copper, Ur 24Hr PSPC | |||||
Cord Blood Eval PSPC | |||||
Cord Drug Toxicology PRL | |||||
Cortisol - PM LC | |||||
Cortisol 1 Hour | |||||
Cortisol AM LC | |||||
Cortisol Free, Ur 24hr CVT | |||||
Cortisol LC | |||||
Cortisol Random CVT | |||||
Cortisol Stimulation 3 Samples | |||||
Cortisol, ACTH Stimulation (Ref) | |||||
Cortisol, AM CPL | 4211153 | 82533 | 301 | 40 | |
Cortisol, AM/PM LC | |||||
Cortisol, Free, Urine | |||||
Cortisol, PM CPL | |||||
Cortisol, Random CPL | 4211154 | 82533 | 301 | 62 | |
Cortisol, Urinary Free LC | |||||
Cortisol, Urine Free CPL | 4211155 | 82530 | 301 | 62 | |
Cortisol/Cortisone, Free Urine 24Hr PML | |||||
Cosyntropin Stim Test Full IP | |||||
Cotinine, Urine CPL | 4211156 | 80302 | 301 | 39.5 | |
Cotton Seed IgE CPL | 4211157 | 86003 | 302 | 80.25 | |
Cottonwood IgE CPL | 4211158 | 86003 | 302 | 34.25 | |
Coxsackie A Ab Panel CPL | 4211159 | 86658 | 302 | 34.25 | |
Coxsackie A9 Ab CPL | |||||
Coxsackie B Ab CPL | 4211161 | 86658 | 302 | 68.5 | |
Coxsackie B Virus Ab IP | |||||
Coxsackie Virus Group B Ab (Ref) | |||||
Cr Cl, (w/o Ser Cr) PSPC | |||||
Cranberry IgE CPL | |||||
Creatine Kinase | 4200075 | 82550 | 301 | 96.75 | |
Creatine Kinase Isoenzymes QST | |||||
Creatine Kinase-MB | 4200063 | 82553 | 301 | 96.75 | |
Creatinine | 4200077 | 82565 | 301 | 72.75 | |
Creatinine | 4200077 | 82565 | 301 | 72.75 | |
Creatinine | 4200077 | 82565 | 301 | 72.75 | |
Creatinine 2 | |||||
Creatinine Clear Ur 24h CVT | |||||
Creatinine Clearance (w/o Serum Creat) | |||||
Creatinine Clearance 1 | 4200137 | 82575 | 301 | 160.75 | |
Creatinine Clearance CPL | |||||
Creatinine Clearance Standard | |||||
Creatinine Level 24 Hour Urine | |||||
Creatinine Level Urine | 4200065 | 82570 | 301 | 86.5 | |
Creatinine, Ur 24hr CVT | |||||
Crohn'S Ibdx Prognostic Panel LC | |||||
Cryoglobulin and Cryofibrinogen Panel AMS | |||||
Cryoglobulin w/Reflex if Indicated CVT | |||||
Cryoglobulin, Panel NLL | |||||
Cryoglobulin, Qualitative Reflex To IgG, IgA, IgM CPL | 4211164 | 82595 | 301 | 149 | |
Cryoglobulin, Qualitative, Serum w/Quant Reflex LC | |||||
Cryptosporidium Ag, DFA QST | |||||
Crystals, Body Fluid CPL | |||||
Crystals, Body Fluid PRL | |||||
Crystals, Fl CVT | |||||
Ct, Ng, Trich vag by NAA LC | |||||
Ct/GC NAA, Pharyngeal LC | |||||
Ct/GC NAA, Rectal LC | |||||
Culture Aerobic ALI | |||||
Culture Aerobic, Sputum PSPC | |||||
Culture Anaerobic ALI | |||||
Culture Cerebrospinal Fluid ALI | |||||
Culture Respiratory Upper ALI | |||||
Culture Sputum ALI | |||||
Culture Stool IP | |||||
Culture Transfusion Reaction ALI | |||||
Culture, AFB w Smear CVT | |||||
Culture, Aerobic and Anaerobic QST | |||||
Culture, Anaerobic CPL | |||||
Culture, Blood CPL | |||||
Culture, Body Fluid CPL | 4200199 | 87070 | 306 | 152.25 | |
Culture, Body Fluid w/GS CVT | |||||
Culture, Fluid NLL | |||||
Culture, Fungus (Other) QST | |||||
Culture, Fungus Skin, Hair CPL | 4210215 | 87101 | 306 | 73 | |
Culture, Fungus w/ Smear CVT | |||||
Culture, Fungus, Blood QST | |||||
Culture, Fungus, Skin, Hair, Nail with DF/KOHÂ QST | |||||
Culture, Genital CPL | |||||
Culture, Group B Streptococcus NLL | |||||
Culture, Herpes Simplex /Typ CVT | |||||
Culture, Mrsa CPL | |||||
Culture, Mycobacterium (AFB) QST | |||||
Culture, Nasal CPL | 4200173 | 87070 | 306 | 141 | |
Culture, Respiratory NLL | |||||
Culture, Routine CPL | 4211166 | 87070 | 306 | 152.25 | |
Culture, Rubeola (Measles) ARUP | |||||
Culture, Sputum CPL | |||||
Culture, Sputum w/GS CVT | |||||
Culture, Stool | |||||
Culture, Stool NLL | |||||
Culture, Stool CVT | |||||
Culture, Stool QST | |||||
Culture, Stool w/ Escherichia coli NLL | |||||
Culture, Strep B - Pregnancy CPL | |||||
Culture, Throat CPL | |||||
Culture, Urine CPL | 4200177 | 87088 | 306 | 155 | |
Culture, Urine CVT | |||||
Culture, Urine QST | |||||
Culture, Viral, Non-Respiratory CPL | 87252 | 306 | |||
Culture, Wound (Aerobic/Anaerobic incl. Gram Stain) NLL | |||||
Culture, Wound w/GS CVT | |||||
Culture-AFB PML | |||||
Culture-AFB PML | |||||
Culture-Fungus PML | |||||
Cyclic Citrulline Peptide IgG CVT | |||||
Cyclospora Smear, Stool LC | |||||
Cyclosporine LC-MS/MS LC | |||||
Cyclosporine, Monoclonal CVT | |||||
Cystatin C LC | |||||
Cystic Fibrosis Genotyping, 39 Mutations (Cf 39) CPL | |||||
Cystic Fibrosis Profile LC | |||||
Cytogenomic SNP Microarray ARUP | |||||
Cytomegalovirus (CMV) Ab, IgG LC | |||||
Cytomegalovirus (CMV) Ab, IgM LC | |||||
Cytomegalovirus (CMV) IgG And Igm Antibody Panel, Elisa (Csf) QST | |||||
Cytomegalovirus Ab (IgG, IgM) QST | |||||
Cytomegalovirus Ab, IgG + IgM NLL | |||||
Cytomegalovirus Ab, IgG and IgM, S CDR | |||||
Cytomegalovirus Abs IgG/IgM ALI | |||||
D-Dimer CPL | 4211170 | 86003 | 302 | 34.25 | |
D-Dimer, High Sensitivity CVT | |||||
D. Farinae IgE CPL | 4210139 | 85379 | 301 | 53.5 | |
D. Pteronyssinus IgE CPL | 4211169 | 86003 | 302 | 34.25 | |
DHEA Sulfate CPL | 4210109 | 82627 | 301 | 40.75 | |
DHEA Sulfate CVT | |||||
DNA DS Ab QST | |||||
DNA DS Antibody CPL | 4211093 | 86255 | 302 | 64.25 | |
DNA DS Antibody Reflex CPL | 4211172 | 86255 | 302 | 80.25 | |
DNase B Ab CPL | 4211173 | 86215 | 302 | 41.75 | |
Dehydroepiandrosterone (DHEA) LC | |||||
Dehydroepiandrosterone Sulfate LC | |||||
Dengue Fever Ab IgG, IgM CVT | |||||
Dengue Fever Antibodies (IgG, IgM) PML | |||||
Dengue Virus IgG and IgM (Ref) | |||||
Dengue Virus IgG and IgM LC | |||||
Des Gamma Carboxy Prothrombin LC | |||||
Dexamethasone CVT | |||||
Dexamethosone Suppression Test IP | |||||
Digoxin Level | 4200059 | 80162 | 301 | 191.75 | |
Dihydrotestosterone CPL | 4211171 | 82542 | 305 | 101.75 | |
Dihydrotestosterone LC | |||||
Dilantin Level | 4200057 | 80185 | 301 | 208.5 | |
Diphtheria / Tetanus Antibody Panel SV | |||||
Direct Coombs CPL | |||||
Dog Dander IgE CPL | 4211174 | 86003 | 302 | 34.25 | |
Drug Abuse Panel 9, Serum CVT | |||||
Drug Confirm Opiate, Expanded NLL | |||||
Drug Screen Austin/20 CPL | 4211175 | 80301 | 301 | 40.75 | |
Drug Screen Cord | |||||
Drug Screen Employer | 4210989 | 301 | 45 | ||
Drug Screen Hair IP | |||||
Drug Screen Stat | |||||
Drug Screen w/ Reflex Confirm, LC | |||||
Drug Screen, Cord | |||||
Drugs of Abuse Screen Urine IP | |||||
E coli Shiga Toxin EIA LC | |||||
E. Purpurascens IgE CPL | 4211176 | 86003 | 302 | 34.25 | |
EBV AB Panel ALI | |||||
EBV Ab Profile, S CDR | |||||
EBV Ab VCA IgG, LC | |||||
EBV Ab VCA IgM, LC | |||||
EBV Acute Infection Antibodies (Ref) | |||||
EBV Acute Infection Antibodies LC | |||||
EBV Early Antigen Ab Prof, Qn LC | |||||
EBV, Chronic/Active Infection LC | |||||
ED Cardiac Panel RCMH | |||||
ENA+DNA/DS+Antich+DNA/SS+Sc LC | |||||
Echinococcus IgG CPL | 4211177 | 86682 | 302 | 75 | |
Egg White IgE CPL | 4211178 | 86003 | 302 | 34.25 | |
Ehrlichia Ab Panel NLL | |||||
Ehrlichia Ab Panel LC | |||||
Ehrlichia Chaffeenisis Dna,Pcr AEL | |||||
Ehrlichia Chaffeensis IgG/IgM CPL | 4211179 | 86003 | 302 | 34.25 | |
Ehrlichia HGE, IgG/IgM PSPC | |||||
Ehrlichia chaffeensis (IgG, IgM) QST | |||||
Ehrlichia/ Anaplasma Species by PCR ALI | |||||
Electrolyte Panel | 4200061 | 80051 | 301 | 110.75 | |
Electrophoresis Serum IP | |||||
Electrophoresis Urine IP | |||||
Electrophoresis, Protein, 24 Hr U CDR | |||||
Electrophoresis, Protein, Random, U CDR | |||||
Electrophoresis, Protein, S CDR | |||||
Elm IgE CPL | 4211180 | 86003 | 302 | 34.25 | |
Elm, Cedar/Fall IgE* CPL | |||||
Endo(IgA)+Glia(IgA/G)+Ret I... LC | |||||
Endomysial Antibody IgA LC | |||||
Endomysial Antibody, IGA Titer SV | |||||
English Plantain IgE CPL | 4211182 | 86003 | 302 | 34.25 | |
Enteric Pathogens Culture, Stool CDR | |||||
Enterovirus Antibodies Pane ARUP | |||||
Enterovirus RNA, Qual R CVT | |||||
Epst-Barr Acute PSPC | |||||
Epstein Barr Ab Panel QST | |||||
Epstein Barr Panel (VCA IgG/IgM, Early, Ebna IgG) CPL | |||||
Epstein Barr Panel NAH | |||||
Epstein Barr Virus (EBV) Ab, IgG, IgM, EBNA NLL | |||||
Epstein Barr Virus Capsid,IgG CVT | |||||
Epstein Barr Virus Capsid,IgM CVT | |||||
Epstein Barr Virus Nuclear,IgG CVT | |||||
Epstein Barr Virus Panel AEL | |||||
Epstein Barr Virus Profile IP | |||||
Epstein-Barr Acute Profile | |||||
Epstein-Barr Chronic Active Profile | |||||
Epstein-Barr VCA IgG CPL | |||||
Epstein-Barr VCA IgM CPL | |||||
Epstein-Barr Virus (EBV) Acute Infection Antibodies Profile SV | |||||
Epstein-Barr Virus (EBV) Quantitative , PCR LC | |||||
Epstein-Barr Virus Serology AMS | |||||
Erythropoietin (EPO), Serum LC | |||||
Erythropoietin CPL | 4210231 | 82668 | 301 | 54.75 | |
Erythropoietin CVT | |||||
Estradiol CPL | 4210239 | 82670 | 301 | 77.75 | |
Estradiol LC | |||||
Estradiol Level Urine | |||||
Estradiol, Free QST | |||||
Estradiol, Sensitive, LC | |||||
Estradiol, Total CVT | |||||
Estradiol, Ultrasens CPL | 4211183 | 82670 | 301 | 80.25 | |
Estriol, Serum LC | |||||
Estrogens Fractionated, S LC | |||||
Estrogens, E1+E2, fractionated, S CDR | |||||
Estrogens, Total LC | |||||
Estrone (E1) CPL | 4211184 | 82679 | 301 | 58.75 | |
Estrone LC | |||||
Ethosuximide CVT | |||||
Extended Ova \T\ Parasite Test SV | |||||
Extractable Nuclear Antigen ABS PSPC | |||||
Extractable Nuclear Antigen Ab IP | |||||
Eye Culture Send Out QST | |||||
Eye Culture w/Gram Stain PRL | |||||
F2-Isoprostane/Creatinine (Ref) | |||||
FIRST TRIMESTER SCREEN | |||||
FISH,B Cell Lymphocytic Leukemia Panel QST | |||||
FSH + LH Profile CPL | 4210163 | 83001 | 301 | 80.5 | |
FSH CPL | 4210163 | 83001 | 301 | 40.25 | |
FSH and LH AMS | |||||
FSH and LH CDR | |||||
FSH and LH LC | |||||
FSH/LH IP | |||||
Factor II, DNA Analysis LC | |||||
Factor V (Leiden) IP | |||||
Factor V Activity CPL | 4211185 | 85220 | 75 | ||
Factor V Activity PRL | |||||
Factor V Leiden CPL | 4210301 | 81241 | 301 | 351.25 | |
Factor V Leiden Mutation LC | |||||
Factor V Mutation Analysis QST | |||||
Factor VIII Activity LC | |||||
Factor Viii Activity CPL | 4211186 | 85240 | 75 | ||
Farr DNA Ds Ab CPL | 4211187 | 86225 | 302 | 80.25 | |
Febrile Ab Panel IP | |||||
Fecal Fat CVT | |||||
Fecal Fat, Qualitative LC | |||||
Fecal Leukocytes | 4210245 | 87205 | 306 | 41 | |
Fecal Leukocytes CPL | 4210245 | 87205 | 306 | 38 | |
Fecal Occult Blood Immunochemical | |||||
Female/Children Testosterone Panel PSPC | |||||
Ferritin | 4200129 | 82728 | 301 | 200.25 | |
Ferritin CPL | 4200129 | 82728 | 301 | 187.25 | |
Ferritin CVT | |||||
Fibrin Degradation Product CVT | |||||
Fibrinogen CPL | 4210097 | 85384 | 305 | 93.5 | |
Fibrinogen Evaluation Profile LC | |||||
Fire Ant IgE CPL | |||||
Firebush, Kochia IgE CPL | 4211188 | 86003 | 302 | 34.25 | |
Fish Allergen Profile ALI | |||||
Fish Test, Urine | |||||
Fish, CML/All, BCR/ABL Translocation 9,22 QST | |||||
Fish, DiGeorge (VCFS) | |||||
Flu A and B Ag Screen | |||||
Folate (Folic Acid) CVT | |||||
Folate Level | 4200031 | 82746 | 301 | 248.75 | |
Folate, RBC CPL | 4211189 | 82747 | 301 | 53.5 | |
Folate, RBC LC | |||||
Folic Acid CPL | 4200031 | 82746 | 301 | 16 | |
Follicle Stim Horm CVT | |||||
Food Allergen Profile II LC | |||||
Food Allergy IgE CPL | |||||
Food Allergy IgE Panel CPL | |||||
Food Allergy Panel (E95) | |||||
Food Allergy Panel Combo E+A | |||||
Food Allergy Profile QST | |||||
Food IgE Panel CPL | |||||
Food Panel 9 Allergens ALI | |||||
Food Panel CDR | |||||
Fractional Excretion Urea | |||||
Fractional Excretion Uric Acid | |||||
Fragile X DNA IP | |||||
Fragile X Screen With Reflex CPL | 4211190 | 81243 | 203.25 | ||
Fragile X with Reflex to Methylation ALI | |||||
Free Cortisol CPL | |||||
Free K+L Lt Chains Ur Qn (Ref) | |||||
Free K+L Lt Chains Ur Qn LC | |||||
Free K+L Lt Chains,Qn,S LC | |||||
Free Kappa/Lambda Light Chain | |||||
Free Light Chains, Serum CPL | 4211191 | 83883 | 301 | 150.25 | |
Free Progesterone CPL | |||||
Free T3 CPL | 4210255 | 84481 | 300 | 107 | |
Free T4 | 4200261 | 84439 | 301 | 181 | |
Free T4 CPL | 4210543 | 84439 | 301 | 16 | |
Free Thyroxine Index (FTI) NLL | |||||
Free and Total Insulin (Ref) | |||||
Free and Total Insulin LC | |||||
Free/Total PSA PRL | |||||
Fructosamine CPL | |||||
Fructosamine LC | |||||
Fungal Antibodies, Quant (Ref) | |||||
Fungus (Mycology) Culture LC | |||||
Fungus Cult (HSN) w KOH QST | |||||
Fungus Culture With Stain LC | |||||
Fungus Culture/Stain AEL | |||||
G6PDH Activity (Ref) | |||||
G6PDH Activity LC | |||||
GAD 65 Ab CVT | |||||
GAD-65 Auto Ab LC | |||||
GC & Chlamydia Amplified, Swab CPL | 4211193 | 87491 | 306 | 64.25 | |
GC & Chlamydia Amplified, Thinprep CPL | 4211194 | 87491 | 64.25 | ||
GC & Chlamydia By TMA CPL | 4211195 | 87491 | 301 | 64.25 | |
GC Amplified CPL | |||||
GC/Chlamydia - Amplified Probe AEL | |||||
GC/Chlamydia by PCR CVT | |||||
GGT CPL | 4200081 | 82977 | 301 | 64.5 | |
GLIADIN IgG & IgA, PSPC | |||||
GM1 Antibody Panel IP | |||||
GTT (1st 3 Specimens) | |||||
GTT 2 Hour | |||||
GTT 2 Hr | |||||
GTT 3 Hour | |||||
GTT 3 Hr | |||||
GTT 3 Hr (Non-Obstetrics) | |||||
GTT 3-Hour | |||||
GTT 4 Hr | |||||
GTT 4 Hr. | |||||
GTT 5 Hr | |||||
GTT OB 3 Hour | |||||
GTT, 3 Hour 100 gms | |||||
GTT, 3 Hour 75 gms | |||||
GTT-1 Hour | |||||
GTT: 1HR 100 gm | |||||
GTT: 1HR 50 gm | |||||
GTT: 1HR 75 gm | |||||
GTT: 3 hr 100 gms | |||||
GTT: 3 hr 75 gms | |||||
GTT: 4 hr | |||||
GTT: 5 hr | |||||
GTT: 6 hr | |||||
Gastric Occult Blood | 4200109 | 82271 | 301 | 62.75 | |
Gastrointestinal Panel (BioFire) | |||||
General Health Panel 1 | |||||
General Health Panel 10 | 4200285 | 80050 | 310 | 560.75 | |
Genital Culture PSPC | |||||
Genital Mycoplasma Profile Aptima Swab LC | |||||
Genital Mycoplasma Profile Aptima Urine LC | |||||
Gentamicin CPL | 4210555 | 80170 | 301 | 90.75 | |
Gentamicin, Trough CVT | |||||
Gentamicin, Peak CVT | |||||
Gentamicin, Trough Level CPL | |||||
Gestational GTT | |||||
Giardia & Cryptosporidium Ag CVT | |||||
Giardia / Cryptosporidium Antigen Screen AMS | |||||
Giardia Lamblia Direct Detection EIA, LC | |||||
Giardia/Cryptosporidium EIA (Ref) | |||||
Giardia/Cryptosporidium EIA LC | |||||
Gliadin (Deamidated) Ab, Eval, S CDR | |||||
Gliadin Ab IP | |||||
Gliadin Ab, Deamidated IgG/IgA AEL | |||||
Gliadin Antibodies IgG & A CVT | |||||
Gliadin Antibodies, IgG, IgA AMS | |||||
Gliadin IgG IgA Ab Prof (Ref) | |||||
Gliadin IgG IgA Ab Prof LC | |||||
Gliadin IgG, IgA Ab QST | |||||
Gliadin, IgG & IgA (RPS) PSPC | |||||
Glidin IgG & IgA | |||||
Glomerular Basement IgG CPL | 4211196 | 83516 | 69.5 | ||
Glomerular Basement Membran Ab CVT | |||||
Glucose 3 Hour | |||||
Glucose 4 Hour | |||||
Glucose 5 Hour | |||||
Glucose 6 Hour | |||||
Glucose Level | 4200083 | 82947 | 301 | 62.75 | |
Glucose POC Lab Request | |||||
Glucose Tolerance Test 2 Hour | |||||
Glucose Tolerance Test 3 Hour | |||||
Glucose Tolerance Test 4 Hour | |||||
Glucose Tolerance Test 5 Hour | |||||
Glucose Tolerance Test 6 Hour | |||||
Glucose Tolerance Test, 4 Hour | |||||
Glucose Tolerance Test, 5 Hour | |||||
Glucose Tolerance Test, 6 Hour | |||||
Glucose, Body Fluid LC | |||||
Glucose, CSF CVT | |||||
Gluten IgE CPL | |||||
Glycohemoglobin | 4200169 | 83036 | 301 | 125 | |
Gonorrhea/Chlamydia Panel NAH | |||||
Goose Feathers IgE CPL | 4211197 | 86003 | 302 | 34.25 | |
Gram Stain CPL | |||||
Gram Stain Evaluation With Sputum Culture Reflex LC | |||||
Gram Stain w/Sputum Cult Rflx LC | |||||
Gram Stain/Body Fluid Culture LC | |||||
Green Bean IgE* CPL | |||||
Group B Strep Screen Molecular | |||||
Growth Hormone, Serum LC | |||||
H Pylori AB, IgG, IgM, IgA NLL | |||||
H pylori, IgM, IgG, IgA Ab LC | |||||
H&H Test | |||||
H. Pylori | 4200133 | 86677 | 302 | 277.75 | |
H. Pylori Ab | |||||
H. Pylori Ag, Stool CPL | 4210337 | 87338 | 306 | 69.5 | |
H. Pylori IgG Antibody CPL | 4211198 | 86677 | 302 | 37.5 | |
H. Pylori IgG, IgM, IgA Quant CPL | |||||
H. Pylori IgG/IgA Abs CPL | |||||
H. Pylori IgM Antibody CPL | 4211199 | 86677 | 302 | 37.5 | |
H. Pylori Tissue | 4200134 | 86677 | 302 | 277.75 | |
H. pylori Ag, Stool by EIA CVT | |||||
H. pylori Breath Test LC | |||||
H. pylori IgG, Abs LC | |||||
H. pylori Stool Ag, EIA LC | |||||
H1N1 PCR CVT | |||||
HAV/HBV (Profile VII) LC | |||||
HBV/HCV (Profile VIII) LC | |||||
HBc Total Ab, w/Reflex, S CDR | |||||
HCG, Quantitative CPL | |||||
HCV Ab w/Rflx to Verification LC | |||||
HCV FibroSure (Ref) | |||||
HCV FibroSure LC | |||||
HCV Genotyping Non Reflex LC | |||||
HCV RNA CPL | 4211201 | 87522 | 300 | 101.75 | |
HCV RNA NAA Qual rfx to Quant LC | |||||
HCV RNA by PCR, Qn Rfx Geno LC | |||||
HCV RNA, PCR, Quant (Reflex to Genotyping LC | |||||
HCV RT-PCR, Quant (Graph) LC | |||||
HCV RT-PCR, Quant (Non-Graph) LC | |||||
HEP C ANTIBODY W/REFLEX PSPC | |||||
HEPA-Score IP | |||||
HEPATOCELLULAR CARCINOMA PANEL | |||||
HIV 1& 2, Rapid EIA | |||||
HIV CPL | 4218996 | 87389 | 302 | 31.75 | |
HLA B-27 CPL | 4210589 | 86812 | 302 | 57.25 | |
HLA B27 Disease Association LC | |||||
HLA Celiac Disease AEL | |||||
HLA-B27 CVT | |||||
HLA-DQ Oligotyping IP | |||||
HNK1 (CD57) Panel LC | |||||
HP5 LC | |||||
HPV Genotypes 16/18,45 LC | |||||
HPV High If Abnormal Thinprep CPL | 87624 | 300 | |||
HPV High Risk With Genotype, Tp CPL | 4211211 | 87624 | 300 | 64.25 | |
HSV (Herpes Simplex) By PCR SV | |||||
HSV 1 & 2 IgG ALI | |||||
HSV 1 IgM Screen CVT | |||||
HSV 1 and 2 IgM Abs, Indirect LC | |||||
HSV 1 and 2-Specific Ab, IgG (Ref) | |||||
HSV 1 and 2-Specific Ab, IgG LC | |||||
HSV 1/2 Ab IgG, CSF IHC | |||||
HSV 1/2 IgG Ab QST | |||||
HSV 1/2 IgM Ab QST | |||||
HSV 1/2 PCR CSF/BLOOD LC | |||||
HSV Ag AEL | |||||
HSV Culture and Typing LC | |||||
HSV I-II Type Specific IgG SV | |||||
HSV I-II Type Specific IgM SV | |||||
HSV I/II Combined AB Screen IGM ALI | |||||
HSV IgG Rflx I/II Type Sp LC | |||||
HSV NAA (Ref) | |||||
HSV NAA LC | |||||
HSV Type 1-Specific Ab, IgG LC | |||||
HSV Type 2-Specific Ab, IgG LC | |||||
HSV Types 1 and 2 Ab, IgG, S CDR | |||||
HSV Types 1/2 Ab NAH | |||||
HSV and VZV PCR Panel LC | |||||
HSV and VZV by PCR NLL | |||||
HSV, IgM I/II Combination LC | |||||
HSV1/HSV2 IgG Ab AEL | |||||
HSV1/HSV2(IgG/M) LC | |||||
HSVIG+HSVIIG+HSVIgM LC | |||||
HYPERSENSITIVITY PNEUMONITIS PANEL | |||||
Hackberry IgE* CPL | |||||
Hantavirus ABs PSPC | |||||
Hantavirus Ab IgM/IgG IP | |||||
Haptoglobin CVT | |||||
Haptoglobin, Quant CPL | 4210339 | 83010 | 301 | 46 | |
Health Fair Male | |||||
Heavy Metal Profile II, LC | |||||
Heavy Metal Screen Blood IP | |||||
Heavy Metal Screen Urine IP | |||||
Heavy Metal Screen w/ Demographics NLL | |||||
Heavy Metal-Prof II Blood SV | |||||
Heavy Metals | |||||
Heavy Metals Panel, 24-Hour Urine QST | |||||
Heavy Metals Panel, Blood QST | |||||
Heavy Metals Profile 1, Blood (Ref) | |||||
Heavy Metals Profile 1, Blood LC | |||||
Heavy Metals Profile, Urine (Ref) | |||||
Heavy Metals Profile, Urine LC | |||||
Heavy Metals Screen, 24 hr Urine AMS | |||||
Heavy Metals, 24 Hr Urine | |||||
Heavy Metals, Blood AEL | |||||
Heavy Metals, Blood IHC | |||||
Heavy Metals, Urine | |||||
Helicobacter pylori Breath Test, Pediatric | |||||
Helicobacter pylori Breath Test, Adult | |||||
Helicobacter pylori Breath Tst CVT | |||||
Helicobacter pylori Culture LC | |||||
Helper T-Lymph-CD4 LC | |||||
Hematocrit | 4200088 | 85014 | 305 | 52.75 | |
Hematocrit | 4200088 | 85014 | 305 | 52.75 | |
Hematocrit | 4200088 | 85014 | 305 | 52.75 | |
Hematocrit CPL | 4200088 | 85014 | 305 | 49.25 | |
Hemochromatosis (HFE) PCR CPL | 4211202 | 81256 | 96.25 | ||
Hemochromotosis Genotype IP | |||||
Hemoglobin | 4200087 | 85018 | 305 | 52.75 | |
Hemoglobin | 4200087 | 85018 | 305 | 52.75 | |
Hemoglobin | 4200087 | 85018 | 305 | 52.75 | |
Hemoglobin A1C With EAG CPL | 4200169 | 83036 | 306 | 116.75 | |
Hemoglobin A1C w/EAG & Int Chart CPL | |||||
Hemoglobin And Hematocrit CPL | 4200087 | 85018 | 305 | 98.5 | |
Hemoglobin CPL | 4200087 | 85018 | 305 | 49.25 | |
Hemoglobin Electrophoresis CPL | 4210267 | 83020 | 301 | 85.75 | |
Hemoglobin Electrophoresis Cascade NLL | |||||
Hemoglobin Eval w/rflx to Electroph. ALI | |||||
Hemoglobin and Hematocrit | |||||
Hemoglobinopathy Eval QST | |||||
Hep A Ab, IgM LC | |||||
Hep A(Rflx To IgM) LC | |||||
Hep B Core Ab CPL | 4210089 | 86704 | 302 | 44.25 | |
Hep B Core Ab Rflx IgM CPL | 4210227 | 68705 | 302 | 116.75 | |
Hep B Surface Ag CPL | 4210077 | 87340 | 302 | 103.25 | |
Hep B Surface Ab CPL | 4210353 | 86706 | 302 | 26.75 | |
Hep B Surface Ab Qual LC | |||||
Hep Bs Ab Quant CPL | 4218986 | 86706 | 301 | 31 | |
Hep C Ab CPL | 4210179 | 86803 | 302 | 47.25 | |
Hep Prof 6 PSPC | |||||
Hepatic Function Panel CPL | 4200179 | 80076 | 301 | 142.25 | |
Hepatic Panel 1 | 4200179 | 80076 | 301 | 152.25 | |
Hepatitis A Ab, Total w/Rfx to IgM QST | |||||
Hepatitis A Total Ab CPL | 4210091 | 86708 | 302 | 19.75 | |
Hepatitis A, IgM CVT | |||||
Hepatitis A,Total CVT | |||||
Hepatitis ABC Profile CPL | |||||
Hepatitis Acute Panel CVT | |||||
Hepatitis B Core Antibody IgG + IgM | |||||
Hepatitis B Core IgM CPL | 4210227 | 86705 | 302 | 116.75 | |
Hepatitis B Core, Total CVT | |||||
Hepatitis B Surf Ab Quant LC | |||||
Hepatitis B Surface Ag CVT | |||||
Hepatitis B Surface Ab, Quant CVT | |||||
Hepatitis B Virus (HBV) Evaluation Profile LC | |||||
Hepatitis B Virus (Profile VI) LC | |||||
Hepatitis B Virus DNA, Quant CVT | |||||
Hepatitis Be Ab CVT | |||||
Hepatitis Be Ag CVT | |||||
Hepatitis C Ab w/Reflex to HCV, RNA Qnt, RT-PCR QST | |||||
Hepatitis C Genotype CPL | 4218985 | 87902 | 301 | 433.75 | |
Hepatitis C Viral RNA Genotype CVT | |||||
Hepatitis C Viral RNA, Quant CVT | |||||
Hepatitis E IGG/IGM | |||||
Hepatitis Panel (4) LC | |||||
Hepatitis Profile (A,B,C) CPL | |||||
Hepatitis Profile 6 | |||||
Hepatitis Profile IP | |||||
Hered.Hemochromatosis, DNA LC | |||||
Herpes Simplex 1 IgG CPL | 4218987 | 86696 | 301 | 108.5 | |
Herpes Simplex 1,2 IgM, PSPC | |||||
Herpes Simplex 1/2 IgG CPL | |||||
Herpes Simplex 1/2, IgG CVT | |||||
Herpes Simplex 1/2, IgG, IgM AMS | |||||
Herpes Simplex 1/2, IgM CVT | |||||
Herpes Simplex 1/2,DNA Qual CVT | |||||
Herpes Simplex 2 IgG CPL | 4218988 | 86696 | 301 | 108.5 | |
Herpes Simplex Culture & Typing CPL | |||||
Herpes Simplex IgM CPL | |||||
Herpes Simplex Type I/II QST | |||||
Herpes Simplex Virus 1/2 by NAAT NLL | |||||
Herpes Simplex Virus Ab Panel IP | |||||
Herpes Simplex Virus IgG & IgM CPL | 4210009 | 86696 | 301 | 62 | |
Herpes Simplex, HSV Types 1 and 2 AB, IgG and IgM NLL | |||||
Herpes Simplex/Varicella Zoster, Rapid Culture QST | |||||
Hgb A1c CPL | 4200169 | 83036 | 301 | 116.75 | |
Hgb Frac. Profile LC | |||||
Histamine, 24 Hr Urine | |||||
Histone Ab IP | |||||
Histoplasma Antibody IP | |||||
Histoplasma Galactomannan Antigen, Urine QST | |||||
Homocyst(e)ine, Plasma LC | |||||
Homocysteine CPL | 4210265 | 83090 | 301 | 44.75 | |
Homocysteine CVT | |||||
Homovanillic Acid, Ur 24Hr CVT | |||||
Honey Bee IgE CPL | |||||
Hops IgE* CPL | |||||
Horse D&er IgE CPL | |||||
Huntingtons Disease Panel IP | |||||
Hydroxyindoleacetic Acid, 5-,Random Urine QST | |||||
Hypercoagulable Panel PSPC | |||||
Hypersensitivity Pneumonitis #2 LC | |||||
Hypersensitivity Pneumonitis I IP | |||||
Hypersensitivity Pneumonitis II IP | |||||
Hyperthyroid Panel IP | |||||
IBD Expanded Panel (Ref) | |||||
IBD Panel IP | |||||
IEP, Urine AEL | |||||
IFE and PE, Random Urine LC | |||||
IFE and PE, Serum LC | |||||
IFE+Protein Electro, 24-Hr Ur LC | |||||
IGF-1 CPL | 4211212 | 84305 | 85.5 | ||
IGF-1 LC | |||||
IGF-1 and IGF Binding Protein 3 AMS | |||||
IGF-BP3 LC | |||||
IGG SYNTHESIS RATE/INDEX, CSF | |||||
IGG Subclasses IP | |||||
IMMUNOFIXATION & PROTEIN ELECTR 24 HR UR PSPC | |||||
INFLUENZA ABS PANEL PSPC | |||||
INTERFERON BETA 1A QST | |||||
INTERFERON BETA 1B QST | |||||
IRON & IRON BINDING CAPACITY PSPC | |||||
IRON AND TOTAL IRON BINDING CAPACITY IHC | |||||
IgA LC | |||||
IgE+Allergens(23) LC | |||||
IgG Allergen, Cow Milk* CPL | |||||
IgG Allergen, Gluten CPL | |||||
IgG Subclasses 1-4 | |||||
IgG Subclasses 1-4 LC | |||||
IgG Subclasses ALI | |||||
IgG Subclasses AMS | |||||
IgG Subclasses, Serum NLL | |||||
IgG Total And Subclasses IHC | |||||
IgG, IgM, IgA, IgE | |||||
IgG, Subclasses(1-4) (Ref) | |||||
IgG, Subclasses(1-4) LC | |||||
IgG,IgA, Indirect Immunoflorescence, Qst | |||||
IgG4 Food Panel II IBT, PSPC | |||||
Immunoelectrophoresis, Serum AMS | |||||
Immunoelectrophoresis, Urine AMS | |||||
Immunoelectrophoresis, Urine SV | |||||
Immunofix & Protein Electrophoresis | |||||
Immunofix & Protein Electrophoresis, 24 Hr Urine | |||||
Immunofix & Protein Electrophoresis With Immunoglobulin Quants, Serum CPL | |||||
Immunofix&SPEP CPL | 4219037 | 84155 | 301 | 80.25 | |
Immunofixation & Protein Electrophoresis, Urine | |||||
Immunofixation + Protein Electrophoresis, Urine CPL | 4219038 | 84155 | 301 | 80.25 | |
Immunofixation IgA, IgG, IgM Qt QST | |||||
Immunofixation, Ser CVT | |||||
Immunofixation, Serum | |||||
Immunofixation, Serum CPL | 4211218 | 84155 | 302 | 58.75 | |
Immunofixation, Serum LC | |||||
Immunofixation, Urine CPL | 4211219 | 86335 | 302 | 58.75 | |
Immunofixation, Urine IHC | |||||
Immunoglobins IgG, IgM, & IgA Quant | |||||
Immunoglobins IgG, IgM,IgA & IgE Quant | |||||
Immunoglobulin A (IgA) CPL | 4219005 | 82784 | 301 | 34.25 | |
Immunoglobulin A CVT | |||||
Immunoglobulin A Subclasses QST | |||||
Immunoglobulin A, Quant. Serum LC | |||||
Immunoglobulin D, Quant, Serum LC | |||||
Immunoglobulin E CPL | 4219008 | 82784 | 301 | 22 | |
Immunoglobulin E CVT | |||||
Immunoglobulin E, Total LC | |||||
Immunoglobulin Free Light Chains NLL | |||||
Immunoglobulin Free Light Chains, Serum AMS | |||||
Immunoglobulin G CPL | 4219006 | 82784 | 301 | 42.75 | |
Immunoglobulin G CVT | |||||
Immunoglobulin G Subclasses QST | |||||
Immunoglobulin G, Qn, Serum LC | |||||
Immunoglobulin Light Chains, Urine AMS | |||||
Immunoglobulin M (IgM) CPL | |||||
Immunoglobulin M, Qn, Serum LC | |||||
Immunoglobulin Panel IP | |||||
Immunoglobulin Panel, Serum QST | |||||
Immunoglobulin Profile ALI | |||||
Immunoglobulin Total Light Chains, Urine NLL | |||||
Immunoglobulins A/E/G/M, Serum LC | |||||
Immunoglobulins A/G/M, Qn, Ser LC | |||||
Immunoglobulins IgG,A,M, S CDR | |||||
Immunoglobulins SV | |||||
Immunoglobulins, IgA, IgG, IgM CPL | 4219003 | 82784 | 301 | 61.75 | |
Immunoglobulins, Quant | |||||
Immunoglobulins, Quant Serum AMS | |||||
Immunoglobulins, Quantitative PSPC | |||||
Immunoglubulin Panel NAH | |||||
Inflammatory Bowel Disease Panel AMS | |||||
Inflammatory Bowel Disease Panel ARUP | |||||
Inflammatory Bowel Disease-IBD (Ref) | |||||
Inflammatory Bowel Disease-IBD LC | |||||
Inflammatory Bowel Panel QST | |||||
Infliximab (IFX) Conc+ IFX Ab LC | |||||
Influenza A & B Antibodies | 4200265 | 87400 | 306 | 78.5 | |
Influenza A & B by PCR | |||||
Influenza A & B, PCR | |||||
Influenza A & B, RSV by PCR | |||||
Influenza A & B, w/ PCR Reflex | |||||
Influenza A + B Rapid. | |||||
Influenza A H1N1 RT PCR (Ref) | |||||
Influenza A and B Antigens | |||||
Influenza A&B 2 | |||||
Influenza A&B 3 | |||||
Influenza A&B 5 | |||||
Influenza A&B Rapid | |||||
Influenza A+B Rapid | |||||
Influenza A/B & RSV by PCR | |||||
Influenza Rapid Viral Culture LC | |||||
Influenza and RSV PCR NAH | |||||
Inhibin A CVT | |||||
Insulin (3 Specimens) LC | |||||
Insulin Abs LC | |||||
Insulin Autoantibody CVT | |||||
Insulin CPL | 4210625 | 83525 | 301 | 36.75 | |
Insulin CVT | |||||
Insulin LC | |||||
Insulin Tolerance 2 Hr IP | |||||
Interpretation QST | |||||
Intrinsic Factor Ab CVT | |||||
Intrinsic Factor Antibodies CPL | 4210209 | 86340 | 302 | 153.75 | |
Iodine, LC | |||||
Iodine, Serum CPL | 4211225 | 83018 | 85.5 | ||
Iodine, Ur CVT | |||||
Iron | 4200281 | 83540 | 301 | 110.75 | |
Iron & Iron Binding | |||||
Iron & TIBC Total Iron Binding Capacity | |||||
Iron & Tibc AEL | |||||
Iron Binding Capacity & Iron Total QST | |||||
Iron CPL | |||||
Iron Deficiency Panel | |||||
Iron Evaluation Panel IP | |||||
Iron Profile | |||||
Iron Profile PSPC | |||||
Iron Profile Standard | |||||
Iron Sat Panel NAH | |||||
Iron and Iron Binding ALI | |||||
Iron and Iron Binding Capacity ARUP | |||||
Iron and TIBC LC | |||||
Iron, IBC & % Saturation DLS | |||||
Islet Cell Antibody Scrn w/Tit CVT | |||||
Isoforms 25-Hydroxy Vit D CPL | 4211226 | 112.25 | |||
Isolate Culture, Urine CPL | |||||
JAK2 V617F Mutation, Whole Blood CPL | |||||
JAK2 V617F, Qualitative, w/reflex QST | |||||
JC Virus DNA,PCR (Whole Blood) LC | |||||
JO-1 Antibody CPL | |||||
JO-1 Antibody CVT | |||||
Jak2 Gene V617F Mutation With Reflex To Calr, Mpl Codon 515 CPL | 4211227 | 81403 | 305 | ||
Johnson Grass IgE CPL | 4211228 | 86003 | 302 | 34.25 | |
June Grass IgE CPL | 4211229 | 86003 | 302 | 34.25 | |
K&L Light Chains, Quant, Serum SV | |||||
Kappa Lambda Lite Chains,Ur CVT | |||||
Kappa-Lambda Free Light Chains,Qnt ALI | |||||
Kappa/Lambda Free Light Chains Qnt Ur ALI | |||||
Kappa/Lambda Light Chains, Free with Ratio QST | |||||
Kappa/Lambda Light Chains, Free with Ratio and Reflex to Immunofixation QST | |||||
Kappa/Lambda Lite Chains,Ser CVT | |||||
Keppra CPL | 4219014 | 80177 | 301 | 80.25 | |
Ketones CVT | |||||
Kidney Stone Eval Panel PSPC | |||||
Kidney Stone Risk Panel IP | |||||
Kidney Stone Urine/Saturation (Ref) | |||||
Kidney Stone Urine/Saturation LC | |||||
L. pneumophila Serogp 1 Ur Ag LC | |||||
LC#LC # 080283 | |||||
LD, Body Fluid LC | |||||
LDH CPL | 4200091 | 83615 | 301 | 103.5 | |
LDH Isoenzymes SV | |||||
LDH LC | |||||
LDL Cholesterol (Direct) LC | |||||
LDL Direct CPL | |||||
LKM Ab CPL | 4210461 | 86376 | 302 | 193 | |
LL Flow Cytometry | |||||
LOWER RESPIRATORY CULTURE CDR | |||||
LTT | |||||
Lacosamide CVT | |||||
Lactate Dehydrogenase | 4200091 | 83615 | 301 | 110.75 | |
Lactate Dehydrogenase Isoenzymes ALI | |||||
Lactate Dehydrogenase Total CVT | |||||
Lactic Acid CPL | |||||
Lactic Acid CVT | |||||
Lamb's Quarter IgE CPL | 4211231 | 86003 | 302 | 34.25 | |
Lamotrigine (Lamictal) CVT | |||||
Lamotrigine (Lamictal), Serum LC | |||||
Lamotrigine CPL | 4210221 | 80175 | 301 | 210 | |
Lead, Bld CVT | |||||
Lead, Blood (Pediatric) LC | |||||
Lead, Venous CPL | 4210173 | 83655 | 301 | 114.25 | |
Legionella IgG/IgM CPL | |||||
Leptin CPL | 4219013 | 82397 | 301 | 112.25 | |
Leuk/Lymp # Markers QST | |||||
Leukemia/Lymphoma Evaluation QST | |||||
Leukocyte Phenotype IP | |||||
Leutinizing Hormone CPL | 4210165 | 83002 | 301 | 40.25 | |
Levetiracetam (Keppra), S LC | |||||
Levetiracetam CVT | |||||
Lipase CPL | 4200093 | 83690 | 301 | 114.5 | |
Lipase Level | 4200093 | 83690 | 301 | 122.5 | |
Lipid Panel - Direct LDL CVT | |||||
Lipid Panel 10 | 4200069 | 80061 | 301 | 292.75 | |
Lipid Panel CPL | 4200069 | 80061 | 301 | 273.5 | |
Lipid Panel with Direct LDL if indicated | |||||
Lipid Panel, Extended 0020468 ARUP | |||||
LipoFit by NMR 2013716 ARUP | |||||
Lipoprotein (A) LC | |||||
Lipoprotein (a) CVT | |||||
Lipoprotein Electrophoresis ARUP | |||||
Lipoprotein Electrophoresis IP | |||||
Lithium (Eskalith), Serum LC | |||||
Lithium CPL | 4210455 | 80178 | 301 | 17.75 | |
Lithium CVT | |||||
Liver Fibrosis, Chronic Viral Hepatitis ALI | |||||
Liver Fibrosis, Fibro Test-ActiTest Panel AMS | |||||
Liver Fibrosis, FibroTest-ActiTest Panel, QST | |||||
Liver Kidney Microsome, IgG CVT | |||||
Lupus (SLE) Panel QST | |||||
Lupus Anticoag PRL | |||||
Lupus Anticoag Prof CDR | |||||
Lupus Anticoag Profile With reflex testing AMS | |||||
Lupus Anticoag/Cardiolipin Ab Panel PSPC | |||||
Lupus Anticoagulant | |||||
Lupus Anticoagulant Comp LC | |||||
Lupus Anticoagulant Eval w/ Reflex NLL | |||||
Lupus Anticoagulant Evaluation w/ Reflex QST | |||||
Lupus Anticoagulant Panel IHS | |||||
Lupus Anticoagulant Reflex (Ref) | |||||
Lupus Anticoagulant Reflex LC | |||||
Lupus Anticoagulant Screen, Reflex Confirmation CPL | 4219074 | 86376 | 301 | 254.75 | |
Lupus Inhibitor Screen SV | |||||
Luteinizing Hormone CVT | |||||
Luteinizing Hormone(LH), S LC | |||||
Lyme Ab Reflex IB CPL | 4219015 | 86617 | 301 | 91 | |
Lyme Ab Total w Reflex LC | |||||
Lyme Ab, Total/IgM Responses LC | |||||
Lyme Disease Ab, Total w/Refl WB (IgG, IgM) QST | |||||
Lyme Disease Ab, Western Blot, S CDR | |||||
Lyme Disease IgG Ab, Bld CVT | |||||
Lyme Disease IgG, IgM Ab QST | |||||
Lyme Disease IgG/IgM, Immunoblot CPL | 4219016 | 86618 | 301 | 53.5 | |
Lyme Total Antibody CPL | |||||
Lyme, Western Blot, Serum (Ref) | |||||
Lyme, Western Blot, Serum LC | |||||
LymeAb+Bab(IgG/M)+Ehrlic LC | |||||
Lytes Urine NAH | |||||
M tuberculosis (GeneXpert) | |||||
M. Racemosus IgE CPL | 4211237 | 86003 | 302 | 34.25 | |
MARK LE PAIN PANEL; STEVEN K CHON PAIN COMM PANEL | |||||
MENINGITIS/ENCEPHALITIS PANEL PSPC | |||||
MISC LAB CHARGE | 4920731 | XXXXX | 300 | 0 | |
MMR Measles/Mumps/Rubella Immunity SV | |||||
MONOCLONAL PROTEIN 24 HR URINE (RPS) PSPC | |||||
MONOCLONAL PROTEIN STUDY, EXP PANEL, SERUM (RPS) PSPC | |||||
MPO/PR-3 (ANCA) Antibodies IHC | |||||
MPO/PR3 (ANCA) Abs ALI | |||||
MRSA/SA Skin and Soft Tissue Infection (GeneXpert) | |||||
MS Panel PSPC | |||||
MTHFR CPL | |||||
MTHFR LC | |||||
MTHFR Mutation IP | |||||
Magnesium CPL | 4200181 | 83735 | 301 | 103.5 | |
Magnesium Level | 4200181 | 83735 | 301 | 110.75 | |
Magnesium Level 24 Hour Urine | |||||
Magnesium, RBC CVT | |||||
Magnesium, RBC LC | |||||
Magnesium, Urine LC | |||||
Malaria Exam AEL | |||||
MaleTestosterone Panel PSPC | |||||
Manual Differential 5 | 4200298 | 85007 | 300 | 57.25 | |
Maple/Box Elder IgE CPL | 4211238 | 86003 | 302 | 34.25 | |
Marshelder, Rough IgE CPL | 4211239 | 86003 | 302 | 34.25 | |
Maternal Screen, Alpha Fetoprotein ALI | |||||
Maternal Screening, Integrated 2 ALI | |||||
Maternal Screening, Sequential 2 ALI | |||||
Maternal Serum AFP CVT | |||||
Measles Only Viral Culture LC | |||||
Measles/Mumps/Rubella Immunity (Ref) | |||||
Measles/Mumps/Rubella Immunity LC | |||||
Measles/Mumps/Rubella/Varicella Zoster Immunity (RPS) PSPC | |||||
Meconium Drug Screen | |||||
Meningitis Panel | |||||
Meningitis Panel (BioFire) | |||||
Meningitis Panel Test | |||||
Mercury, Blood LC | |||||
Mesquite Tree IgE CPL | 4211240 | 86003 | 302 | 34.25 | |
Metanephrines Fract, Ur 24hr CVT | |||||
Metanephrines Fract, Ur CVT | |||||
Metanephrines Free, Pl CVT | |||||
Metanephrines Random Urine, LC | |||||
Metanephrines, 24-HR AEL | |||||
Metanephrines, Frac, Qn, 24-Hr LC | |||||
Metanephrines, Plasma CPL | 4210459 | 83835 | 301 | 115 | |
Metanephrines, Plasma IP | |||||
Metanephrines, Urine IP | |||||
Methadone Screen | 4200039 | 301 | 65 | ||
Methaqualone Scr | 4200041 | 301 | 69.5 | ||
Methaqualone Screen, Urine LC | |||||
Methylmalonic Acid & Homocysteine QST | |||||
Methylmalonic Acid, Serum CPL | 4210609 | 83921 | 300 | 70.25 | |
Methylmalonic Acid, Serum LC | |||||
Methylmalonic Acid, Ur by GCMS CVT | |||||
Microalb/Cr, Rndm Ur PSPC | |||||
Microalb/Crea Ratio CPL | 4200287 | 82044 | 300 | 55 | |
Microalb/Creat Ratio | |||||
Microalb/Creat Ratio, Randm Ur LC | |||||
Microalbumin CPL | 4210055 | 82043 | 300 | 73 | |
Microalbumin Creatinine Ratio AEL | |||||
Microalbumin Creatinine Ratio, Urine Quant Random | |||||
Microalbumin Creatinine with Ratio, Urine CDR | |||||
Microalbumin, 24 Hour LC | |||||
Microalbumin, 24 Hr Urine (w/ Creatinine) DLS | |||||
Microalbumin, Random Urine LC | |||||
Microalbumin, Ur CVT | |||||
Microalbumin, Urine w/ Creat QST | |||||
Microalbumin/Crea Ratio, Random SV | |||||
Microalbumin/Creat Level 24 Hour Urine | |||||
Microalbumin/Creat Ratio, Ur CVT | |||||
Misc Send Out | LABMISC | XXXXXX | 300 | 0 | |
Mitochondrial (M2) Antibody LC | |||||
Mitochondrial Ab, IgG CVT | |||||
Mitochondrial M2 Ab CPL | 4210381 | 83516 | 302 | 70.25 | |
Mixed Nuts Allergen Panel ALI | |||||
Mixing Studies | |||||
Mixing Study ALI | |||||
Monoclonal Protein Study, S CDR | |||||
Monoclonal Protein Study, U CDR | |||||
Mononucleosis Screen | 4200227 | 86308 | 302 | 148.75 | |
Mountain Cedar CPL | 4211242 | 86003 | 302 | 34.25 | |
Mulberry Tree IgE CPL | 4211243 | 86003 | 302 | 34.25 | |
Multiple Sclerosis Panel IHC | |||||
Multiple Sclerosis Panel IP | |||||
Multiple Sclerosis Profile AMS | |||||
Mumps Antibodies (IgG, IgM) QST | |||||
Mumps Antibodies, IgG LC | |||||
Mumps Antibodies, IgM LC | |||||
Mumps IgG CPL | |||||
Mumps Virus, IgG CVT | |||||
Myasthenia Gravis Complete Ab Profile (Ref) | |||||
Myasthenia Gravis Evaluation, Adult PSPC | |||||
Myasthenia Gravis NLL | |||||
Myasthenia Gravis Panel 3 QST | |||||
Myasthenia Gravis Panel III (Ref) | |||||
Myasthenia Gravis Panel III LC | |||||
Myasthenia Gravis Panel SV | |||||
Mycophenolic Acid and Metabo. LC | |||||
Mycoplasma Antibodies AMS | |||||
Mycoplasma Pneumoniae Abs (IgG, IgM), EIA QST | |||||
Mycoplasma Pneumoniae IgG And IgM CPL | 4210443 | 86738 | 302 | 75.25 | |
Mycoplasma pneu IgG IgM Abs (Ref) | |||||
Mycoplasma pneu IgG IgM Abs LC | |||||
Myeloperoxidase Antibody CVT | |||||
Myoglobin, Ur CVT | |||||
Myoglobin, Urine LC | |||||
Myoglobin, Urine, Quant CPL | |||||
Myomarker Panel 3 CPL | 4211246 | 83520 | 302 | 561.75 | |
Mysoline Level | |||||
N-Telo,Collagen Cross-Linked CVT | |||||
N-Telopeptide, Urine (Ref) | |||||
NASH FibroSURE NLL | |||||
NASH FibroSure LC | |||||
NBS (PRIVATE) PKU | |||||
NBS (STATE) PKU | |||||
NEUTROPHIL CYTOPLASMIC AB, IgG IHC | |||||
NGI HBV Superquant LC | |||||
NGI HCV QuantaSure LC | |||||
NMR LipoProfile LC | |||||
NMR Lipoprofile w/IR Markers LC | |||||
NW Region Allergy Panel IP | |||||
Neiss gonorrhoeae PCR CVT | |||||
Neonatal Bili | |||||
Neonatal Bilirubin NAH | |||||
Neonatal Bilirubin. | |||||
Neonatal Screen (Perkin Elmer) | |||||
Neutrophil Cytoplasmic Ab CPL | 4219022 | 86255 | 301 | 55.75 | |
Neutrophil Cytoplasmic Ab With Mpo & Pr3 CPL | |||||
Neutrophil Cytoplasmic Ab With Reflex Mpo & Pr3 CPL | |||||
Newborn Metabolic Screen OK | |||||
Newborn Screen 3 | |||||
Newborn Screen 5 | |||||
Newborn Screening Test | |||||
Nicotine & Metabolites, Serum PSPC | |||||
Nicotine Serum/Plasma, Quant CPL | 4211251 | 80323 | 301 | 107 | |
Norovirus Ag CVT | |||||
Norovirus RT-PCR (Ref) | |||||
Norovirus, EIA, Stool QST | |||||
Northeast Allergen Panel ALI | |||||
Norwalk Virus Antigen IP | |||||
Nut Mix Allergen Profile ALI | |||||
O & P Screen PSPC | |||||
O/P, Fregn Trav PSPC | |||||
OPIATES, SERUM/PLASMA QUANT (RPS) PSPC | |||||
OVA & Parasites AEL | |||||
Oak Tree IgE CPL | 4211252 | 86003 | 302 | 34.25 | |
Occult Blood | 4200273 | 82272 | 301 | 62.75 | |
Occult Blood Diagnostic | 4200185 | 82270 | 301 | 62.75 | |
Occult Blood Screen | 4200185 | 82270 | G0328 | 301 | 62.75 |
Oligoclonal Banding LC | |||||
Opiate Confirm Mec NAH | |||||
Opiate Screen | 4200043 | 301 | 69.5 | ||
Osmolality LC | |||||
Osmolality, Ser CVT | |||||
Osmolality, Serum CPL | 4210125 | 83930 | 301 | 57.25 | |
Osmolality, Ur CVT | |||||
Osmolality, Urine CPL | 4210345 | 83935 | 301 | 57.25 | |
Osmolality, Urine LC | |||||
Ova & Parasite Concentration & Identification Send Out QST | |||||
Ova & Parasites CPL | 4210343 | 87177 | 306 | 73.25 | |
Ova + Parasite Exam LC | |||||
Ova and Parasite Exam AMS | |||||
Ova and Parasites Smear CVT | |||||
Ova and Parasites with Stain NLL | |||||
Oxalate, 24 Hr Urine | |||||
Oxalate, 24-Hr Ur PSPC | |||||
Oxalix Acid, 24 Hr Urine QST | |||||
Oxcarbazepine (Trileptal), LC | |||||
Oxcarbazepine Metabolite CPL | 4219024 | 80183 | 301 | 129.25 | |
Oxcarbazepine Metabolite CVT | |||||
P. Chrysogenum IgE CPL | 4211254 | 86003 | 302 | 34.25 | |
PAIN CARE PHYSICIANS PANEL ORAL FLUID | |||||
PAIN MANAGEMENT PANEL 2 RFLX LC | |||||
PATHWAY FIR V2 1503 | |||||
PATHWAY FIT 1727 | |||||
PCP Screen | 4200045 | 301 | 69.5 | ||
PE and FLC, Serum LC | |||||
PNH-CD59 PSPC | |||||
PNT 1002836 Drug Screen 10 w/ confirmation | |||||
PNT 1011215 Chromium, Unirine | |||||
PNT 1209072 Aspergillus AB | |||||
PNT Coccidiodies Abs IGG/IGM | |||||
PNT Non-Severe Hemophilia | |||||
PSA (Free and Total) QST | |||||
PSA Diagnostic | 4200203 | 84153 | 301 | 289.5 | |
PSA Free & Total | |||||
PSA Free & Total (Serial Monitor) | |||||
PSA Free IP | |||||
PSA Free and Total IP | |||||
PSA Screen | 4200157 | G0103 | 301 | 289.5 | |
PSA T & F, Serial PSPC | |||||
PSA Total and Free, S CDR | |||||
PSA Total+% Free (Ref) | |||||
PSA Total+% Free (Serial) LC | |||||
PSA Total+% Free LC | |||||
PSA w/Reflex To Free PSA CPL | |||||
PSA, Free & Total CPL | |||||
PSA, Free and Total | |||||
PSA, Free and Total SLHS | |||||
PSA, Total CPL | 4200203 | 84153 | 301 | 270.5 | |
PT Gene Mutate PRL | |||||
PTH (Serial Monitor) | |||||
PTH Intact CVT | |||||
PTH, Intact (ICMA) w/ Ionized Calcium QST | |||||
PTH, Intact CPL | 4210429 | 83970 | 301 | 102.75 | |
PTH, Intact LC | |||||
PTH, Intact w/ Calcium QST | |||||
PTH, Intact, With Calcium, Phosphorus, Creatinine CPL | |||||
PTT+PT+APCR+AT3 Funct+D Dimer LC | |||||
Paecilomyces Variotti IgE CPL | 4211255 | 86003 | 302 | 34.25 | |
Pain Management 2 Panel PML | |||||
Pancreatic Polypeptide LC | |||||
Pancreatitis: 3-gene Panel (Ref) | |||||
Panorama Extended Panel | |||||
Pap Comprehensive, QST | |||||
Pap IG, Ct-Ng (Ref) | |||||
Pap IG, Ct-Ng TV rfx HPV all (Ref) | |||||
Pap IG, Ct-Ng TV rfx HPV all LC | |||||
Pap IG, Ct-Ng, HPV-hr (Ref) | |||||
Pap IG, Ct-Ng, HPV-hr LC | |||||
Pap IG, Ct-Ng, rfx HPV ASCU (Ref) | |||||
Pap IG, Ct-Ng, rfx HPV all (Chart) LC | |||||
Pap IG, Ct-Ng, rfx HPV all (Ref) | |||||
Pap IG, Ct-Ng, rfx HPV all LC | |||||
Pap IG, HPV, rfx 16/18 (Chart) LC | |||||
Pap IG, HPV, rfx 16/18 (Ref) | |||||
Pap IG, HPV-h+lr (Ref) | |||||
Pap IG, HPV-hr (Chart) LC | |||||
Pap IG, HPV-hr LC | |||||
Pap IG, rfx HPV ASCU (Chart) LC | |||||
Pap IG, w Mat Indx (Ref) | |||||
Pap Lb, HPV-h+lr LC | |||||
Pap Lb, HPV-hr LC | |||||
Pap Smear, 1 sld w Mat Indx (Ref) | |||||
Pap Smear, 2 Slide (Ref) | |||||
Pap Smear, 2 sld w Mat Indx (Ref) | |||||
Pap Test, Mc 1 Yr Thinprep, Imaged CPL | 4211256 | G0145 | 301 | 53.5 | |
Pap Test, Surepath CPL | |||||
Pap Test, Thinprep CPL | |||||
Pap Test, Thinprep, Imaged CPL | 4211257 | 88175 | 301 | 53.5 | |
PapIG, CtNgTvHSV rfxHPV ASCU (Ref) | |||||
Paper Wasp IgE CPL | |||||
Paraneoplastic Autoanti. Eval LC | |||||
Paraneoplastic Autoantibody Evaluation Profile PSPC | |||||
Parasite Panel | |||||
Parasitic Examination CDR | |||||
Parathyroid Hormone (Intact & CA) SV | |||||
Parathyroid Hormone With Calcium AEL | |||||
Paroxysmal Noct Hemo - RBC IP | |||||
Partial Thromboplastin Time | 4200159 | 85730 | 305 | 95 | |
Parvo B19 Antibodies SV | |||||
Parvovirus B-19 Ab (IgG) QST | |||||
Parvovirus B19 Abs IP | |||||
Parvovirus B19 IgG CPL | 4211258 | 86747 | 302 | 40.75 | |
Parvovirus B19 IgM CPL | 4211259 | 86747 | 302 | 40.75 | |
Parvovirus B19, Human, IgG/IgM (Ref) | |||||
Parvovirus B19, Human, IgG/IgM LC | |||||
Path Interp/Peripheral Smear PRL | |||||
Pathologist Smear Review CPL | 4219030 | 85060 | 301 | 92 | |
Pea IgE CPL | |||||
Peanut IgE CPL | |||||
Pecan Nut IgE CPL | |||||
Pedi Aeroallergen IgE CPL | |||||
Penicilloyl G IgE CPL | 4211261 | 86003 | 302 | 37.5 | |
Penicilloyl V IgE CPL | 4211262 | 86003 | 302 | 37.5 | |
Penta Screen QST | |||||
Phenobarbital CVT | |||||
Phenobarbital Level | 4200171 | 80184 | 301 | 217.5 | |
Phenytoin (Dilantin) CPL | 4200057 | 80185 | 301 | 194.75 | |
Phenytoin, F & T PSPC | |||||
Phos Value, Ur 24-Hr PSPC | |||||
Phosphatidylserine Antibodies (IgG, IgA, IgM) QST | |||||
Phospholipid Ab (Cardiolipin) IgG, IgM NLL | |||||
Phosphorus CPL | 4200245 | 84100 | 301 | 58.75 | |
Phosphorus Level | 4200245 | 84100 | 301 | 62.75 | |
Phosphorus Level 24 Hour Urine | |||||
Phosphorus, Random Urine LC | |||||
Phosphorus, Ur CVT | |||||
Pigweed/Careless IgE CPL | 86003 | 302 | |||
Pinworm Prep | 4200271 | 87172 | 306 | 78.5 | |
Plasma Renin Activity CVT | |||||
Platelet Antibody Profile (Ref) | |||||
Plt Circulating PRL | |||||
Pneumococcal Ab (23 Serotype) LC | |||||
Pneumococcal Ab (7 Serotype) (Ref) | |||||
Pneumococcal Antibody Titer 23 serotype | |||||
Pneumococcal IM (14 Serotype) (Ref) | |||||
Pneumococcal IM (14 Serotype) LC | |||||
Poliovirus (Types 1,3) Antibodies ARUP | |||||
Porphobilinogen, 24 Hr Urine | |||||
Porphyrin Urine Fractionated IP | |||||
Potassium CPL | 84132 | 301 | |||
Potassium Level | 4200249 | 84132 | 301 | 69.5 | |
Potassium Level 24 Hour Urine | |||||
Potassium, Random Urine CPL | 4210403 | 84133 | 301 | 17.25 | |
Potassium, Ur CVT | |||||
Prealbumin CPL | 4210349 | 84134 | 301 | 40 | |
Prealbumin CVT | |||||
Prealbumin LC | |||||
Pregnancy Test, Urine CPL | 4200193 | 84703 | 301 | 41.25 | |
Pregnenolone MS LC | |||||
Prenat Infect Dis Ab, IgM, Qn LC | |||||
Prenatal Panel MAYO | |||||
Prenatal Panel SV | |||||
Prenatal Risk Panel | |||||
Primidone (Mysoline), Serum (Ref) | |||||
Primidone (Mysoline), Serum LC | |||||
Primidone and Phenobarbital AMS | |||||
Procalcitonin CVT | |||||
Procalcitonin LC | |||||
Progesterone CPL | |||||
Progesterone CVT | |||||
Prolactin CPL | 4210517 | 84146 | 301 | 42 | |
Prolactin CVT | |||||
Prolactin LC | |||||
Prolactin, Total and Monomeric QST | |||||
Prostate Specific Ag, Free And Total IHC | |||||
Prostate-Specific Antigen (PSA) Free:Total Ratio SV | |||||
Prostrate Specfic Ag, Tot & Fr CVT | |||||
Prot Electrophoresis Ur 24 CVT | |||||
Prot Values, 24 Hr Ur PSPC | |||||
Prot+CreatU (Random) LC | |||||
Prot/Creat Ur PSPC | |||||
Prot/Creat,Spot PRL | |||||
Protein / Creatinine Ratio, Urine SV | |||||
Protein C Activity CVT | |||||
Protein C And S Activity Profile CPL | 4211264 | 85303 | 301 | 128.5 | |
Protein C Deficiency Profile LC | |||||
Protein C-Functional LC | |||||
Protein Elec + Interp, Serum (Ref) | |||||
Protein Elec + Interp, Serum LC | |||||
Protein Electro Serum LC | |||||
Protein Electro Serum w/ T.Protein NLL | |||||
Protein Electro Urine Timed w/ T.Protein NLL | |||||
Protein Electro, 24-Hour Urine (Ref) | |||||
Protein Electro, 24-Hour Urine LC | |||||
Protein Electro, Random Urine LC | |||||
Protein Electrophoresis (Serum) AEL | |||||
Protein Electrophoresis 24H Urine QST | |||||
Protein Electrophoresis 24H Urine & Immunofix QST | |||||
Protein Electrophoresis QST | |||||
Protein Electrophoresis Reflex To Immunofixation CPL | |||||
Protein Electrophoresis Urine NAH | |||||
Protein Electrophoresis Urine QST | |||||
Protein Electrophoresis and Total w/ Reflex QST | |||||
Protein Electrophoresis(Serum) SV | |||||
Protein Electrophoresis, 24 Hr Urine | |||||
Protein Electrophoresis, Ser CVT | |||||
Protein Electrophoresis, Serum AMS | |||||
Protein Electrophoresis, Ur CVT | |||||
Protein Electrophoresis, Urine SV | |||||
Protein Immunofixation (Serum) SV | |||||
Protein Level Urine | 4200296 | 84156 | 300 | 86.5 | |
Protein S Activity CVT | |||||
Protein S Ag | |||||
Protein S Deficiency Profile SV | |||||
Protein S Panel (Ref) | |||||
Protein S Panel LC | |||||
Protein S-Functional LC | |||||
Protein Total | 4200213 | 84155 | 301 | 72.75 | |
Protein Total, Qn, 24-Hr Urine LC | |||||
Protein electrophoresis, Urine AMS | |||||
Protein, 24 Hr Ur CPL | |||||
Protein, 24HR Urine | 4200001 | 84156 | 301 | 72.75 | |
Protein, Body Fluid LC | |||||
Protein, Total And Protein Electrophoresis QST | |||||
Protein, Total w/Creat, Urine QST | |||||
Protein/Crea Ratio Urine Random | |||||
Protein/Creatinine Ratio Urine | |||||
Protein/Creatinine Ratio, Ur CVT | |||||
Protein/Creatinine Ratio, Urine CPL | 4211265 | 82570 | 300 | 27.75 | |
Protein/Creatinine Ratio, Urine AMS | |||||
Protein/Creatinine, Urine | |||||
Prothrombin Gene Mutation CPL | 4211266 | 81240 | 305 | 176.5 | |
Prothrombin Gene Mutation IP | |||||
Prothrombin Time | 4200155 | 85610 | 305 | 75 | |
Prothrombin Time CPL | |||||
Prothrombin Time/ PTT | |||||
Protime And PTT CPL | 4211267 | 85610 | 305 | 29 | |
Protime/PTT | |||||
Q FEVER IGG, IGM QST | |||||
Q Fever Ab IgG, IgM | |||||
Q Fever Antibodies SV | |||||
Q Fever Antibodies, IgG and IgM NLL | |||||
Q Fever IgG/IgM Antibody Scrn LC | |||||
QUAD SCRN (2nd Tri) MATERNAL, S CDR | |||||
Quad Panel Prenatal | |||||
Quadruple Screening Test With Interpretation CPL | |||||
QuantiFERON Client Incubated LC | |||||
Quantiferon (R) TB Gold CVT | |||||
Quantiferon TB Gold CPL | 4211095 | 86480 | 302 | 107 | |
Queen Palm IgE CPL | 4211268 | 86003 | 302 | 34.25 | |
RFLX Thyroglob CPL | 4211272 | 86800 | 302 | 55.75 | |
RMSF IgG IgM LC | |||||
RNP Antibody CPL | |||||
RNP Antibody CVT | |||||
RPR (DX) w/Refl Titer and Confirm Testing QST | |||||
RPR 1 | 4200267 | 86592 | 302 | 68 | |
RPR CPL | 4200267 | 86592 | 302 | 63.5 | |
RPR Reflex To Fta-Abs CPL | |||||
RPR Reflex To MHA-TP CPL | 4211275 | 86592 | 302 | 63.5 | |
RSV By DFA CPL | 4210313 | 87280 | 306 | 53.5 | |
RTA Conc+RTA Ab LC | |||||
Rabies Neut. Abs Titrat. (RFFIT) LC | |||||
Ragweed, Common IgE CPL | 4211269 | 86003 | 302 | 34.25 | |
Ragweed, Giant IgE CPL | 4211270 | 86003 | 302 | 34.25 | |
Ragweed, Western IgE CPL | 4211271 | 86003 | 302 | 34.25 | |
Rapid Flu A & B | |||||
Rapid Plasma Reagin CVT | |||||
Rapid Plasma Reagin, Quant LC | |||||
Rapid Strep A | 4200197 | 87430 | 306 | 87.5 | |
Rapid Strep A | 86403 | 86403 | 300 | 54.25 | |
Reference Bacterial Culture ID LC | |||||
Region X IgE Panel CPL | |||||
Renal Failure Index Test | |||||
Renal Panel 1 | 4200153 | 80069 | 301 | 181 | |
Renal Panel 3 | 4200153 | 80069 | 301 | 181 | |
Renin Activity, Plasma LC | |||||
Renin CPL | 4210513 | 84244 | 301 | 87.75 | |
Respiratory Allergens Region 2 AEL | |||||
Respiratory Allergy Profile Region X: OK, TXÂ QST | |||||
Respiratory Panel 1 (BioFire) | |||||
Respiratory Panel NAH | |||||
Respiratory Pathogen Panel | |||||
Respiratory Pathogen Panel PSPC | |||||
Respiratory Virus Panel IP | |||||
Retic Count CPL | 4210363 | 85045 | 305 | 10.5 | |
Reticulin Antibody IGA IP | |||||
Reticulocyte Count LC | |||||
Reticulocyte Count, Auto. CVT | |||||
Reverse T3 LC | |||||
Rheumatoid Factor CVT | |||||
Rheumatoid Arthritis Factor LC | |||||
Rheumatoid Factor 2 | 4211090 | 86431 | 302 | 48 | |
Rheumatoid Factor CPL | 4211102 | 85431 | 302 | 44.75 | |
Rhodotorula IgE CPL | 4211273 | 86003 | 302 | 34.25 | |
Ribosomal P Antibody CVT | |||||
Rickettsia (RMSF) IgG, IgM, w/Refl to Titers QST | |||||
Rickettsia IgG & IgM CPL | 4210501 | 86757 | 302 | 374.5 | |
Rituxan Therapy Panel PSPC | |||||
Rocky MT Spotted Fever IP | |||||
Rotavirus Ag CVT | |||||
Rubella Ab CPL | |||||
Rubella Antibodies (IgG, IgM) Diagnostic QST | |||||
Rubella Antibodies, IgG LC | |||||
Rubella IgM Antibody CPL | |||||
Rubella, IgG CVT | |||||
Rubeola Antibodies, IgG LC | |||||
Rubeola IgG CPL | |||||
S. Herbarum IgE CPL | 4211276 | 86003 | 302 | 34.25 | |
S. Rostrata IgE CPL | 4211277 | 86003 | 302 | 34.25 | |
SHBG CVT | |||||
SLE Profile | |||||
SLE Profile (A) PSPC | |||||
SM and SM/RNP Antibodies QST | |||||
SPECIMEN: Blood | |||||
SPEP w/ Immunofx PSPC | |||||
SS-A/Ro Antibody CVT | |||||
SS-B/La Antibody CVT | |||||
SSA & SSB Ab CPL | 4211101 | 86235 | 306 | 57.5 | |
SSA And SSB Abs. IgG IHC | |||||
SSA/SSB CDR | |||||
STD 5 Panel QST | |||||
STD Panel - Chlam trach/ N. gonorr. Molecular ALI | |||||
STD Tri Panel - Chlam trach/ N. gonorr. and Trichomonas | |||||
Saccharomyces cerevisiae Panel (Ref) | |||||
Saccharomyces cerevisiae Panel LC | |||||
Salicylate Level | 4200207 | 80329 | 301 | 125 | |
Salivary Cortisol CPL | 4211278 | 82533 | 301 | 133.75 | |
Salmonella, Total Ab by EIA CVT | |||||
Scl-70 (Scleroderma) Antibody CVT | |||||
Scl-70 Antibody CPL | |||||
Scleroderma Autoantibodies Panel CPL | 4211279 | 83520 | 302 | 556.5 | |
Scleroderma Diag. Profile | |||||
Sedimentation Rate | 4200099 | 85652 | 305 | 86.5 | |
Sedimentation Rate CPL | 4200099 | 85652 | 305 | 80.75 | |
Selenium CPL | |||||
Selenium, Serum/Plasma LC | |||||
Sensori Motor Neuropathy Comp. LC | |||||
Sensorimotor Neuropathy Profile Complete (ATH287) NLL | |||||
Sensory Motor Neuropathy Panel PSPC | |||||
Serotonin QST | |||||
Sertraline CPL | |||||
Serum Coma Overdose Profile (Ref) | |||||
Serum Protein Electrophoresis CPL | |||||
Sex Horm Bind Globulin CPL | |||||
Sex Hormone Binding Globulin LC | |||||
Sheep Sorrel IgE CPL | 4211280 | 86003 | 302 | 34.25 | |
Shiga Toxin 1 | |||||
Shiga Toxin EIA QST | |||||
Shiga Toxin-Producing E.Coli AEL | |||||
Shigatoxin 1 | |||||
Shigatoxin Screen | |||||
Sickle Cell Prep CVT | |||||
Sirolimus (Rapamune), Blood LC | |||||
Sirolimus Level CVT | |||||
Sjogren's Ab SS-A/SS-B QST | |||||
Sjogren's Ab, Anti-SS-A/-SS-B (Ref) | |||||
Sjogren's Ab, Anti-SS-A/-SS-B LC | |||||
Sjogren's Antibodies (Anti-SS-A/Anti-SS-B) SV | |||||
Sjogren's Antibodies PSPC | |||||
Sjogren's SS-A Ab CPL | 4211281 | 86235 | 306 | 75 | |
Sjogren's SS-B Ab CPL | 4211282 | 86235 | 306 | 75 | |
Sjogrens Ab SSA SSB NAH | |||||
Sjogrens group AMS | |||||
Sjorgens Ab | |||||
Sm (Smith) Antibody CVT | |||||
Sm/RNP Antibody CVT | |||||
Smith & RNP Abs CPL | 4211091 | 86235 | 306 | 34 | |
Smooth Muscle Ab (F-Actin), Reflex IFA Titer CPL | 4219041 | 86256 | 301 | 144.5 | |
Smooth Muscle Antibody QST | |||||
Sodium Level | 4200103 | 84295 | 301 | 49 | |
Sodium Level 24 Hour Urine | |||||
Sodium, Random Urine CPL | 4210409 | 84300 | 302 | 27.5 | |
Sodium, Ur 24hr Quant CVT | |||||
Sodium, Ur CVT | |||||
Sodium, Urine LC | |||||
Soluble Liver Antigen Auto Ab CVT | |||||
Soybean IgE CPL | 86003 | 302 | |||
Spotted Fever Group Ab, IgG + IgM NLL | |||||
Spotted Fever Group IgG and IgM AMS | |||||
Sputum Culture Send QST | |||||
Sputum Culture with Gram Stain AMS | |||||
Stone Risk Diagnostic Profile SLHS | |||||
Stone Risk QST | |||||
Stool Culture (St Francis) SV | |||||
Stool Culture AEL | |||||
Stool Culture CPL | 4200199 | 87070 | 306 | 152.5 | |
Stool Culture LC | |||||
Stool Culture PRL | |||||
Stool Culture PSPC | |||||
Stool Culture with Shiga toxin AMS | |||||
Stool Culture, No Sensitivity CPL | |||||
Stool Culture, Yersinia Only LC | |||||
Strep Gp B Culture LC | |||||
Strep Pneumoniae IgG Ab-14 NLL | |||||
Streptococcus Group A Culture QST | |||||
Streptococcus Pneumoniae IgG Ab (23 Serotypes) QST | |||||
Streptococcus pneumoniae IgG Antibody (14 Serotypes) QST | |||||
SurePath Imaging Pap and C. trachomatis, N. gonorrhoeae QST | |||||
SurePath Imaging Pap and HPV DNA, C. Trachomatis, N. Gonorrhoeae QST | |||||
SurePath Imaging Pap and HPV DNA Reflex HPV 16,18 QST | |||||
SurePath Pap & C. Trachomatis & N. Gonorrhoeae QST | |||||
SurePath Pap and HPV mRNA E6/E7 reflex Genotypes 16, 18/45 QST | |||||
SureSwab (R), Vaginosis/Vaginitis Plus QST | |||||
SureSwab(R) Trichomonas Vaginalis RNA, QL, TMA QST | |||||
SureSwab, Mycoplasma/Ureaplasma Panel, PCR QST | |||||
SureSwab®, Bacterial Vaginosis DNA, Quantitative, Real-Time PCR QST | |||||
Surepath PAP and HR HPV DNA QST | |||||
Suscept Panel, Anaerobic Bacteria, MIC (Gradient) QST | |||||
Susceptibility, Gram Pos Rods LC | |||||
Swab GC/CT | |||||
Sycamore/Maple Leaf IgE CPL | 4211289 | 86003 | 302 | 34.25 | |
Synovial Fluid Analysis, Complete QST | |||||
Synovial Fluid Path Interp. PRL | |||||
Synthetic Stimulants, Quant, UA PRL | |||||
Systemic Lupus Profile A (Ref) | |||||
Systemic Lupus Profile A LC | |||||
Systemic Lupus Profile B (Ref) | |||||
T- and B-Lymphocyte/Nat Killer (Ref) | |||||
T- and B-Lymphocyte/Nat Killer LC | |||||
T-Cell Clonality (Immunodefic) IP | |||||
T-Lymphocyte Helper/Suppressor LC | |||||
T. Pallidum Total Ab CPL | 4219047 | 86780 | 301 | 62.75 | |
T3 Reverse CVT | |||||
T3 Total CPL | 4210133 | 84480 | 309 | 39.25 | |
T3 Uptake | 4200113 | 84479 | 301 | 125 | |
T3 Uptake | 4200113 | 84479 | 301 | 125 | |
T3 Uptake CPL | |||||
T3 Uptake LC | |||||
T3 Uptake. | 4200113 | 84479 | 301 | 125 | |
T3 Uptake. | 4200113 | 84479 | 301 | 125 | |
T3, Free CVT | |||||
T3, Total CVT | |||||
T3, Uptake CVT | |||||
T4 CPL | 4200175 | 84436 | 301 | 114.5 | |
T4, Total | 4200175 | 84436 | 301 | 122.5 | |
TESTOSTERONE, TOTAL, FREE & BIOAVAILABLE, AND SHBG IHC | |||||
THE INSTITUTE FOR LIFESTYLE PREVENTIVE & FAMILY MEDICINE URINE | |||||
TIBC CPL | 4211293 | 83550 | 301 | 32 | |
TIBC and Iron | |||||
TMA GREATER HOUSTON PHYSICIANS MEDICAL PANEL-URINE | |||||
TPMT and NUDT15 Genotyping AMS | |||||
TSH | 4200257 | 84443 | 301 | 280.5 | |
TSH | 4200257 | 84443 | 301 | 280.5 | |
TSH | 4200257 | 84443 | 301 | 280.5 | |
TSH + Free T4 Profile CPL | 4211298 | 84443 | 37.5 | ||
TSH CPL | 4200258 | 84443 | 301 | 262.25 | |
TSH Gen 3 | 4200258 | 84443 | 301 | 280.5 | |
TSH Gen 3 | 4200257 | 84443 | 301 | 280.5 | |
TTG IgA CPL | 4210605 | 83516 | 302 | 91 | |
Tacrolimus (FK506), Blood LC | |||||
Tacrolimus CPL | 4210597 | 80197 | 301 | 108.75 | |
Tacrolimus, (Prograf) CVT | |||||
Tay-Sachs, DNA Analysis LC | |||||
Test/Free (Q) PRL | |||||
TestT+TestF+SHBG LC | |||||
Testicular Cancer Monitor Panel LC | |||||
Testo, T & FED PSPC | |||||
Testost., Bioavailable w/SHBG LC | |||||
Testosterone Bioavailable Pan ALI | |||||
Testosterone CPL | 4211094 | 84403 | 305 | 56 | |
Testosterone Free | |||||
Testosterone Free & Total, Women/ Child ALI | |||||
Testosterone Free + Total by LC/MS/MS AEL | |||||
Testosterone Free MS/Dialysis LC | |||||
Testosterone Free Panel (Male Only) ALI | |||||
Testosterone Free and Total IP | |||||
Testosterone Free, Total, Bio QST | |||||
Testosterone, Free & Total | |||||
Testosterone, Free & Total CVT | |||||
Testosterone, Free & Weak | |||||
Testosterone, Free CPL | 4210417 | 84402 | 301 | 57.75 | |
Testosterone, Free and Total AMS | |||||
Testosterone, Free and Total NLL | |||||
Testosterone, Free and Total QST | |||||
Testosterone, Free+Total LC/MS LC | |||||
Testosterone, Free, Direct LC | |||||
Testosterone, Free/Tot Equilib LC | |||||
Testosterone, Total & Free | |||||
Testosterone, Total CVT | |||||
Testosterone, Total and Bioavailable AMS | |||||
Testosterone, Total and Bioavail SV | |||||
Testosterone, Total and Free DLS | |||||
Testosterone, Total and Free Esoterix (PED ONLY) SV | |||||
Testosterone, Total and Free and Sex Hormone Binding Globulin QST | |||||
Testosterone, Total and Free, S CDR | |||||
Testosterone,Free and Total LC | |||||
Testosterone,Free+Weakly Bound LC | |||||
Tetanus Antitoxoid IgG Ab LC | |||||
Tetanus/Diphtheria Ab LC | |||||
Thalassemia and Hemoglobinopathy Comp QST | |||||
Theophylline Level CVT | |||||
Theophylline, Serum LC | |||||
Therapeutic Phlebotomy | |||||
Throat Culture, No Sens CPL | |||||
Thrombophilia Profile NLL | |||||
Thrombophilia Screen Ii, Inherited QST | |||||
Thrombosis Panel AMS | |||||
Thrombotic Risk Assessment LC | |||||
Thrombotic Risk Profile I (Ref) | |||||
Thrombotic Risk Profile I LC | |||||
Thryoglobulin Ab CPL | 4210423 | 86800 | 302 | 114.5 | |
Thyr Peroxidase,Thryoglob Ab CVT | |||||
Thyroglob RFLX CPL | 4211272 | 86800 | 302 | 114.5 | |
Thyroglobulin - Reflex Profile SV | |||||
Thyroglobulin Antibody | |||||
Thyroglobulin Antibody LC | |||||
Thyroglobulin Antibody QST | |||||
Thyroglobulin Panel QST | |||||
Thyroglobulin Reflex Profile LC | |||||
Thyroglobulin Tumor Marker NLL | |||||
Thyroglobulin, Tumor Marker AMS | |||||
Thyroid Ab Profile AEL | |||||
Thyroid Antibodies (Ref) | |||||
Thyroid Antibodies CDR | |||||
Thyroid Antibodies LC | |||||
Thyroid Antibodies PRL | |||||
Thyroid Antibody Group (Tpo + Tg) CPL | |||||
Thyroid Autoantibodies AMS | |||||
Thyroid Autoantibodies Panel NLL | |||||
Thyroid Autoantibodies SV | |||||
Thyroid Autoantibody Group IP | |||||
Thyroid Cascade Reflex CPL | |||||
Thyroid I Profile (T3U, T4, T7) CPL | |||||
Thyroid II Profile (T3U, T4, T7, TSH) CPL | 4211292 | 84443 | 300 | 42.75 | |
Thyroid Panel | |||||
Thyroid Panel 4 | |||||
Thyroid Panel 5 | |||||
Thyroid Panel 7 | |||||
Thyroid Panel LC | |||||
Thyroid Panel With TSH (Ref) | |||||
Thyroid Perioxidase and Thyroglobulin Ab QST | |||||
Thyroid Peroxidase (TPO) Ab LC | |||||
Thyroid Peroxidase Ab CPL | 4210557 | 86376 | 302 | 36 | |
Thyroid Peroxidase Antibody CVT | |||||
Thyroid Stim Immunoglobulin LC | |||||
Thyroid Stimulating Hormone | |||||
Thyroid Stimulating Imm CPL | 4210577 | 84445 | 300 | 143 | |
Thyrotropin Receptor Ab, Serum LC | |||||
Thyrotropin Receptor AutoAb CPL | 4210579 | 83520 | 301 | 144.5 | |
Thyroxine (T4) LC | |||||
Thyroxine Free Index PSPC | |||||
Thyroxine Total | 4200175 | 84436 | 301 | 122.5 | |
Thyroxine Total | 4200175 | 84436 | 301 | 122.5 | |
Thyroxine Total | 4200175 | 84436 | 301 | 122.5 | |
Tick-Borne Ab Panel NLL | |||||
Tick-Bourne Disease Panel PCR, Bld ALI | |||||
Tissue Culture CDR | |||||
Tissue Transglutaminase Ab, IgA/IgG AMS | |||||
Tissue Transglutaminase QST | |||||
Tissue Transglutaminase, IgA CVT | |||||
Tissue Transglutaminase, IgG CVT | |||||
Tissue transglutaminase IgG QST | |||||
Tobramycin, Peak CVT | |||||
Tobramycin, Trough CVT | |||||
Topiramate (Topamax), Serum LC | |||||
Topiramate CPL | 4219045 | 80201 | 301 | 25.75 | |
Total Estrogens CPL | |||||
Total Iron Binding Capacity | 4200089 | 83550 | 301 | 122.5 | |
Total Iron Binding Capacity | |||||
Total Iron Binding Capacity. | 4200089 | 83550 | 301 | 122.5 | |
Total Protein, Body Fl CVT | |||||
Total Protein, Ur 24hr Quant CVT | |||||
Toxoplasma Ab IgM + IgG IP | |||||
Toxoplasma gondii Ab, IgG, Qn LC | |||||
Toxoplasma gondii Abs,IgG & IgM ALI | |||||
Toxoplasma gondii IgM Ab LC | |||||
Toxoplasmosis Antibodies NAH | |||||
Transferrin CPL | |||||
Transferrin LC | |||||
Transforming Growth Factor, Beta CPL | 4211295 | 83520 | 289 | ||
Treponema pallidum Ab CVT | |||||
Trichomonas Vaginalis PCR CVT | |||||
Triglycerides | 4200013 | 84478 | 301 | 72.75 | |
Triiodothyronine (T3) LC | |||||
Troponin I | 4200095 | 84484 | 301 | 229 | |
Troponin I CPL | |||||
Troponin T CPL | 84484 | 301 | |||
Trypanosoma Cruzi IgG CPL | 4219048 | 86753 | 301 | 133.75 | |
Tryptase CPL | |||||
Tularemia Ab CPL | 4211299 | 86668 | 139 | ||
Tularemia Agglutinins Abs SV | |||||
Type And Screen SV | |||||
Type and Scr | |||||
U Concentrated IP | |||||
U Methadone Scr | 4200033 | 301 | 69.5 | ||
U Methaqualone Scrn | 4200041 | 301 | 69.5 | ||
U Micro/Creat | |||||
U Total Protein QST | |||||
U24 17 Ketosteroids PSPC | |||||
U24 Catecholamines PSPC | |||||
U24 Cortisol, Free PSPC | |||||
UREAPLASMA PCR PSPC | |||||
Ultrasensitive PSA CPL | |||||
Ultrasensitive TSH CPL | 4211300 | 84443 | 301 | 165.75 | |
Upper Resp IgE CPL | |||||
Ur Creatinine | 4200065 | 82570 | 301 | 86.5 | |
Ur Creatinine, Random CPL | |||||
Ur GC, Amplified CPL | |||||
Ur Protein, Random CPL | 4200296 | 84156 | 300 | 80.75 | |
Ureaplasma/Mycoplasma hominis LC | |||||
Uric A+ANA+RA Qn+CRP+ASO LC | |||||
Uric A+ESR-Wes+ANA+RA Qn+CR... (Ref) | |||||
Uric Acid | 4200123 | 84550 | 301 | 81.75 | |
Uric Acid 24 Hour Urine | |||||
Uric Acid CPL | 4200123 | 84550 | 301 | 76.5 | |
Uric Acid Level Urine | |||||
Uric Acid Value, 24 Hr Ur PSPC | |||||
Uric Acid, 24 hr Urine LC | |||||
Uric Acid, Synovial Fluid CVT | |||||
Uric Acid, Ur CVT | |||||
Urinalysis (Culture If Indicated) CPL | 4200123 | 81001 | 307 | 68 | |
Urinalysis 4 | 4200053 | 81001 | 307 | 72.75 | |
Urinalysis CPL | 4200123 | 81001 | 307 | 68 | |
Urinalysis With Microscopic CPL | 4200123 | 81001 | 307 | 68 | |
Urine Amphetamine Screen | 4200027 | 301 | 69.5 | ||
Urine Barbiturate Screen | 4200033 | 301 | 69.5 | ||
Urine Benzodiazepine Screen | 4200035 | 301 | 69.5 | ||
Urine Cocaine Screen | 4200037 | 301 | 69.5 | ||
Urine Dianon Panel | |||||
Urine Drug Screen - Employee | |||||
Urine Drug Screen 10 | 4200407 | 80307 | 301 | 694.75 | |
Urine Drug Screen 10 BCE | 4200027 | 301 | 69.5 | ||
Urine Drug Screen 13 | 4202398 | 301 | 98.25 | ||
Urine Drug Screen Panel 10 | 80301 | 301 | 98.25 | ||
Urine Drug Screen Standard | |||||
Urine Drug Screen W/Rfx Confirmation AEL | |||||
Urine Electrolytes | |||||
Urine MicroAlbumin 4 | 4200287 | 82044 | 300 | 58.75 | |
Urine Opiate Screen | 4200043 | 301 | 69.5 | ||
Urine PCP Screen | 4200045 | 301 | 69.5 | ||
Urine Propoxyphene Screen | 4200047 | 301 | 69.5 | ||
Urine Propoxyphene Screen | 4200047 | 301 | 69.5 | ||
Urine Protein Electrophoresis CPL | |||||
Urine Protein Electrophoresis Ran/24 HR (RPS) PSPC | |||||
Urine THC Screen | 4200049 | 301 | 69.5 | ||
Urine THC Screen | 4200049 | 301 | 69.5 | ||
Urine, GC Chlamydia | |||||
VAP CHOLESTEROL PSPC | |||||
VAP Cholesterol Profile LC | |||||
VAP Cholesterol Test CPL | |||||
VDRL, Serum With Reflex Titer CPL | 86592 | ||||
VMA, 24 Hr Urine | |||||
VMA, Random Urine (Ref) | |||||
VMA, Ur 24hr CVT | |||||
VON WILLEBRAND PANEL IHC | |||||
VZV Real Time PCR LC | |||||
Vag Patho D Probe PSPC | |||||
Vaginitis Panel | |||||
Vaginitis Panel QST | |||||
Vaginitis Panel, DNA Direct Probe DLS | |||||
Vaginitis Screen Reproductive Age ALI | |||||
Vaginitis Scrn Prepub./Postmeno. ALI | |||||
Vaginitis/Vaginosis, DNA Probe LC | |||||
Valproic Acid (Depakote) LC | |||||
Valproic Acid Level | 4200241 | 80164 | 301 | 285 | |
Valproic Acid, (Depakene) CVT | |||||
Valproic Acid, Free And Total CPL | 4219050 | 80164 | 301 | 273.75 | |
Vancomycin Lvl Peak | 4200243 | 80202 | 301 | 248 | |
Vancomycin Lvl Trough | 4200243 | 80202 | 301 | 248 | |
Vancomycin, Peak CVT | |||||
Vancomycin, Trough CVT | |||||
Varicella Zoster Abs, IgG/IgM LC | |||||
Varicella Zoster Antibodies IP | |||||
Varicella Zoster IgG CPL | |||||
Varicella Zoster IgG/IgM CPL | 4219052 | 86787 | 301 | 34.25 | |
Varicella Zoster Virus Abs QST | |||||
Varicella Zoster-IgG And IgM Antibodies SV | |||||
Varicella-Zoster Ab, IgG CVT | |||||
Varicella-Zoster Ab, IgM EIA CVT | |||||
Varicella-Zoster IgM Ab LC | |||||
Varicella-Zoster V Ab, IgG LC | |||||
Venous Thrombosis Profile LC | |||||
Viral Culture,Rapid,Lesion LC | |||||
Viscosity, Serum LC | |||||
Vit B12 & Folate PSPC | |||||
Vit B12 CPL | 4200201 | 82607 | 301 | 169.25 | |
Vit D,1,25-Dihydroxy CPL | 4219056 | 82652 | 305 | 102 | |
Vitamin A (Retinol) CVT | |||||
Vitamin A and E LC | |||||
Vitamin A, Serum LC | |||||
Vitamin B 12 & Folic Acid CPL | 4211307 | 82607 | 301 | 55.75 | |
Vitamin B-12 & Folate | |||||
Vitamin B-12 & Folate Level | |||||
Vitamin B1 (Thiamine) Whl Blood LC | |||||
Vitamin B1 CPL | 4210419 | 84425 | 302 | 508.5 | |
Vitamin B1 Thiamine, Bld CVT | |||||
Vitamin B12 / Folate DLS | |||||
Vitamin B12 Level | 4200201 | 82607 | 301 | 181 | |
Vitamin B12 Level CVT | |||||
Vitamin B12 and Folate LC | |||||
Vitamin B12/Folate Panel | |||||
Vitamin B6 CPL | |||||
Vitamin B6 LC | |||||
Vitamin B6, Plasma CVT | |||||
Vitamin D 25 Hydroxy Level | 4210527 | 82306 | 301 | 109.25 | |
Vitamin D Total 25-Hydroxy CVT | |||||
Vitamin D, 25 Hydroxy & 1,25 Dihydroxy QST | |||||
Vitamin D, 25 OH CPL | 4210527 | 82306 | 301 | 102 | |
Vitamin D,1,25-Dihydroxy CVT | |||||
Vitamin E (Tocopherol) CVT | |||||
Vitamin K CVT | |||||
Von Willebrand Factor Panel PSPC | |||||
Von Willebrand Panel IP | |||||
Von Willebrand Profile AMS | |||||
Vonwillebrand Factor Profile SV | |||||
Waterhemp, Western IgE CPL | 4211308 | 86003 | 302 | 34.25 | |
West Nile AB, IgM & IgG PSPC | |||||
West Nile Ab, IgM/IgG AEL | |||||
West Nile IgG and IgM NLL | |||||
West Nile Virus AB Panel, Serum ALI | |||||
West Nile Virus AB, IgG + IgM NLL | |||||
West Nile Virus Ab IgG & IgM | |||||
West Nile Virus Ab Panel, Serum SV | |||||
West Nile Virus Ab, IgG and IgM, S CDR | |||||
West Nile Virus Ab, IgG,M CVT | |||||
West Nile Virus Antibodies QST | |||||
West Nile Virus Antibody IgG and IgM, Serum AMS | |||||
West Nile Virus Antibody, CSF LC | |||||
West Nile Virus CPL | |||||
West Nile Virus LC | |||||
Wet Prep 7 | 4200125 | 87210 | 306 | 101.75 | |
Wheat IgE CPL | 4211309 | 86003 | 302 | 34.25 | |
White Ash IgE CPL | 4211310 | 86003 | 302 | 34.25 | |
White Blood Count | |||||
White-Faced Hornet IgE CPL | |||||
Willow IgE CPL | 4211311 | 86003 | 302 | 34.25 | |
Women's Health Panel | |||||
Wormwood/Sagebrush IgE CPL | 4211312 | 86003 | 302 | 34.25 | |
Wound Culture (Aerobic and Anaerobic) AMS | |||||
Wound Culture PSPC | |||||
Wound Culture Send Out QST | |||||
Wound Source PSPC | |||||
YERSINIA ENTEROCOLITICA AB (IGG,IGA) | |||||
YTURRI ROCKDALE PAIN MGMT PANEL-URINE | |||||
Yellow Dock Weed IgE CPL | 4211313 | 86003 | 302 | 34.25 | |
Yellow Hornet IgE CPL | |||||
Yellow Jacket IgE CPL | |||||
Zika Viru NAA | |||||
Zika Virus Comp Profile NAA (REF) | |||||
Zinc CPL | 4219059 | 84630 | 301 | 124.25 | |
Zinc, Pl CVT | |||||
Zinc, Plasma or Serum LC | |||||
Zinc, RBC CPL | |||||
Zonisamide CPL | 4211315 | 80203 | 80.25 | ||
Zonisamide CVT | |||||
dsDNA Ab with Reflex IgG NAH | |||||
hCG Qualitative, Serum | 4200193 | 84703 | 301 | 113 | |
hCG Qualitative, Urine | 4200193 | 84703 | 301 | 113 | |
hCG Quantitative | 4200165 | 84702 | 301 | 217.25 | |
informaSeq(R) with XY Analysis LC | |||||
pH, Fluid CVT | |||||
pH, Urine CVT | |||||
t-Transglutaminase (tTG) IgA LC | |||||
t-Transglutaminase (tTG) IgG LC | |||||
von Willebrand Comprehensive Panel 2 QST | |||||
von Willebrand Factor Profile (Ref) | |||||
von Willebrand Factor Profile LC | |||||
zzC CSF | |||||
zzGram Stain - Anaerobic Send Out | |||||
BILL THD Base Denton | |||||
BILL THD Custom Female Panel Denton | |||||
BILL THD Custom Male Panel Denton | |||||
BILL THD Follow Up Denton | |||||
Bill BRCA True (1829) | |||||
Bill BRCA True Ashkenazi Jewish (1839) | |||||
Bill BRCA True with Reflex Breast True High Risk Panel (1855-2) | |||||
Bill Breast True High Risk Panel (1849) | |||||
Bill Cardiac DNA Insight (1710) | |||||
Bill Colo True (1942) | |||||
Bill Healthy Weight (1534) | |||||
Bill Lynch True (1430) | |||||
Bill THD Brown | |||||
Bill THD Evans | |||||
Bill THD Follow-up | |||||
Bill THD Gerstenberg | |||||
Bill THD Montgomery | |||||
Bill THD Panel 10 Genetics Baseline | |||||
Bill THD Panel 11 Male Baseline | |||||
Bill THD Panel 12 Female Baseline | |||||
Bill THD Panel 13 Rheum Baseline | |||||
Bill THD Panel 14 Baseline | |||||
Bill THD Panel 15 Follow-Up | |||||
Bill THD Panel 16 Special | |||||
Bill THD Panel 17 Baseline | |||||
Bill THD Panel 18 Cardiac | |||||
Bill THD Panel 18 Genetics | |||||
Bill THD Panel 19 Baseline | |||||
Bill THD Panel 20 ISM Thyroid | |||||
Bill THD Panel 21 Baseline | |||||
Bill THD Panel 22 Follow-Up | |||||
Bill THD Panel 23 Male | |||||
Bill THD Panel 24 Custom | |||||
Bill THD Panel 25 Anemia | |||||
Bill THD Panel 26 Female + Prolactin | |||||
Bill THD Panel 27 Baseline | |||||
Bill THD Panel 28 Follow-Up | |||||
Bill THD Panel 29 Thyroid Panel | |||||
Bill THD Panel 30 Wellness | |||||
Bill THD Panel 31 Custom Baseline | |||||
Bill THD Panel 32 Female Hormone Assessment | |||||
Bill THD Panel 33 Male Hormone Assessment | |||||
Bill THD Panel 34 Rheum-Autoimmune | |||||
Bill THD Panel 35 Custom Male Hormone Panel | |||||
Bill THD Panel 36 Custom Female Hormone Panel | |||||
Bill THD Panel 38 Baseline Assessment | |||||
Bill THD Panel 39 Male Hormone Panel | |||||
Bill THD Panel 4 Baseline | |||||
Bill THD Panel 4 Follow-Up | |||||
Bill THD Panel 5 Baseline | |||||
Bill THD Panel 5 Follow-Up | |||||
Bill THD Panel 6 Baseline | |||||
Bill THD Panel 6 Baseline Follow-Up | |||||
Bill THD Panel 7 Baseline | |||||
Bill THD Panel 75 Shavano | |||||
Bill THD Panel 8 Baseline | |||||
Bill THD Panel 8 Baseline Lite | |||||
Bill THD Panel 8 Baseline Screen | |||||
Bill THD Panel 9 Cardiac Baseline | |||||
Bill THD Reddy | |||||
LYNCHSYNDROME TRUE 1429 | |||||
MENTAL HEALTH 1467 | |||||
PAIN MEDICATION 1273 | |||||
96375 IV INJ EA ADD NEW DRUG | 3100023 | 96375 | 260 | 282.5 | |
96376 IV INJ EA ADD SAME DRUG | 3100035 | 96376 | 260 | 282.5 | |
96401 CHEMO ADM IM NON HORMONAL CHARGE | 3350005 | 96401 | 331 | 68 | |
96413 CHEMO IV INFUSION 1 HR | 3350011 | 96413 | 335 | 642.5 | |
96415 CHEMO ADM IV EA ADD HR CHARGE | 3350009 | 96415 | 335 | 507.5 | |
(VFC) IZ administration by intranasal or oral route ea add'l vaccine | |||||
2016 Code Deleted | 90669 | ||||
90471 ADMN INFLUENZA VACCINE CHARGE | 3350003 | 90471 | G0008 | 771 | 27.5 |
90471 ADMN PNEUMOCOCCAL VAC CHARGE | 3350001 | 90471 | G0009 | 771 | 68 |
90471 IMMUNIZATION ADMINISTRATION | 3350015 | 90471 | 761 | 45.5 | |
90633 THS Hep A Pedi/Adolescent | 4920727 | 90633 | |||
90648 THS Hib PRP-T Conjugate | 4920717 | 90648 | |||
90658 THS Flu Vaccine 3Yrs & > | 4920957 | 90658 | |||
90669 THS Prevnar 7 Valent |